Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
interferon-gamma-mediated signaling pathway (GO:0060333),9/68,2.9338022881203492e-8,4.341368154928028e-5,0,0,15.439634941329857,267.79091791693946,CIITA;IRF1;HLA-DPB1;HLA-DRA;HLA-DQA1;HLA-DRB1;HLA-DPA1;HLA-E;HLA-DQB1
regulation of apoptotic process (GO:0042981),26/742,4.2375482234534194e-8,4.341368154928028e-5,0,0,3.892411022534681,66.08027821291027,TOP2A;TFRC;FLT3;LEF1;HMGB1;SOCS2;PRDX2;TCL1A;UBB;PMAIP1;NCKAP1L;SOX4;SNCA;CD74;BNIP3L;XBP1;JUN;ARHGEF12;HSPA5;ADAM10;HNRNPK;CAT;CTNNB1;PTMA;PPIA;ARHGEF6
negative regulation of programmed cell death (GO:0043069),17/381,4.085961948298471e-7,2.370481893947291e-4,0,0,4.853146853146853,71.39240347071416,CD74;BNIP3L;XBP1;TFRC;HSPA5;LEF1;ADAM10;SOCS2;PRDX2;TCL1A;HNRNPK;UBB;CAT;CTNNB1;NCKAP1L;PTMA;SNCA
cellular response to interferon-gamma (GO:0071346),10/121,4.6275878847189677e-7,2.370481893947291e-4,0,0,9.141357852698059,133.33639315045662,CIITA;IRF1;HLA-DPB1;HLA-DRA;HLA-DQA1;HLA-DRB1;GBP4;HLA-E;HLA-DPA1;HLA-DQB1
"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",4/8,7.125088534121116e-7,2.919739380689498e-4,0,0,98.96,1400.7266974649235,MYB;HLA-DRA;NCKAP1L;HLA-DRB1
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),9/100,8.549749284595894e-7,2.919739380689498e-4,0,0,9.994082840236686,139.63926121646787,CD74;CANX;MARCHF8;HLA-DPB1;HLA-DRA;HLA-DQA1;HLA-DRB1;HLA-DPA1;HLA-DQB1
antigen processing and presentation of exogenous peptide antigen (GO:0002478),9/103,1.0987025685467398e-6,3.2160593756460997e-4,0,0,9.673649754500818,132.73582966086232,CD74;CANX;HLA-DPB1;HLA-DRA;HLA-DQA1;HLA-DRB1;HLA-E;HLA-DPA1;HLA-DQB1
"negative regulation of transcription, DNA-templated (GO:0045892)",27/948,1.3927244227148665e-6,3.5671154276784516e-4,0,0,3.1262076961298515,42.15456210250269,CIITA;SET;UHRF1;UBE2D3;LEF1;HMGB2;HNRNPU;ENO1;HMGB1;MACROH2A1;UBB;IFI16;MYB;NRIP1;SNCA;JUN;CBX5;PARP1;XRCC5;NONO;H1-0;ZEB2;IFI27;IRF1;MDM2;CTNNB1;HDGF
hydrogen peroxide catabolic process (GO:0042744),5/21,1.8728042340938976e-6,4.263750972953773e-4,0,0,31.061557788944725,409.6421121129661,PRDX2;PRDX1;CAT;HBA1;HBD
regulation of translation (GO:0006417),11/178,2.2362994923238312e-6,4.4565241108173364e-4,0,0,6.699109552914895,87.16002474328269,EIF4A2;RBM3;DDX6;EIF5;DHX9;NCL;YBX1;SOX4;GSPT1;EIF4B;EIF1
cellular response to cytokine stimulus (GO:0071345),18/482,2.392681366618501e-6,4.4565241108173364e-4,0,0,4.031979977753059,52.186303559956386,XBP1;MME;DHX9;FLT3;DOCK8;LEF1;HNRNPU;YBX3;RHOA;SOCS2;TCL1A;UBB;IFI16;WNK1;IRF1;RBMX;GBP4;HLA-DPA1
negative regulation of apoptotic process (GO:0043066),18/485,2.6099701966719393e-6,4.4565241108173364e-4,0,0,4.0054569316847415,51.49484227337561,CD74;BNIP3L;XBP1;SET;TFRC;HSPA5;LEF1;ADAM10;SOCS2;PRDX2;TCL1A;HNRNPK;UBB;CAT;CTNNB1;NCKAP1L;PTMA;SNCA
neutrophil mediated immunity (GO:0002446),18/488,2.844958661335486e-6,4.484092536212624e-4,0,0,3.9792724776938915,50.81515841047754,CD53;KMT2E;MME;XRCC5;TUBB;ADAM10;IQGAP1;HMGB1;RHOA;EEF1A1;PKM;FTH1;CAT;STOM;NCKAP1L;SPTAN1;PPIA;FTL
positive regulation of T cell differentiation (GO:0045582),6/43,4.657051014462932e-6,6.467516189141751e-4,0,0,16.182637182637183,198.6763103288992,XBP1;LEF1;HLA-DRA;NCKAP1L;SOX4;HLA-DRB1
"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",4/12,4.8794904309467675e-6,6.467516189141751e-4,0,0,49.47,605.0413391973427,HLA-DRA;NCKAP1L;HMGB1;HLA-DRB1
mRNA stabilization (GO:0048255),6/44,5.346849424105763e-6,6.467516189141751e-4,0,0,15.75598086124402,191.26189993855513,DHX9;HNRNPU;YBX1;PABPC1;YBX3;TENT5C
nucleosome organization (GO:0034728),8/94,5.365923631791594e-6,6.467516189141751e-4,0,0,9.35453251067869,113.52138707528233,SET;NASP;H2BC21;H2BC11;HMGB2;NAP1L1;MACROH2A1;H1-0
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),8/98,7.326500011752737e-6,8.339999180045199e-4,0,0,8.936961451247166,105.67074520084813,CD74;CANX;HLA-DPB1;HLA-DRA;HLA-DQA1;HLA-DRB1;HLA-DPA1;HLA-DQB1
neutrophil degranulation (GO:0043312),17/481,9.495468664820392e-6,8.665435136584089e-4,0,0,3.7876175548589344,43.802645040035,CD53;MME;XRCC5;TUBB;ADAM10;IQGAP1;HMGB1;RHOA;EEF1A1;PKM;FTH1;CAT;STOM;NCKAP1L;SPTAN1;PPIA;FTL
hydrogen peroxide metabolic process (GO:0042743),5/29,1.0227929260062039e-5,8.665435136584089e-4,0,0,20.69932998324958,237.843341476322,PRDX2;PRDX1;CAT;HBD;HBA1
regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),3/5,1.0300398023557763e-5,8.665435136584089e-4,0,0,147.71641791044777,1696.2760808658522,DHX9;UHRF1;HNRNPU
CRD-mediated mRNA stabilization (GO:0070934),3/5,1.0300398023557763e-5,8.665435136584089e-4,0,0,147.71641791044777,1696.2760808658522,DHX9;HNRNPU;YBX1
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),3/5,1.0300398023557763e-5,8.665435136584089e-4,0,0,147.71641791044777,1696.2760808658522,DHX9;UHRF1;HNRNPU
positive regulation of gamma-delta T cell activation (GO:0046645),3/5,1.0300398023557763e-5,8.665435136584089e-4,0,0,147.71641791044777,1696.2760808658522,LEF1;NCKAP1L;SOX4
neutrophil activation involved in immune response (GO:0002283),17/485,1.0572761269624316e-5,8.665435136584089e-4,0,0,3.7544677544677545,43.015798922468875,CD53;MME;XRCC5;TUBB;ADAM10;IQGAP1;HMGB1;RHOA;EEF1A1;PKM;FTH1;CAT;STOM;NCKAP1L;SPTAN1;PPIA;FTL
positive regulation of immune response (GO:0050778),7/75,1.1436469919781353e-5,9.012818025243074e-4,0,0,10.308748880262765,117.30019380047374,CD74;XBP1;DHX9;RIOK3;MYB;HLA-DRA;HLA-DRB1
positive regulation by host of viral transcription (GO:0043923),4/16,1.737521160277515e-5,0.0013185855027439363,0,0,32.973333333333336,361.4030985113359,JUN;LEF1;NUCKS1;CHD1
regulation of T-helper cell differentiation (GO:0045622),3/6,2.0445785524375437e-5,0.0014961933764087597,0,0,98.4726368159204,1063.2813173017134,MYB;HLA-DRA;HLA-DRB1
negative regulation of transcription by RNA polymerase II (GO:0000122),20/684,2.46213735748713e-5,0.0017396273949969413,0,0,3.1318753273965427,33.235134156082125,JUN;CIITA;CBX5;PARP1;UHRF1;UBE2D3;HNRNPU;ENO1;HMGB1;H1-0;MACROH2A1;ZEB2;IFI27;UBB;IFI16;MYB;NRIP1;MDM2;HDGF;SNCA
nucleosome assembly (GO:0006334),6/58,2.7230046183399314e-5,0.0018598121543261731,0,0,11.505827505827506,120.93993390355047,NASP;H2BC21;H2BC11;HMGB2;NAP1L1;MACROH2A1
positive regulation of cytoplasmic translation (GO:2000767),3/7,3.55109625278213e-5,0.0023131899050711285,0,0,73.85074626865672,756.6503094667596,PKM;DHX9;YBX3
cytoplasmic translational initiation (GO:0002183),4/19,3.612595264142319e-5,0.0023131899050711285,0,0,26.374666666666666,269.77325271150914,EIF4A2;EIF2S3;EIF5;EIF4B
"regulation of mRNA splicing, via spliceosome (GO:0048024)",7/90,3.784441388149812e-5,0.0023497940619148375,0,0,8.439300348602531,85.92918548464118,RBM3;HNRNPK;NCL;HNRNPU;HNRNPA1;MBNL3;RBMX
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),17/547,4.853907490409933e-5,0.002925193072897045,0,0,3.304631217838765,32.82536921541772,DDX6;JUN;CIITA;SET;CBX5;XRCC5;NONO;LEF1;HMGB2;ENO1;YBX1;IFI16;NCL;IRF1;MYB;MDM2;CTNNB1
positive regulation of transcription by RNA polymerase II (GO:0045944),23/908,5.6289378984670777e-5,0.0032095455674071532,0,0,2.7153166651059712,26.569386305548417,RNF10;XBP1;JUN;CIITA;PARP1;DHX9;UHRF1;LEF1;HMGB2;HNRNPU;HMGB1;YBX1;ZEB2;UBB;IFI16;IRF1;MYB;NRIP1;CTNNB1;ERG;SSBP2;RBMX;SOX4
positive regulation of isomerase activity (GO:0010912),3/8,5.639025887098952e-5,0.0032095455674071532,0,0,59.07761194029851,577.9689278673463,DHX9;UHRF1;HNRNPU
cytokine-mediated signaling pathway (GO:0019221),18/621,7.116142074485095e-5,0.0038792174005672355,0,0,3.0802439415824105,29.418053746646113,CIITA;FLT3;ADIPOR1;HLA-E;SOCS2;CA1;IFI27;UBB;HNRNPDL;IRF1;CANX;HLA-DPB1;HLA-DRA;PPIA;HLA-DQA1;HLA-DRB1;HLA-DPA1;HLA-DQB1
"positive regulation of transcription, DNA-templated (GO:0045893)",27/1183,7.36680390608381e-5,0.0038792174005672355,0,0,2.459679784176881,23.406168973092317,KMT2E;RNF10;CIITA;DHX9;UHRF1;LEF1;HMGB2;HNRNPU;HMGB1;YBX1;UBB;IFI16;MYB;NRIP1;SOX4;CD74;XBP1;JUN;PARP1;H1-0;ZEB2;IRF1;CTNNB1;ERG;SSBP2;RBMX;HLA-DRB1
cellular response to glucose starvation (GO:0042149),5/43,7.383576311474972e-5,0.0038792174005672355,0,0,13.06400423168474,124.2865905020657,XBP1;IFI16;HSPA5;PMAIP1;HNRNPA1
DNA topological change (GO:0006265),3/9,8.394952177440964e-5,0.004095537383708699,0,0,49.22885572139303,462.02732710765895,TOP2A;HMGB2;HMGB1
regulation of PERK-mediated unfolded protein response (GO:1903897),3/9,8.394952177440964e-5,0.004095537383708699,0,0,49.22885572139303,462.02732710765895,PPP1R15A;PPP1R15B;HSPA5
T-helper 1 type immune response (GO:0042088),3/9,8.394952177440964e-5,0.004095537383708699,0,0,49.22885572139303,462.02732710765895,LEF1;HMGB1;HLA-DRB1
negative regulation of nucleic acid-templated transcription (GO:1903507),15/464,8.821691820530508e-5,0.004203638730294654,0,0,3.419768798387952,31.925975913983603,EIF4A2;JUN;CIITA;SET;CBX5;XRCC5;NONO;LEF1;HMGB2;ENO1;IFI16;IRF1;MYB;MDM2;CTNNB1
apoptotic nuclear changes (GO:0030262),4/24,9.5159746559803e-5,0.004431416379569009,0,0,19.776,183.12484112475292,TOP2A;HMGB2;HMGB1;H1-0
chromatin assembly (GO:0031497),6/73,1.0088878449665958e-4,0.0045688081237957945,0,0,8.92311171415649,82.10593919177452,H2BC21;H2BC11;HMGB2;NAP1L1;MACROH2A1;H1-0
regulation of fibroblast proliferation (GO:0048145),5/46,1.0256963089048636e-4,0.0045688081237957945,0,0,12.10626302242922,111.1956465023294,CD74;CDK6;DHX9;FTH1;CTNNB1
chromosome organization (GO:0051276),7/106,1.076130612072481e-4,0.0046016169598384685,0,0,7.069630313285136,64.59498969771658,MSH6;TOP2A;UBB;PARP1;HMGB2;NUCKS1;HMGN2
protein-DNA complex assembly (GO:0065004),8/143,1.1194279057620942e-4,0.0046016169598384685,0,0,5.944368858654573,54.079030127065494,UBB;MCM7;PARP1;H2BC21;H2BC11;HMGB2;NAP1L1;MACROH2A1
positive regulation of T cell migration (GO:2000406),4/25,1.1238455887210676e-4,0.0046016169598384685,0,0,18.833333333333332,171.26249878954266,WNK1;DOCK8;ADAM10;RHOA
regulation of DNA binding (GO:0051101),5/47,1.1383645786251716e-4,0.0046016169598384685,0,0,11.817420435510888,107.31101367271955,JUN;IFI16;LEF1;HMGB2;HMGB1
positive regulation of lymphocyte proliferation (GO:0050671),6/75,1.1734032414920966e-4,0.0046016169598384685,0,0,8.663592446201141,78.4092551070385,CD74;TFRC;HLA-DPB1;NCKAP1L;HLA-DPA1;HLA-E
positive regulation of T cell activation (GO:0050870),6/75,1.1734032414920966e-4,0.0046016169598384685,0,0,8.663592446201141,78.4092551070385,XBP1;TFRC;DOCK8;HLA-DPB1;NCKAP1L;HLA-DPA1
formation of translation preinitiation complex (GO:0001731),3/10,1.1902669539845721e-4,0.0046016169598384685,0,0,42.19402985074627,381.27212118656706,EIF2S3;EIF5;EIF4B
antigen receptor-mediated signaling pathway (GO:0050851),9/185,1.226042372812031e-4,0.004652149670170095,0,0,5.145104895104895,46.339639210129135,PRKCB;WNK1;HLA-DPB1;HLA-DRA;NCKAP1L;HLA-DQA1;HLA-DRB1;HLA-DPA1;HLA-DQB1
regulation of mRNA stability (GO:0043488),8/146,1.29317954469563e-4,0.004799333295207947,0,0,5.8142561372375035,52.05640981951842,SET;XPO1;UBB;HNRNPU;YBX1;PABPC1;TENT5C;DCP2
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),4/26,1.3176225137361596e-4,0.004799333295207947,0,0,17.976363636363637,160.6100255756175,PARP1;HNRNPU;HNRNPA1;DCP2
DNA metabolic process (GO:0006259),11/277,1.3544523083150218e-4,0.004799333295207947,0,0,4.184619580038178,37.27216891242658,TOP2A;MSH6;PCNA;PARP1;UBB;MCM7;XRCC5;UHRF1;HMGB2;DNTT;HMGB1
positive regulation of type I interferon production (GO:0032481),6/77,1.3585228458860951e-4,0.004799333295207947,0,0,8.418693982074263,74.95956634372568,IFI16;DHX9;RIOK3;XRCC5;IRF1;CTNNB1
response to cytokine (GO:0034097),8/150,1.5589321894813758e-4,0.005413986536012439,0,0,5.64932451853981,49.52389542674897,CD74;CIITA;MME;FLT3;LEF1;ADAM10;RHOA;SNCA
positive regulation of cytokine production (GO:0001819),12/335,1.7730852194744974e-4,0.0060122749566119,0,0,3.7679953560371517,32.54650933768495,CD74;XBP1;TMED10;IFI16;DHX9;XRCC5;IRF1;HLA-DPB1;CTNNB1;HMGB1;HLA-E;HLA-DPA1
positive regulation of programmed cell death (GO:0043068),11/286,1.7898915195379496e-4,0.0060122749566119,0,0,4.04580310880829,34.90793914303118,TOP2A;BNIP3L;JUN;ARHGEF12;UBB;CTNNB1;PMAIP1;HMGB1;SOX4;ARHGEF6;SNCA
regulation of telomere maintenance via telomerase (GO:0032210),5/52,1.8507787959845718e-4,0.00611652540801998,0,0,10.557575109590505,90.73954817535504,XRCC5;HNRNPU;CTNNB1;HNRNPA1;DCP2
IRE1-mediated unfolded protein response (GO:0036498),5/53,2.0267855741993272e-4,0.006543363950008607,0,0,10.337102177554438,87.90557254806906,XBP1;HSPA5;EDEM1;HDGF;PDIA6
negative regulation of mRNA catabolic process (GO:1902373),4/29,2.043803283555641e-4,0.006543363950008607,0,0,15.8168,134.37206640345076,HNRNPU;YBX1;PABPC1;TENT5C
regulation of transcription by RNA polymerase II (GO:0006357),40/2206,2.115890358121976e-4,0.006669937451987583,0,0,1.9852262234533702,16.79673042581083,RNF10;CIITA;DHX9;UHRF1;UBE2D3;LEF1;HMGB2;HNRNPU;NUCKS1;ENO1;HMGB1;YBX1;MACROH2A1;CHD1;UBB;IFI16;MYB;NRIP1;SOX4;SNCA;XBP1;JUN;CBX5;PARP1;PRKCB;EBF1;ATP2B4;PAX5;H1-0;KLF3;ZEB2;HNRNPK;IFI27;IRF1;MDM2;CTNNB1;HDGF;ERG;SSBP2;RBMX
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",10/251,2.657396734807436e-4,0.008250008953970357,0,0,4.182529837019293,34.434740541470575,HNRNPK;DHX9;NONO;HNRNPU;PABPC1;SRSF5;YBX1;HNRNPA1;SF3B1;RBMX
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),3/13,2.7733847906159407e-4,0.008356860935253034,0,0,29.53134328358209,241.86972963766425,PPP1R15A;PPP1R15B;HSPA5
"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",3/13,2.7733847906159407e-4,0.008356860935253034,0,0,29.53134328358209,241.86972963766425,HLA-DRA;NCKAP1L;HLA-DRB1
cellular response to oxidative stress (GO:0034599),7/125,2.992743195037647e-4,0.008598115258569308,0,0,5.925578594166739,48.081033245551524,PRDX2;JUN;PARP1;PRDX1;CAT;PPIA;SNCA
regulation of type I interferon production (GO:0032479),6/89,3.0094191972520706e-4,0.008598115258569308,0,0,7.197152245345016,58.358780256586684,CYLD;IFI16;DHX9;XRCC5;IRF1;CTNNB1
modulation by host of symbiont process (GO:0051851),4/32,3.021299651620255e-4,0.008598115258569308,0,0,14.12,114.43770438340947,JUN;LEF1;NUCKS1;CHD1
positive regulation of immune effector process (GO:0002699),4/32,3.021299651620255e-4,0.008598115258569308,0,0,14.12,114.43770438340947,XBP1;MYB;HLA-DRA;HLA-DRB1
RNA stabilization (GO:0043489),4/33,3.41075762809542e-4,0.00957097260980007,0,0,13.632413793103447,108.83309307560945,HNRNPU;YBX1;PABPC1;TENT5C
antigen processing and presentation of endogenous peptide antigen (GO:0002483),3/14,3.5032842642020753e-4,0.00957097260980007,0,0,26.845318860244234,213.5985239574359,HLA-DRA;HLA-DRB1;HLA-E
response to chemokine (GO:1990868),3/14,3.5032842642020753e-4,0.00957097260980007,0,0,26.845318860244234,213.5985239574359,WNK1;DOCK8;RHOA
positive regulation of apoptotic process (GO:0043065),11/310,3.569066642434541e-4,0.009622391513616282,0,0,3.7164815360354897,29.501565174323673,TOP2A;BNIP3L;JUN;ARHGEF12;UBB;CTNNB1;PMAIP1;HMGB1;SOX4;ARHGEF6;SNCA
positive regulation of macromolecule biosynthetic process (GO:0010557),7/129,3.625134492211963e-4,0.009646624122782223,0,0,5.730132312557211,45.396680912406254,RBM3;SLC25A37;XBP1;CIITA;PCNA;DHX9;SOX4
bicarbonate transport (GO:0015701),4/35,4.2953676389541074e-4,0.011131886062726875,0,0,12.751612903225807,98.86074561764592,CA1;CA2;SLC4A1;HBA1
regulation of cytoplasmic translation (GO:2000765),3/15,4.346270790718155e-4,0.011131886062726875,0,0,24.606965174129353,190.4830632950432,PKM;DHX9;YBX3
positive regulation of histone H3-K4 methylation (GO:0051571),3/15,4.346270790718155e-4,0.011131886062726875,0,0,24.606965174129353,190.4830632950432,KMT2E;MYB;CTNNB1
platelet aggregation (GO:0070527),4/36,4.793991094820074e-4,0.012127021917637447,0,0,12.3525,94.40987454787246,UBASH3B;CLIC1;PPIA;ACTG1
regulation of innate immune response (GO:0045088),5/64,4.918616262465386e-4,0.012142463520230814,0,0,8.405161400221447,64.02474628103327,IFI16;DHX9;RIOK3;IRF1;HLA-E
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),5/64,4.918616262465386e-4,0.012142463520230814,0,0,8.405161400221447,64.02474628103327,XBP1;MDM2;ENO1;YBX3;PPIA
ribonucleoprotein complex assembly (GO:0022618),7/136,4.986191614658685e-4,0.01216274597432815,0,0,5.417266753236532,41.19109762651781,EIF2S3;EIF5;DHX9;XRCC5;SRSF5;SF3B1;EIF4B
"mRNA splicing, via spliceosome (GO:0000398)",10/274,5.301376660106861e-4,0.012276721579195052,0,0,3.8136519837550766,28.763988949345553,HNRNPK;DHX9;NONO;HNRNPU;PABPC1;SRSF5;YBX1;HNRNPA1;SF3B1;RBMX
apoptotic DNA fragmentation (GO:0006309),3/16,5.309166049096651e-4,0.012276721579195052,0,0,22.71297359357061,171.27638980886377,HMGB2;HMGB1;H1-0
regulation of monocyte differentiation (GO:0045655),3/16,5.309166049096651e-4,0.012276721579195052,0,0,22.71297359357061,171.27638980886377,CD74;CDK6;HLA-DRB1
negative regulation of histone modification (GO:0031057),3/16,5.309166049096651e-4,0.012276721579195052,0,0,22.71297359357061,171.27638980886377,SET;MACROH2A1;SNCA
regulation of erythrocyte differentiation (GO:0045646),4/37,5.332494975833869e-4,0.012276721579195052,0,0,11.977575757575758,90.26925293635809,FAM210B;CDK6;HMGB2;NCKAP1L
positive regulation of translation (GO:0045727),6/100,5.627788019171534e-4,0.012769587989283349,0,0,6.3513862024500325,47.525034189125094,RBM3;EIF2S3;PKM;DHX9;YBX3;SOX4
positive regulation of T cell proliferation (GO:0042102),5/66,5.671217701438676e-4,0.012769587989283349,0,0,8.128758546832524,60.761954084443225,TFRC;HLA-DPB1;NCKAP1L;HMGB1;HLA-DPA1
response to estradiol (GO:0032355),4/38,5.912643221098929e-4,0.01307209134696931,0,0,11.624705882352941,86.4093147177555,SOCS2;FAM210B;NRIP1;CTNNB1
cellular response to chemical stress (GO:0062197),6/101,5.933160054993391e-4,0.01307209134696931,0,0,6.28421052631579,46.6903231007202,PRDX2;PARP1;PRDX1;CAT;PPIA;SNCA
regulation of translational initiation (GO:0006446),5/68,6.507110816869575e-4,0.01418411708911251,0,0,7.869905080960358,57.7449942796252,EIF4A2;PPP1R15B;EIF5;EIF4B;EIF1
defense response to Gram-positive bacterium (GO:0050830),5/70,7.431999354975731e-4,0.016011268727555945,0,0,7.626981059141863,54.94893174220877,H2BC21;H2BC11;HMGB2;GBP4;HLA-E
DNA conformation change (GO:0071103),3/18,7.620769144630721e-4,0.016011268727555945,0,0,19.682587064676618,141.31040694810108,TOP2A;HMGB2;HMGB1
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",3/18,7.620769144630721e-4,0.016011268727555945,0,0,19.682587064676618,141.31040694810108,RBM3;NCL;RBMX
positive regulation of protein serine/threonine kinase activity (GO:0071902),6/106,7.657903051734908e-4,0.016011268727555945,0,0,5.968484848484849,42.82150439770476,CCND3;TCL1A;FLT3;ATP2B4;RHOA;SNCA
nucleic acid metabolic process (GO:0090304),5/71,7.92963379602986e-4,0.016411939038449678,0,0,7.511040048728491,53.62682438315985,HNRNPK;HNRNPU;DNTT;HNRNPA1;RBMX
positive regulation of transferase activity (GO:0051347),7/148,8.241122798783436e-4,0.01688606061470726,0,0,4.953198689563307,35.17367323438238,CD74;PCNA;XRCC5;FLT3;CTNNB1;SERINC1;HLA-DRB1
regulation of cell population proliferation (GO:0042127),18/764,8.670828425567705e-4,0.017447068901188786,0,0,2.4712444867248986,17.423202905666095,XBP1;JUN;TFRC;XRCC5;FLT3;UHRF1;LEF1;HMGB2;ADAM10;NAP1L1;RHOA;TCL1A;CDK6;FTH1;IRF1;MDM2;CTNNB1;SOX4
positive regulation of ATPase activity (GO:0032781),4/42,8.685217315379483e-4,0.017447068901188786,0,0,10.398947368421053,73.29924698392094,MSH6;DHX9;UHRF1;HNRNPU
regulation of histone H3-K4 methylation (GO:0051569),3/19,8.981935111747552e-4,0.017696139465356475,0,0,18.45149253731343,129.4395269842083,MYB;CTNNB1;MACROH2A1
maintenance of protein localization in organelle (GO:0072595),3/19,8.981935111747552e-4,0.017696139465356475,0,0,18.45149253731343,129.4395269842083,HSPA5;HNRNPU;HK1
cellular glucose homeostasis (GO:0001678),4/43,9.500283871908798e-4,0.018539125384324884,0,0,10.131794871794872,70.50734990203006,XBP1;NUCKS1;SOX4;HK1
hemoglobin metabolic process (GO:0020027),2/5,0.0010145693548244859,0.01901750507327885,0,0,65.32343234323433,450.29343070918674,ALAS2;AHSP
intracellular sequestering of iron ion (GO:0006880),2/5,0.0010145693548244859,0.01901750507327885,0,0,65.32343234323433,450.29343070918674,FTH1;FTL
negative regulation of PERK-mediated unfolded protein response (GO:1903898),2/5,0.0010145693548244859,0.01901750507327885,0,0,65.32343234323433,450.29343070918674,PPP1R15A;PPP1R15B
"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)",2/5,0.0010145693548244859,0.01901750507327885,0,0,65.32343234323433,450.29343070918674,HLA-DRA;HLA-DRB1
protein ubiquitination (GO:0016567),14/525,0.0010316258580954905,0.01901750507327885,0,0,2.780821917808219,19.1226534425632,RNF10;PCNA;UHRF1;UBE2D3;LNPEP;MIB1;UBB;MKRN1;H2BC11;MARCHF8;MDM2;CTNNB1;TRIM58;FBXO7
homotypic cell-cell adhesion (GO:0034109),4/44,0.0010367700000605963,0.01901750507327885,0,0,9.878,67.8781109686311,UBASH3B;CLIC1;PPIA;ACTG1
negative regulation of telomere maintenance via telomerase (GO:0032211),3/20,0.0010487935935971254,0.01901750507327885,0,0,17.36523266022827,119.1274884291729,HNRNPU;HNRNPA1;DCP2
positive regulation of alpha-beta T cell activation (GO:0046635),3/20,0.0010487935935971254,0.01901750507327885,0,0,17.36523266022827,119.1274884291729,HLA-DRA;HLA-DRB1;HLA-E
mRNA processing (GO:0006397),10/300,0.0010607712412475656,0.019065967309791772,0,0,3.467116956985425,23.74544863426711,HNRNPK;DHX9;NONO;HNRNPU;PABPC1;SRSF5;YBX1;HNRNPA1;SF3B1;RBMX
regulation of T cell proliferation (GO:0042129),5/76,0.0010799495525456741,0.01924188376666162,0,0,6.980324155991224,47.68148408582792,TFRC;HLA-DPB1;NCKAP1L;HLA-DRB1;HLA-DPA1
innate immune response (GO:0045087),10/302,0.001115133485854828,0.01969748717686675,0,0,3.443016523089959,23.40831588101381,CYLD;CD74;CIITA;IFI27;H2BC21;H2BC11;TRIM58;HMGB1;HLA-E;SNCA
T cell receptor signaling pathway (GO:0050852),7/158,0.0012072005233838125,0.021141486089003694,0,0,4.622819107809191,31.06280747974915,WNK1;HLA-DPB1;HLA-DRA;HLA-DQA1;HLA-DRB1;HLA-DPA1;HLA-DQB1
erythrocyte differentiation (GO:0030218),4/46,0.0012266743129078195,0.021300471755492562,0,0,9.406666666666666,63.05710632933091,KMT2E;ALAS2;AHSP;NCKAP1L
response to interferon-gamma (GO:0034341),5/80,0.0013599236428433704,0.023415828102403915,0,0,6.606700167504187,43.60637968478301,CD74;CIITA;GBP4;HLA-DPA1;SNCA
cellular response to ionizing radiation (GO:0071479),4/48,0.001439664713046099,0.02437911567794592,0,0,8.978181818181818,58.74734138443085,IFI16;XRCC5;MDM2;NUCKS1
positive regulation of DNA repair (GO:0045739),4/48,0.001439664713046099,0.02437911567794592,0,0,8.978181818181818,58.74734138443085,PCNA;PARP1;DHX9;HMGB1
cellular hyperosmotic response (GO:0071474),2/6,0.0015116345112816804,0.024978541238840024,0,0,48.99009900990099,318.1693214221626,RCSD1;YBX3
cellular response to X-ray (GO:0071481),2/6,0.0015116345112816804,0.024978541238840024,0,0,48.99009900990099,318.1693214221626,XRCC5;NUCKS1
peptide antigen assembly with MHC protein complex (GO:0002501),2/6,0.0015116345112816804,0.024978541238840024,0,0,48.99009900990099,318.1693214221626,HLA-DRA;HLA-DRB1
regulation of interleukin-4 production (GO:0032673),3/23,0.0015930529746219677,0.025702090905515056,0,0,14.75820895522388,95.07390209622169,LEF1;HLA-DRB1;HLA-E
"DNA catabolic process, endonucleolytic (GO:0000737)",3/23,0.0015930529746219677,0.025702090905515056,0,0,14.75820895522388,95.07390209622169,HMGB2;HMGB1;H1-0
positive regulation of mRNA processing (GO:0050685),3/23,0.0015930529746219677,0.025702090905515056,0,0,14.75820895522388,95.07390209622169,RBM3;NCL;RBMX
cellular response to organic substance (GO:0071310),6/123,0.0016542173528015334,0.026480401217893294,0,0,5.096866096866097,32.64250827640719,SOCS2;MME;FLT3;LEF1;CTNNB1;RHOA
protein-containing complex assembly (GO:0065003),9/267,0.0017352339163261325,0.027561971275598802,0,0,3.495169946332737,22.217442901847527,CD74;TMED10;WIPF1;DHX9;LEF1;MDM2;CTNNB1;ADAM10;NCKAP1L
G1/S transition of mitotic cell cycle (GO:0000082),5/85,0.0017811019392301797,0.02783926636653085,0,0,6.192211055276382,39.19993474925023,PCNA;CDK6;NASP;BCAT1;GSPT1
DNA duplex unwinding (GO:0032508),4/51,0.001805548027196397,0.02783926636653085,0,0,8.403829787234043,53.08607773263329,MCM7;PARP1;UBB;DHX9
canonical glycolysis (GO:0061621),3/24,0.0018070387636645207,0.02783926636653085,0,0,14.054726368159203,88.77057676234604,PKM;ENO1;HK1
glucose catabolic process to pyruvate (GO:0061718),3/24,0.0018070387636645207,0.02783926636653085,0,0,14.054726368159203,88.77057676234604,PKM;ENO1;HK1
myeloid cell differentiation (GO:0030099),4/52,0.0019405877643574848,0.02967361439677975,0,0,8.2283333333333335,51.384002910676365,KMT2E;ALAS2;IFI16;AHSP
regulation of neutrophil chemotaxis (GO:0090022),3/25,0.002038129063063172,0.03033223474882089,0,0,13.415196743554953,83.11684325360336,MPP1;CD74;NCKAP1L
glycolytic process through glucose-6-phosphate (GO:0061620),3/25,0.002038129063063172,0.03033223474882089,0,0,13.415196743554953,83.11684325360336,PKM;ENO1;HK1
positive regulation of B cell activation (GO:0050871),4/53,0.0020824584791884187,0.03033223474882089,0,0,8.06,49.76410134401949,CD74;XBP1;TFRC;NCKAP1L
regulation of T cell mediated immune response to tumor cell (GO:0002840),2/7,0.0021020875228563037,0.03033223474882089,0,0,39.19009900990099,241.60007741930562,HMGB1;HLA-DRB1
hyperosmotic response (GO:0006972),2/7,0.0021020875228563037,0.03033223474882089,0,0,39.19009900990099,241.60007741930562,RCSD1;YBX3
lymphoid progenitor cell differentiation (GO:0002320),2/7,0.0021020875228563037,0.03033223474882089,0,0,39.19009900990099,241.60007741930562,FLT3;SOX4
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),2/7,0.0021020875228563037,0.03033223474882089,0,0,39.19009900990099,241.60007741930562,CD74;HMGB1
protein localization to cytoplasmic stress granule (GO:1903608),2/7,0.0021020875228563037,0.03033223474882089,0,0,39.19009900990099,241.60007741930562,DHX9;YBX1
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",4/54,0.0022313336616004015,0.03197204666167289,0,0,7.8984,48.22096271087017,HNRNPU;HNRNPA1;MBNL3;RBMX
DNA geometric change (GO:0032392),3/26,0.002286786739816303,0.0321493227379769,0,0,12.831278390655418,78.02196912021368,DHX9;HMGB2;HMGB1
positive regulation of T cell mediated cytotoxicity (GO:0001916),3/26,0.002286786739816303,0.0321493227379769,0,0,12.831278390655418,78.02196912021368,HLA-DRA;HLA-DRB1;HLA-E
positive regulation of binding (GO:0051099),5/90,0.002290776534770438,0.0321493227379769,0,0,5.826485368016553,35.418414601619844,DHX9;EPB41;STMN1;HMGB2;HMGB1
RNA metabolic process (GO:0016070),6/133,0.0024550095415247063,0.03421982687472193,0,0,4.693151992364591,28.204081811162727,RBM3;HNRNPK;DHX9;HNRNPU;HNRNPA1;RBMX
positive regulation of cellular biosynthetic process (GO:0031328),7/180,0.0025359038822934804,0.034880198635371944,0,0,4.030427510929844,24.09069205257909,RBM3;SLC25A37;ZEB2;PCNA;DHX9;SOX4;SNCA
negative regulation of protein polymerization (GO:0032272),3/27,0.002553455244170713,0.034880198635371944,0,0,12.296019900497512,73.41102400386812,STMN1;SSH2;SNCA
positive regulation of erythrocyte differentiation (GO:0045648),3/27,0.002553455244170713,0.034880198635371944,0,0,12.296019900497512,73.41102400386812,FAM210B;HMGB2;NCKAP1L
apoptotic process (GO:0006915),8/231,0.002624258260708905,0.034996296425139656,0,0,3.582502059119612,21.29065565471246,PPP1R15A;IFI27;PARP1;IRF1;MDM2;PMAIP1;PPIA;ARHGEF6
regulation of kinase activity (GO:0043549),5/94,0.0027690879252124916,0.034996296425139656,0,0,5.563491615380272,32.76472223872509,EEF1A1;CD74;FLT3;HNRNPU;HLA-DRB1
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",2/8,0.0027839903939959804,0.034996296425139656,0,0,32.65676567656766,192.14816343516293,LNPEP;HLA-E
"regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",2/8,0.0027839903939959804,0.034996296425139656,0,0,32.65676567656766,192.14816343516293,HLA-DRA;HLA-DRB1
"regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",2/8,0.0027839903939959804,0.034996296425139656,0,0,32.65676567656766,192.14816343516293,IRF1;HLA-E
regulation of chaperone-mediated autophagy (GO:1904714),2/8,0.0027839903939959804,0.034996296425139656,0,0,32.65676567656766,192.14816343516293,EEF1A1;SNCA
cellular response to epinephrine stimulus (GO:0071872),2/8,0.0027839903939959804,0.034996296425139656,0,0,32.65676567656766,192.14816343516293,ATP2B4;SNCA
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),2/8,0.0027839903939959804,0.034996296425139656,0,0,32.65676567656766,192.14816343516293,UBB;MDM2
response to epinephrine (GO:0071871),2/8,0.0027839903939959804,0.034996296425139656,0,0,32.65676567656766,192.14816343516293,ATP2B4;SNCA
macromolecule modification (GO:0043412),2/8,0.0027839903939959804,0.034996296425139656,0,0,32.65676567656766,192.14816343516293,PARP1;CHD1
negative regulation of monooxygenase activity (GO:0032769),2/8,0.0027839903939959804,0.034996296425139656,0,0,32.65676567656766,192.14816343516293,ATP2B4;SNCA
positive regulation of leukocyte differentiation (GO:1902107),2/8,0.0027839903939959804,0.034996296425139656,0,0,32.65676567656766,192.14816343516293,NCKAP1L;HMGB1
positive regulation of MHC class II biosynthetic process (GO:0045348),2/8,0.0027839903939959804,0.034996296425139656,0,0,32.65676567656766,192.14816343516293,CIITA;XBP1
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",3/28,0.0028385590354469458,0.03524974220382298,0,0,11.803582089552238,69.22162011834958,CD74;MDM2;PMAIP1
positive regulation of fibroblast proliferation (GO:0048146),3/28,0.0028385590354469458,0.03524974220382298,0,0,11.803582089552238,69.22162011834958,CD74;CDK6;DHX9
cellular iron ion homeostasis (GO:0006879),4/58,0.002900307252438442,0.03579957566413475,0,0,7.311851851851852,42.72270141159079,ALAS2;TFRC;FTH1;FTL
regulation of T cell mediated cytotoxicity (GO:0001914),3/29,0.003142504001105735,0.03810053667612811,0,0,11.34902411021814,65.40142236300478,HLA-DRA;HLA-DRB1;HLA-E
glycolytic process (GO:0006096),3/29,0.003142504001105735,0.03810053667612811,0,0,11.34902411021814,65.40142236300478,PKM;ENO1;HK1
positive regulation of viral genome replication (GO:0045070),3/29,0.003142504001105735,0.03810053667612811,0,0,11.34902411021814,65.40142236300478,TOP2A;PABPC1;PPIA
protein modification by small protein conjugation (GO:0032446),11/409,0.003295557139680593,0.03972115634826785,0,0,2.7778529955476867,15.875929991217735,RANBP2;PCNA;UBB;UHRF1;UBE2D3;MKRN1;H2BC11;MDM2;TRIM58;FBXO7;MIB1
regulation of cell cycle (GO:0051726),9/296,0.0034607981398972905,0.04024909101511609,0,0,3.1373358348968106,17.77694812475578,PPP1R15A;CYLD;JUN;CDK6;IRF1;MDM2;HNRNPU;ADAM10;IQGAP1
ion homeostasis (GO:0050801),3/30,0.0034656778669152704,0.04024909101511609,0,0,10.928137092316197,61.90622498238376,WNK1;FHL1;SLC4A1
positive regulation of B cell proliferation (GO:0030890),3/30,0.0034656778669152704,0.04024909101511609,0,0,10.928137092316197,61.90622498238376,CD74;TFRC;NCKAP1L
iron ion homeostasis (GO:0055072),4/61,0.003483897883660749,0.04024909101511609,0,0,6.925964912280702,39.198215469713695,ALAS2;TFRC;FTH1;FTL
positive regulation of DNA biosynthetic process (GO:2000573),4/61,0.003483897883660749,0.04024909101511609,0,0,6.925964912280702,39.198215469713695,PCNA;XRCC5;CTNNB1;HNRNPA1
positive regulation of cell population proliferation (GO:0008284),12/474,0.0035521693629519597,0.04024909101511609,0,0,2.615530303030303,14.752105577392344,CD74;TCL1A;XBP1;CDK6;DHX9;FLT3;LEF1;MDM2;HNRNPU;ADAM10;NAP1L1;SOX4
ATF6-mediated unfolded protein response (GO:0036500),2/9,0.0035554345894270433,0.04024909101511609,0,0,27.99009900990099,157.84394888758456,XBP1;HSPA5
"regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",2/9,0.0035554345894270433,0.04024909101511609,0,0,27.99009900990099,157.84394888758456,IRF1;HLA-E
positive regulation of B cell differentiation (GO:0045579),2/9,0.0035554345894270433,0.04024909101511609,0,0,27.99009900990099,157.84394888758456,XBP1;NCKAP1L
"positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",2/9,0.0035554345894270433,0.04024909101511609,0,0,27.99009900990099,157.84394888758456,NCKAP1L;HLA-E
positive regulation of memory T cell differentiation (GO:0043382),2/9,0.0035554345894270433,0.04024909101511609,0,0,27.99009900990099,157.84394888758456,HLA-DRA;HLA-DRB1
regulation of neurogenesis (GO:0050767),4/62,0.003694900278502629,0.04114592755789069,0,0,6.806206896551724,38.12021524641531,MME;HMGB2;CTNNB1;NAP1L1
double-strand break repair via nonhomologous end joining (GO:0006303),4/62,0.003694900278502629,0.04114592755789069,0,0,6.806206896551724,38.12021524641531,XRCC5;HMGB2;DNTT;HMGB1
negative regulation of kinase activity (GO:0033673),4/62,0.003694900278502629,0.04114592755789069,0,0,6.806206896551724,38.12021524641531,UBASH3B;HNRNPU;PPIA;SNCA
negative regulation of DNA binding (GO:0043392),3/31,0.0038084506021276838,0.04173002825539906,0,0,10.537313432835822,58.698450508894936,JUN;IFI16;LEF1
positive regulation of leukocyte cell-cell adhesion (GO:1903039),3/31,0.0038084506021276838,0.04173002825539906,0,0,10.537313432835822,58.698450508894936,HLA-DPB1;RHOA;HLA-DPA1
positive regulation of RNA splicing (GO:0033120),3/31,0.0038084506021276838,0.04173002825539906,0,0,10.537313432835822,58.698450508894936,RBM3;NCL;RBMX
amyloid fibril formation (GO:1990000),4/63,0.003914407454741454,0.04243714748553037,0,0,6.690508474576271,37.086099408661646,UBB;MDM2;ADAM10;SNCA
cell cycle G1/S phase transition (GO:0044843),4/63,0.003914407454741454,0.04243714748553037,0,0,6.690508474576271,37.086099408661646,CDK6;NASP;BCAT1;GSPT1
regulation of cell death (GO:0010941),5/102,0.003936292538425523,0.042449807427546823,0,0,5.102574729316687,28.255589096444023,BNIP3L;UBB;HBA1;SOX4;SNCA
negative regulation of DNA biosynthetic process (GO:2000279),3/32,0.004171174816784193,0.04369755452736074,0,0,10.173443129181678,55.74596713044938,HNRNPU;HNRNPA1;DCP2
regulation of cell-matrix adhesion (GO:0001952),4/65,0.0043795683675581796,0.04369755452736074,0,0,6.470491803278689,35.139979921437735,CDK6;UTRN;RHOA;ACTG1
protein autoubiquitination (GO:0051865),4/65,0.0043795683675581796,0.04369755452736074,0,0,6.470491803278689,35.139979921437735,RNF10;UHRF1;UBE2D3;MDM2
B cell homeostasis (GO:0001782),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,DOCK11;NCKAP1L
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,XBP1;HSPA5
cellular response to interleukin-4 (GO:0071353),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,XBP1;LEF1
regulation of memory T cell differentiation (GO:0043380),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,HLA-DRA;HLA-DRB1
regulation of neutrophil migration (GO:1902622),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,MPP1;NCKAP1L
dosage compensation (GO:0007549),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,HNRNPU;MACROH2A1
endothelial tube morphogenesis (GO:0061154),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,CTNNB1;RHOA
removal of superoxide radicals (GO:0019430),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,PRDX2;PRDX1
response to interleukin-4 (GO:0070670),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,XBP1;LEF1
modulation by symbiont of host process (GO:0044003),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,UBB;ENO1
negative regulation of peptidyl-lysine acetylation (GO:2000757),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,SET;SNCA
positive regulation by symbiont of entry into host (GO:0075294),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,CD74;HLA-DRB1
positive regulation of monocyte differentiation (GO:0045657),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,CD74;HLA-DRB1
positive regulation of viral entry into host cell (GO:0046598),2/10,0.004414540647712871,0.04369755452736074,0,0,24.49009900990099,132.80617000141103,CD74;HLA-DRB1
positive regulation of telomere maintenance via telomerase (GO:0032212),3/33,0.0045541861503708165,0.04486311260629713,0,0,9.833830845771145,53.02114872876838,XRCC5;CTNNB1;HNRNPA1
cell-cell junction assembly (GO:0007043),4/66,0.004625533455426317,0.045347933254394845,0,0,6.365806451612904,34.2236167576451,CD9;CTNNB1;RHOA;ACTG1
positive regulation of protein phosphorylation (GO:0001934),10/371,0.0049204858373642375,0.04769267460704483,0,0,2.7750806751006656,14.747744451992157,CD74;TCL1A;CCND3;TFRC;XRCC5;ATP2B4;IQGAP1;PPIA;HLA-DRB1;SNCA
negative regulation of blood vessel endothelial cell migration (GO:0043537),3/34,0.004957803656076403,0.04769267460704483,0,0,9.516129032258064,50.50012167867984,ATP2B4;HMGB1;RHOA
positive regulation of DNA binding (GO:0043388),3/34,0.004957803656076403,0.04769267460704483,0,0,9.516129032258064,50.50012167867984,HMGB2;HMGB1;H1-0
positive regulation of protein dephosphorylation (GO:0035307),3/34,0.004957803656076403,0.04769267460704483,0,0,9.516129032258064,50.50012167867984,PPP1R15A;PPP1R15B;PPIA
positive regulation of protein kinase activity (GO:0045860),6/154,0.0050451335498030905,0.0483059749698436,0,0,4.022932022932023,21.27861967856129,TCL1A;XRCC5;STRADB;IQGAP1;RHOA;SNCA
protein polyubiquitination (GO:0000209),9/314,0.005075296334770702,0.048368754371837984,0,0,2.949457755359395,15.583077696515335,IFI27;UBB;UBE2D3;MKRN1;MARCHF8;MDM2;CTNNB1;LNPEP;FBXO7
cellular response to superoxide (GO:0071451),2/11,0.0053594577958809494,0.0493518187377423,0,0,21.76787678767877,113.82188694681741,PRDX2;PRDX1
erythrocyte development (GO:0048821),2/11,0.0053594577958809494,0.0493518187377423,0,0,21.76787678767877,113.82188694681741,ALAS2;NCKAP1L
T cell homeostasis (GO:0043029),2/11,0.0053594577958809494,0.0493518187377423,0,0,21.76787678767877,113.82188694681741,PMAIP1;NCKAP1L
V(D)J recombination (GO:0033151),2/11,0.0053594577958809494,0.0493518187377423,0,0,21.76787678767877,113.82188694681741,HMGB2;HMGB1
negative regulation of oxidative stress-induced neuron death (GO:1903204),2/11,0.0053594577958809494,0.0493518187377423,0,0,21.76787678767877,113.82188694681741,NONO;FBXO7
nucleus localization (GO:0051647),2/11,0.0053594577958809494,0.0493518187377423,0,0,21.76787678767877,113.82188694681741,SUN2;SYNE3
positive regulation of immunoglobulin production (GO:0002639),3/35,0.005382330177657852,0.0493518187377423,0,0,9.218283582089553,48.1621567189254,XBP1;TFRC;HLA-E
positive regulation of lymphocyte activation (GO:0051251),3/35,0.005382330177657852,0.0493518187377423,0,0,9.218283582089553,48.1621567189254,HLA-DPB1;NCKAP1L;HLA-DPA1
regulation of interleukin-6 production (GO:0032675),5/110,0.005419306596384586,0.0493518187377423,0,0,4.711892797319933,24.585654896095484,CD74;XBP1;DHX9;NCKAP1L;HMGB1
regulation of protein kinase activity (GO:0045859),5/110,0.005419306596384586,0.0493518187377423,0,0,4.711892797319933,24.585654896095484,UBASH3B;XRCC5;IQGAP1;PPIA;SNCA
regulation of protein serine/threonine kinase activity (GO:0071900),5/111,0.005628960010890154,0.0510342436385572,0,0,4.667203944249549,24.17532569787944,CCND3;TCL1A;MACROH2A1;RHOA;SNCA
mitotic cell cycle phase transition (GO:0044772),7/209,0.005738567713519872,0.051149102664446895,0,0,3.446700507614213,17.786855232316494,CCND3;TUBA1A;CDK6;NASP;TUBB;BCAT1;GSPT1
negative regulation of DNA metabolic process (GO:0051053),3/36,0.00582805271797298,0.051149102664446895,0,0,8.938489371325192,45.98917447095539,MSH6;XRCC5;H1-0
positive regulation of innate immune response (GO:0045089),3/36,0.00582805271797298,0.051149102664446895,0,0,8.938489371325192,45.98917447095539,DHX9;RIOK3;HLA-E
positive regulation of interferon-beta production (GO:0032728),3/36,0.00582805271797298,0.051149102664446895,0,0,8.938489371325192,45.98917447095539,DHX9;RIOK3;IRF1
positive regulation of myeloid leukocyte differentiation (GO:0002763),3/36,0.00582805271797298,0.051149102664446895,0,0,8.938489371325192,45.98917447095539,CD74;LEF1;HLA-DRB1
positive regulation of T cell mediated immunity (GO:0002711),3/36,0.00582805271797298,0.051149102664446895,0,0,8.938489371325192,45.98917447095539,HLA-DRA;HLA-DRB1;HLA-E
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),3/36,0.00582805271797298,0.051149102664446895,0,0,8.938489371325192,45.98917447095539,XRCC5;CTNNB1;HNRNPA1
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),9/321,0.005841332368706965,0.051149102664446895,0,0,2.882248520710059,14.822817209099018,IFI27;UBB;HSPA5;EDEM1;UBE2D3;MDM2;CTNNB1;STT3B;DCAF12
regulation of G1/S transition of mitotic cell cycle (GO:2000045),4/71,0.005995251140514676,0.052051989775061744,0,0,5.889253731343284,30.134060464129842,KMT2E;CCND3;CDK6;FHL1
myeloid leukocyte differentiation (GO:0002573),4/71,0.005995251140514676,0.052051989775061744,0,0,5.889253731343284,30.134060464129842,PARP1;IFI16;LEF1;HLA-DRB1
positive regulation of kinase activity (GO:0033674),5/114,0.006292204357176855,0.05300710736413724,0,0,4.538057258770919,23.000888247254636,CD74;XRCC5;FLT3;IQGAP1;HLA-DRB1
regulation of transport (GO:0051049),3/37,0.006295242804464661,0.05300710736413724,0,0,8.67515364354697,43.96534069215056,EPB41;ACTG1;SNCA
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",3/37,0.006295242804464661,0.05300710736413724,0,0,8.67515364354697,43.96534069215056,PCNA;UBB;PARP1
positive regulation of myeloid cell differentiation (GO:0045639),3/37,0.006295242804464661,0.05300710736413724,0,0,8.67515364354697,43.96534069215056,FAM210B;HMGB2;NCKAP1L
cytoskeleton-dependent cytokinesis (GO:0061640),4/72,0.006298197899753762,0.05300710736413724,0,0,5.802352941176471,29.4033755681036,STMN1;SEPTIN6;SEPTIN9;RHOA
positive regulation of neurogenesis (GO:0050769),4/72,0.006298197899753762,0.05300710736413724,0,0,5.802352941176471,29.4033755681036,MME;CTNNB1;NAP1L1;RHOA
regulation of MHC class II biosynthetic process (GO:0045346),2/12,0.0063883635667253465,0.05300710736413724,0,0,19.59009900990099,98.99419942329884,CIITA;XBP1
gas transport (GO:0015669),2/12,0.0063883635667253465,0.05300710736413724,0,0,19.59009900990099,98.99419942329884,CA2;HBA1
negative regulation of histone acetylation (GO:0035067),2/12,0.0063883635667253465,0.05300710736413724,0,0,19.59009900990099,98.99419942329884,SET;SNCA
negative regulation of microtubule polymerization (GO:0031115),2/12,0.0063883635667253465,0.05300710736413724,0,0,19.59009900990099,98.99419942329884,STMN1;SNCA
positive regulation of nucleic acid-templated transcription (GO:1903508),12/511,0.006389826998019472,0.05300710736413724,0,0,2.416958917835671,12.21300963086194,KMT2E;CD74;RNF10;JUN;CIITA;IRF1;MYB;LEF1;HMGB2;CTNNB1;SOX4;HLA-DRB1
positive regulation of cell migration (GO:0030335),8/269,0.006522399447472811,0.053888695434966896,0,0,3.0549691140824144,15.374171650856066,SUN2;XBP1;HSPA5;LEF1;GAB1;ADAM10;NCKAP1L;ACTG1
double-strand break repair (GO:0006302),6/164,0.006813095690577916,0.05606438983933393,0,0,3.7663981588032223,18.79021647430987,PARP1;XRCC5;HMGB2;NUCKS1;DNTT;HMGB1
"regulation of transcription, DNA-templated (GO:0006355)",35/2244,0.006976663758793543,0.05718073616707187,0,0,1.6488357204657653,8.18677347655064,KMT2E;RNF10;CIITA;SET;PCNA;DHX9;LEF1;HMGB2;NUCKS1;ENO1;HMGB1;YBX1;CHD1;IFI16;MYB;SOX4;CD74;JUN;CBX5;PRKCB;XRCC5;NONO;EBF1;ATP2B4;PAX5;KLF3;ZEB2;HNRNPK;IRF1;MDM2;CTNNB1;HDGF;ERG;SSBP2;HLA-DRB1
regulation of gene expression (GO:0010468),20/1079,0.007290229714878878,0.05908114521196807,0,0,1.923163772221538,9.464312447037377,RBM38;CD74;TFRC;NONO;LEF1;ATP2B4;ADAM10;YBX1;MACROH2A1;YBX3;ACTG1;HNRNPK;CDK6;HNRNPDL;IFI16;MYB;TRIM58;MBNL3;SSBP2;SOX4
regulation of viral entry into host cell (GO:0046596),3/39,0.007295036475660284,0.05908114521196807,0,0,8.192371475953566,40.31106437617102,CD74;CIITA;HLA-DRB1
"nucleotide-excision repair, DNA incision (GO:0033683)",3/39,0.007295036475660284,0.05908114521196807,0,0,8.192371475953566,40.31106437617102,PCNA;UBB;PARP1
cellular response to lipid (GO:0071396),7/219,0.007349525542355386,0.059288101717662155,0,0,3.2824442103246816,16.127040722733717,FAM210B;XBP1;NCOA4;NRIP1;HMGB2;HMGB1;RHOA
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),2/13,0.007499463418107064,0.05932973182896283,0,0,17.808280828082808,87.13456119433339,CD74;HMGB1
entry into host (GO:0044409),2/13,0.007499463418107064,0.05932973182896283,0,0,17.808280828082808,87.13456119433339,CTNNB1;PPIA
mitochondrial outer membrane permeabilization (GO:0097345),2/13,0.007499463418107064,0.05932973182896283,0,0,17.808280828082808,87.13456119433339,BNIP3L;PMAIP1
negative regulation of cellular senescence (GO:2000773),2/13,0.007499463418107064,0.05932973182896283,0,0,17.808280828082808,87.13456119433339,CDK6;YBX1
positive regulation of cellular carbohydrate metabolic process (GO:0010676),2/13,0.007499463418107064,0.05932973182896283,0,0,17.808280828082808,87.13456119433339,PMAIP1;SNCA
positive regulation of interleukin-6 production (GO:0032755),4/76,0.007611338066426398,0.059983198838875734,0,0,5.478888888888889,26.7266571539503,CD74;XBP1;DHX9;HMGB1
regulation of mRNA catabolic process (GO:0061013),5/122,0.008325955251357755,0.06531547657769403,0,0,4.226044753682944,20.235897632773256,SET;XPO1;UBB;PABPC1;DCP2
carbohydrate catabolic process (GO:0016052),3/41,0.008383587281568341,0.06531547657769403,0,0,7.760408483896308,37.106233142458976,PKM;ENO1;HK1
regulation of mitochondrial membrane potential (GO:0051881),3/41,0.008383587281568341,0.06531547657769403,0,0,7.760408483896308,37.106233142458976,TCL1A;UBB;PMAIP1
regulation of lipase activity (GO:0060191),2/14,0.008690990362893284,0.06546999725576595,0,0,16.323432343234323,77.46233204422032,RHOA;SNCA
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),2/14,0.008690990362893284,0.06546999725576595,0,0,16.323432343234323,77.46233204422032,NCL;MACROH2A1
response to X-ray (GO:0010165),2/14,0.008690990362893284,0.06546999725576595,0,0,16.323432343234323,77.46233204422032,XRCC5;NUCKS1
T-helper cell differentiation (GO:0042093),2/14,0.008690990362893284,0.06546999725576595,0,0,16.323432343234323,77.46233204422032,LEF1;HMGB1
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",2/14,0.008690990362893284,0.06546999725576595,0,0,16.323432343234323,77.46233204422032,CD74;MDM2
nuclear migration (GO:0007097),2/14,0.008690990362893284,0.06546999725576595,0,0,16.323432343234323,77.46233204422032,SUN2;SYNE3
positive regulation of lymphocyte migration (GO:2000403),2/14,0.008690990362893284,0.06546999725576595,0,0,16.323432343234323,77.46233204422032,DOCK8;RHOA
positive regulation of regulatory T cell differentiation (GO:0045591),2/14,0.008690990362893284,0.06546999725576595,0,0,16.323432343234323,77.46233204422032,HLA-DRA;HLA-DRB1
positive regulation of T cell chemotaxis (GO:0010820),2/14,0.008690990362893284,0.06546999725576595,0,0,16.323432343234323,77.46233204422032,WNK1;ADAM10
defense response to symbiont (GO:0140546),5/124,0.00889793527473979,0.06678340431480524,0,0,4.154596511971623,19.617738921604854,BNIP3L;IFI27;IFI16;IRF1;PMAIP1
negative regulation of protein modification process (GO:0031400),4/81,0.009490668236068358,0.07097218691862797,0,0,5.121818181818182,23.85459290498654,PPP1R15A;PPP1R15B;ATP2B4;PPIA
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),3/43,0.009562545887048374,0.07124966008204407,0,0,7.371641791044776,34.277406608692765,HLA-DRA;HLA-DRB1;HLA-E
regulation of T cell chemotaxis (GO:0010819),2/15,0.009961204596400444,0.0731559434337796,0,0,15.067022086824068,69.44476770588811,WNK1;ADAM10
macrophage differentiation (GO:0030225),2/15,0.009961204596400444,0.0731559434337796,0,0,15.067022086824068,69.44476770588811,PARP1;HLA-DRB1
modulation by host of viral genome replication (GO:0044827),2/15,0.009961204596400444,0.0731559434337796,0,0,15.067022086824068,69.44476770588811,IFI27;NUCKS1
positive regulation of response to cytokine stimulus (GO:0060760),2/15,0.009961204596400444,0.0731559434337796,0,0,15.067022086824068,69.44476770588811,CD74;DHX9
antibacterial humoral response (GO:0019731),3/44,0.01018638490716654,0.07454250955280085,0,0,7.1914816163087005,32.9851921979975,H2BC21;H2BC11;HLA-E
RNA processing (GO:0006396),6/179,0.010251191282386543,0.07474978981355881,0,0,3.437204414083027,15.74363827602281,RBM3;HNRNPK;NONO;HNRNPU;SRSF5;SF3B1
nuclear export (GO:0051168),4/84,0.010751076390100645,0.07811686355785893,0,0,4.929,22.341921793139147,XPO1;STRADB;SRSF5;HNRNPA1
chromosome condensation (GO:0030261),3/45,0.010833348063501596,0.07843650241029954,0,0,7.019900497512438,31.765935091320298,TOP2A;SET;H1-0
gene expression (GO:0010467),9/356,0.011091924605396765,0.08002589266358441,0,0,2.5868765240523164,11.644922840994534,RANBP2;EEF1A1;RBM3;HNRNPK;HNRNPU;RPL15;SRSF5;PTMA;GSPT1
regulation of ATP biosynthetic process (GO:2001169),2/16,0.011308393132852779,0.08017611601804618,0,0,13.990099009900991,62.7065627163399,PARP1;ENO1
regulation of interleukin-1 production (GO:0032652),2/16,0.011308393132852779,0.08017611601804618,0,0,13.990099009900991,62.7065627163399,TMED10;HMGB1
regulation of interleukin-13 production (GO:0032656),2/16,0.011308393132852779,0.08017611601804618,0,0,13.990099009900991,62.7065627163399,LEF1;HLA-E
sympathetic nervous system development (GO:0048485),2/16,0.011308393132852779,0.08017611601804618,0,0,13.990099009900991,62.7065627163399,CTNNB1;SOX4
protein localization to endoplasmic reticulum (GO:0070972),2/16,0.011308393132852779,0.08017611601804618,0,0,13.990099009900991,62.7065627163399,PPP1R15A;HSPA5
regulation of B cell proliferation (GO:0030888),3/46,0.011503582919535415,0.08099945499013081,0,0,6.85629989586949,30.614042271799896,CD74;TFRC;NCKAP1L
interleukin-12-mediated signaling pathway (GO:0035722),3/46,0.011503582919535415,0.08099945499013081,0,0,6.85629989586949,30.614042271799896,CA1;HNRNPDL;PPIA
regulation of interferon-gamma production (GO:0032649),4/86,0.011648596611565292,0.08146066367609994,0,0,4.8082926829268295,21.409257677658704,HLA-DPB1;HMGB1;HLA-DRB1;HLA-DPA1
glucose homeostasis (GO:0042593),4/86,0.011648596611565292,0.08146066367609994,0,0,4.8082926829268295,21.409257677658704,NUCKS1;ADIPOR1;SOX4;HK1
defense response to virus (GO:0051607),5/133,0.011809181802962847,0.0823027670553431,0,0,3.860709798994975,17.13721952549904,BNIP3L;IFI27;IFI16;IRF1;PMAIP1
telomere organization (GO:0032200),3/47,0.012197224855688953,0.08471902959087005,0,0,6.700135685210312,29.524461623788078,PCNA;PARP1;XRCC5
cellular response to gamma radiation (GO:0071480),2/17,0.012730869441244937,0.08666296174455441,0,0,13.056765676567657,56.97614224616206,XRCC5;MDM2
regulation of stem cell proliferation (GO:0072091),2/17,0.012730869441244937,0.08666296174455441,0,0,13.056765676567657,56.97614224616206,HMGB2;HNRNPU
gliogenesis (GO:0042063),2/17,0.012730869441244937,0.08666296174455441,0,0,13.056765676567657,56.97614224616206,CDK6;CD9
negative regulation of cell aging (GO:0090344),2/17,0.012730869441244937,0.08666296174455441,0,0,13.056765676567657,56.97614224616206,CDK6;YBX1
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),2/17,0.012730869441244937,0.08666296174455441,0,0,13.056765676567657,56.97614224616206,CD74;MDM2
positive regulation of DNA replication (GO:0045740),2/17,0.012730869441244937,0.08666296174455441,0,0,13.056765676567657,56.97614224616206,PCNA;DHX9
cellular response to interleukin-12 (GO:0071349),3/48,0.012914397373668859,0.08733201392292901,0,0,6.5509121061359865,28.49261909572259,CA1;HNRNPDL;PPIA
positive regulation of endocytosis (GO:0045807),3/48,0.012914397373668859,0.08733201392292901,0,0,6.5509121061359865,28.49261909572259,HNRNPK;NCKAP1L;SNCA
negative regulation of protein kinase activity (GO:0006469),4/90,0.013584832391140089,0.09143637310948527,0,0,4.583720930232558,19.704505832772664,UBASH3B;PPIA;MACROH2A1;SNCA
receptor internalization (GO:0031623),3/49,0.013655212382382865,0.09143637310948527,0,0,6.408176508760545,27.514364348420884,TFRC;CD9;SNCA
regulation of interferon-beta production (GO:0032648),3/49,0.013655212382382865,0.09143637310948527,0,0,6.408176508760545,27.514364348420884,DHX9;RIOK3;IRF1
toll-like receptor signaling pathway (GO:0002224),4/91,0.014098884316424427,0.09254307256914944,0,0,4.53080459770115,19.308746960368286,UBB;UBE2D3;HMGB1;PIK3AP1
regulation of B cell differentiation (GO:0045577),2/18,0.014226973088961481,0.09254307256914944,0,0,12.240099009900991,52.052436030078844,XBP1;NCKAP1L
cellular response to dsRNA (GO:0071359),2/18,0.014226973088961481,0.09254307256914944,0,0,12.240099009900991,52.052436030078844,DHX9;RIOK3
DNA strand elongation involved in DNA replication (GO:0006271),2/18,0.014226973088961481,0.09254307256914944,0,0,12.240099009900991,52.052436030078844,PCNA;MCM7
glycoprotein catabolic process (GO:0006516),2/18,0.014226973088961481,0.09254307256914944,0,0,12.240099009900991,52.052436030078844,EDEM1;STT3B
negative regulation of signal transduction by p53 class mediator (GO:1901797),2/18,0.014226973088961481,0.09254307256914944,0,0,12.240099009900991,52.052436030078844,CD74;MDM2
positive regulation of lymphocyte chemotaxis (GO:0140131),2/18,0.014226973088961481,0.09254307256914944,0,0,12.240099009900991,52.052436030078844,WNK1;ADAM10
positive regulation of phosphoprotein phosphatase activity (GO:0032516),2/18,0.014226973088961481,0.09254307256914944,0,0,12.240099009900991,52.052436030078844,PPP1R15A;PPP1R15B
positive regulation of response to endoplasmic reticulum stress (GO:1905898),2/18,0.014226973088961481,0.09254307256914944,0,0,12.240099009900991,52.052436030078844,XBP1;PMAIP1
regulation of cellular component movement (GO:0051270),3/50,0.014419770490905719,0.09350034726539816,0,0,6.271514766592569,26.585923577223326,CDK6;CD9;RHOA
positive regulation of peptidyl-serine phosphorylation (GO:0033138),4/93,0.015163630641969168,0.09801349900755466,0,0,4.428539325842697,18.550511042696886,TCL1A;TFRC;ATP2B4;SNCA
chromatin organization (GO:0006325),5/142,0.015309084062210673,0.09864249447631972,0,0,3.6054359388181787,15.068230497442078,MYB;HMGB2;NUCKS1;HMGN2;CHD1
positive regulation of phosphorylation (GO:0042327),7/253,0.01536322506880411,0.09868102873347843,0,0,2.823861994965127,11.791822510195768,CD74;CCND3;TFRC;FLT3;NCKAP1L;PPIA;HLA-DRB1
cellular macromolecule biosynthetic process (GO:0034645),8/314,0.015558080737018556,0.09962033571922194,0,0,2.599706549286381,10.823033609144879,EEF1A1;ALAS2;SET;MCM7;NAP1L1;RPL15;PTMA;GSPT1
receptor-mediated endocytosis (GO:0006898),5/143,0.015736318375628396,0.0998891888717666,0,0,3.5791275216663023,14.859764255972433,TFRC;CANX;CD9;HBA1;SNCA
carbohydrate derivative catabolic process (GO:1901136),2/19,0.015795069396999695,0.0998891888717666,0,0,11.519510774606873,47.78359250200557,BPGM;STT3B
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),2/19,0.015795069396999695,0.0998891888717666,0,0,11.519510774606873,47.78359250200557,NONO;PPIA
positive regulation of neutrophil chemotaxis (GO:0090023),2/19,0.015795069396999695,0.0998891888717666,0,0,11.519510774606873,47.78359250200557,CD74;NCKAP1L
negative regulation of protein-containing complex assembly (GO:0031333),3/52,0.016020463611061984,0.10100286135097233,0,0,6.014925373134329,24.865030216301573,HSPA5;RIOK3;HMGB1
cellular transition metal ion homeostasis (GO:0046916),4/96,0.016853650963294144,0.10562529729885088,0,0,4.283478260869566,17.49024690999969,ALAS2;TFRC;FTH1;FTL
regulation of DNA replication (GO:0006275),3/53,0.016856745835394944,0.10562529729885088,0,0,5.894328358208956,24.066568362183276,PCNA;DHX9;NUCKS1
regulation of macromolecule metabolic process (GO:0060255),6/200,0.01691901151449511,0.1056922396134161,0,0,3.0618556701030926,12.490280951020742,HNRNPK;CDK6;HNRNPDL;TRIM58;YBX1;YBX3
modification-dependent protein catabolic process (GO:0019941),6/201,0.017296422750444705,0.106313518031191,0,0,3.045998445998446,12.358394180400143,XBP1;UBB;UHRF1;MDM2;FBXO7;MIB1
cellular response to interferon-beta (GO:0035458),2/20,0.01743354907685709,0.106313518031191,0,0,10.878987898789878,44.05292561489402,IFI16;IRF1
cellular response to nitrogen compound (GO:1901699),2/20,0.01743354907685709,0.106313518031191,0,0,10.878987898789878,44.05292561489402,RIOK3;ATP2B4
regulation of T cell migration (GO:2000404),2/20,0.01743354907685709,0.106313518031191,0,0,10.878987898789878,44.05292561489402,DOCK8;RHOA
maintenance of protein location in nucleus (GO:0051457),2/20,0.01743354907685709,0.106313518031191,0,0,10.878987898789878,44.05292561489402,SUN2;HNRNPU
myeloid cell development (GO:0061515),2/20,0.01743354907685709,0.106313518031191,0,0,10.878987898789878,44.05292561489402,ALAS2;NCKAP1L
negative regulation of viral life cycle (GO:1903901),2/20,0.01743354907685709,0.106313518031191,0,0,10.878987898789878,44.05292561489402,CIITA;PPIA
positive regulation of lymphocyte differentiation (GO:0045621),2/20,0.01743354907685709,0.106313518031191,0,0,10.878987898789878,44.05292561489402,XBP1;NCKAP1L
regulation of peptidyl-serine phosphorylation (GO:0033135),4/98,0.01804320957407287,0.10949830807286162,0,0,4.191914893617021,16.83047904878946,TCL1A;TFRC;ATP2B4;SNCA
regulation of angiogenesis (GO:0045765),6/203,0.018068555557301285,0.10949830807286162,0,0,3.0147669589293953,12.100014742813013,XBP1;PRKCB;GAB1;ATP2B4;CTNNB1;GLUL
cellular response to oxygen-containing compound (GO:1901701),8/323,0.01811611831952176,0.10949830807286162,0,0,2.524263038548753,10.124700967876873,FAM210B;XBP1;JUN;NRIP1;HMGB2;ATP2B4;HMGB1;RHOA
pyruvate metabolic process (GO:0006090),3/55,0.01860147271036573,0.11112893986828888,0,0,5.667049368541906,22.580440513897557,PKM;ENO1;HK1
interstrand cross-link repair (GO:0036297),3/55,0.01860147271036573,0.11112893986828888,0,0,5.667049368541906,22.580440513897557,MSH6;UBB;NUCKS1
positive regulation of response to DNA damage stimulus (GO:2001022),3/55,0.01860147271036573,0.11112893986828888,0,0,5.667049368541906,22.580440513897557,PCNA;DHX9;PMAIP1
response to UV (GO:0009411),4/99,0.018657079216540445,0.11112893986828888,0,0,4.147578947368421,16.513708439606248,MSH6;PCNA;PARP1;CAT
organic anion transport (GO:0015711),4/99,0.018657079216540445,0.11112893986828888,0,0,4.147578947368421,16.513708439606248,CA1;CA2;SLC4A1;HBA1
cellular response to organic cyclic compound (GO:0071407),5/150,0.01895099511865503,0.1120558753568228,0,0,3.405129093744585,13.504397509225127,FAM210B;RIOK3;NCOA4;NRIP1;CTNNB1
regulation of cell-substrate junction assembly (GO:0090109),2/21,0.01914082790380087,0.1120558753568228,0,0,10.3058884835852,40.76939031744604,RHOA;ACTG1
cellular response to estradiol stimulus (GO:0071392),2/21,0.01914082790380087,0.1120558753568228,0,0,10.3058884835852,40.76939031744604,FAM210B;NRIP1
error-prone translesion synthesis (GO:0042276),2/21,0.01914082790380087,0.1120558753568228,0,0,10.3058884835852,40.76939031744604,PCNA;UBB
innate immune response in mucosa (GO:0002227),2/21,0.01914082790380087,0.1120558753568228,0,0,10.3058884835852,40.76939031744604,H2BC21;H2BC11
positive regulation of phosphatase activity (GO:0010922),2/21,0.01914082790380087,0.1120558753568228,0,0,10.3058884835852,40.76939031744604,PPP1R15A;PPP1R15B
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",3/56,0.019510004118453834,0.11356817738270429,0,0,5.5598422979442415,21.888142351829547,PCNA;MDM2;SOX4
telomere maintenance (GO:0000723),3/56,0.019510004118453834,0.11356817738270429,0,0,5.5598422979442415,21.888142351829547,PCNA;PARP1;XRCC5
negative regulation of protein phosphorylation (GO:0001933),5/152,0.019943103453843213,0.1157603937023364,0,0,3.358458961474037,13.147936571743413,PPP1R15B;UBASH3B;PPIA;MACROH2A1;SNCA
"positive regulation of gene expression, epigenetic (GO:0045815)",3/57,0.02044268945320505,0.11773501294458427,0,0,5.456605859590934,21.226905848947467,MACROH2A1;SF3B1;H1-0
intrinsic apoptotic signaling pathway (GO:0097193),4/102,0.020575884645902813,0.11773501294458427,0,0,4.02,15.612214859494337,MSH6;PPP1R15A;IFI16;PMAIP1
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),2/22,0.020915346369852938,0.11773501294458427,0,0,9.79009900990099,37.86097688832336,XBP1;PMAIP1
cellular response to osmotic stress (GO:0071470),2/22,0.020915346369852938,0.11773501294458427,0,0,9.79009900990099,37.86097688832336,RCSD1;YBX3
error-free translesion synthesis (GO:0070987),2/22,0.020915346369852938,0.11773501294458427,0,0,9.79009900990099,37.86097688832336,PCNA;UBB
heme biosynthetic process (GO:0006783),2/22,0.020915346369852938,0.11773501294458427,0,0,9.79009900990099,37.86097688832336,ALAS2;FECH
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",2/22,0.020915346369852938,0.11773501294458427,0,0,9.79009900990099,37.86097688832336,PARP1;UBB
positive regulation of granulocyte chemotaxis (GO:0071624),2/22,0.020915346369852938,0.11773501294458427,0,0,9.79009900990099,37.86097688832336,CD74;NCKAP1L
positive regulation of neural precursor cell proliferation (GO:2000179),2/22,0.020915346369852938,0.11773501294458427,0,0,9.79009900990099,37.86097688832336,CTNNB1;NAP1L1
positive regulation of neutrophil migration (GO:1902624),2/22,0.020915346369852938,0.11773501294458427,0,0,9.79009900990099,37.86097688832336,CD74;NCKAP1L
positive regulation of signal transduction by p53 class mediator (GO:1901798),2/22,0.020915346369852938,0.11773501294458427,0,0,9.79009900990099,37.86097688832336,UBB;PMAIP1
receptor metabolic process (GO:0043112),3/58,0.021399548630225574,0.11980239110200054,0,0,5.357123473541384,20.59484753136975,TFRC;CD9;SNCA
regulation of calcium ion transport (GO:0051924),3/58,0.021399548630225574,0.11980239110200054,0,0,5.357123473541384,20.59484753136975,EPB41;SARAF;CTNNB1
positive regulation of NF-kappaB transcription factor activity (GO:0051092),5/155,0.021494148576940403,0.12000411562438934,0,0,3.290787269681742,12.636539332471749,TFRC;UBB;PRKCB;DHX9;PPIA
response to reactive oxygen species (GO:0000302),3/59,0.022380592618769304,0.12400574887173774,0,0,5.2611940298507465,19.990228157543854,JUN;CAT;HBA1
mitotic spindle organization (GO:0007052),5/157,0.022570653715718775,0.12400574887173774,0,0,3.247156836815657,12.310311625731948,RANBP2;SUN2;XPO1;STMN1;RHOA
regulation of B cell receptor signaling pathway (GO:0050855),2/23,0.022755569339079254,0.12400574887173774,0,0,9.323432343234323,35.27003509816899,PRKCB;PAX5
cytoskeleton-dependent intracellular transport (GO:0030705),2/23,0.022755569339079254,0.12400574887173774,0,0,9.323432343234323,35.27003509816899,TUBA1A;TUBB
regulation of necroptotic process (GO:0060544),2/23,0.022755569339079254,0.12400574887173774,0,0,9.323432343234323,35.27003509816899,CYLD;YBX3
membrane protein ectodomain proteolysis (GO:0006509),2/23,0.022755569339079254,0.12400574887173774,0,0,9.323432343234323,35.27003509816899,ADAM10;RBMX
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),2/23,0.022755569339079254,0.12400574887173774,0,0,9.323432343234323,35.27003509816899,STMN1;SNCA
negative regulation of phosphoprotein phosphatase activity (GO:0032515),2/23,0.022755569339079254,0.12400574887173774,0,0,9.323432343234323,35.27003509816899,PPP1R15A;NCKAP1L
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",2/23,0.022755569339079254,0.12400574887173774,0,0,9.323432343234323,35.27003509816899,PARP1;UBB
cellular response to starvation (GO:0009267),5/158,0.023121785128131615,0.1256672088263705,0,0,3.225769369724439,12.151408786603032,XBP1;HSPA5;IFI16;PMAIP1;HNRNPA1
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),9/404,0.023228855797881243,0.12576785493803147,0,0,2.266913339824732,8.528944047782467,SOCS2;UBASH3B;FLT3;STMN1;GAB1;NCKAP1L;HNRNPA1;RHOA;ACTG1
cellular response to chemokine (GO:1990869),3/60,0.02338582368540263,0.12576785493803147,0,0,5.168630531552762,19.41143941292859,WNK1;DOCK8;RHOA
response to organic cyclic compound (GO:0014070),3/60,0.02338582368540263,0.12576785493803147,0,0,5.168630531552762,19.41143941292859,SOCS2;PMAIP1;CTNNB1
Notch signaling pathway (GO:0007219),3/60,0.02338582368540263,0.12576785493803147,0,0,5.168630531552762,19.41143941292859,ADAM10;YBX1;MIB1
response to lipopolysaccharide (GO:0032496),5/159,0.023681560684290923,0.1270249158170474,0,0,3.2046596619460943,11.995228791911462,XBP1;HMGB2;HMGB1;RHOA;SNCA
"regulation of DNA-templated transcription, initiation (GO:2000142)",3/61,0.02441523562157777,0.1285707653113731,0,0,5.0792588780236745,18.85699203773558,JUN;LEF1;CTNNB1
negative regulation of response to stimulus (GO:0048585),3/61,0.02441523562157777,0.1285707653113731,0,0,5.0792588780236745,18.85699203773558,CDK6;UBASH3B;YBX1
regulation of cell migration (GO:0030334),9/408,0.024551608957264746,0.1285707653113731,0,0,2.243724696356275,8.31743783820524,CD74;SUN2;XBP1;HSPA5;LEF1;ADAM10;TMSB10;RHOA;ACTG1
cellular response to catecholamine stimulus (GO:0071870),2/24,0.024659985733220903,0.1285707653113731,0,0,8.8991899189919,32.94990351773024,ATP2B4;SNCA
response to gamma radiation (GO:0010332),2/24,0.024659985733220903,0.1285707653113731,0,0,8.8991899189919,32.94990351773024,XRCC5;MDM2
negative regulation of NIK/NF-kappaB signaling (GO:1901223),2/24,0.024659985733220903,0.1285707653113731,0,0,8.8991899189919,32.94990351773024,CYLD;ADIPOR1
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",2/24,0.024659985733220903,0.1285707653113731,0,0,8.8991899189919,32.94990351773024,CYLD;UBB
"nucleotide-excision repair, DNA gap filling (GO:0006297)",2/24,0.024659985733220903,0.1285707653113731,0,0,8.8991899189919,32.94990351773024,PCNA;UBB
porphyrin-containing compound biosynthetic process (GO:0006779),2/24,0.024659985733220903,0.1285707653113731,0,0,8.8991899189919,32.94990351773024,ALAS2;FECH
positive regulation of viral life cycle (GO:1903902),2/24,0.024659985733220903,0.1285707653113731,0,0,8.8991899189919,32.94990351773024,CD74;HLA-DRB1
"protein alpha-1,2-demannosylation (GO:0036508)",2/24,0.024659985733220903,0.1285707653113731,0,0,8.8991899189919,32.94990351773024,UBB;EDEM1
positive regulation of intracellular signal transduction (GO:1902533),11/546,0.02480369094872389,0.12899178363942956,0,0,2.0519200038739043,7.585461555943227,CD74;TFRC;PRKCB;FLT3;GAB1;PMAIP1;IQGAP1;HMGB1;PIK3AP1;HLA-DRB1;RHOA
positive regulation of cysteine-type endopeptidase activity (GO:2001056),3/62,0.025468813981809085,0.13178181779981518,0,0,4.992916772071844,18.325505206469185,IFI16;PMAIP1;HMGB1
positive regulation of interleukin-1 production (GO:0032732),3/62,0.025468813981809085,0.13178181779981518,0,0,4.992916772071844,18.325505206469185,TMED10;IFI16;HMGB1
positive regulation of multicellular organismal process (GO:0051240),8/345,0.0256173200882392,0.13221634473753682,0,0,2.356809786229032,8.63649785756496,XBP1;TFRC;IFI16;LEF1;CTNNB1;ENO1;ADIPOR1;MACROH2A1
positive regulation of cell motility (GO:2000147),6/221,0.026102374152485376,0.13438131818704155,0,0,2.759830866807611,10.061595440273335,SUN2;XBP1;HSPA5;LEF1;ADAM10;ACTG1
response to endoplasmic reticulum stress (GO:0034976),4/110,0.026269422354702514,0.13438163719126256,0,0,3.7150943396226417,13.520527337779066,PPP1R15A;PPP1R15B;JUN;HSPA5
response to tumor necrosis factor (GO:0034612),4/110,0.026269422354702514,0.13438163719126256,0,0,3.7150943396226417,13.520527337779066,TCL1A;DHX9;ADAM10;YBX3
positive regulation of DNA metabolic process (GO:0051054),3/63,0.02654653629560089,0.13438163719126256,0,0,4.909452736318408,17.815697016356694,PCNA;DHX9;HMGB1
positive regulation of viral process (GO:0048524),3/63,0.02654653629560089,0.13438163719126256,0,0,4.909452736318408,17.815697016356694,DHX9;PABPC1;PPIA
cellular response to hexose stimulus (GO:0071331),2/25,0.026627108198951973,0.13438163719126256,0,0,8.511838140335772,30.86243958452893,XBP1;SOX4
response to dsRNA (GO:0043331),2/25,0.026627108198951973,0.13438163719126256,0,0,8.511838140335772,30.86243958452893,RIOK3;PMAIP1
negative regulation of actin filament polymerization (GO:0030837),2/25,0.026627108198951973,0.13438163719126256,0,0,8.511838140335772,30.86243958452893,SSH2;TMSB10
negative regulation of ion transport (GO:0043271),2/25,0.026627108198951973,0.13438163719126256,0,0,8.511838140335772,30.86243958452893,WNK1;SNCA
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),6/224,0.027639328652620917,0.138851752082702,0,0,2.7214345287739783,9.765910177490152,CD74;TFRC;PRKCB;RIOK3;HLA-DRB1;RHOA
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),3/64,0.027648372303437,0.138851752082702,0,0,4.828725226327379,17.32637594343963,H2BC21;H2BC11;HMGN2
protein-containing complex subunit organization (GO:0043933),4/112,0.027826095863917977,0.13915938742615241,0,0,3.645925925925926,13.05890820323066,CD74;WIPF1;MDM2;NCKAP1L
regulation of MAPK cascade (GO:0043408),5/166,0.027845460636760605,0.13915938742615241,0,0,3.064234214551016,10.973284160281443,CD74;FLT3;IQGAP1;HMGB1;HLA-DRB1
glial cell development (GO:0021782),2/26,0.028655472782532877,0.14104906280224766,0,0,8.156765676567657,28.976182743409304,CDK6;SOX4
global genome nucleotide-excision repair (GO:0070911),2/26,0.028655472782532877,0.14104906280224766,0,0,8.156765676567657,28.976182743409304,UBB;PARP1
mononuclear cell differentiation (GO:1903131),2/26,0.028655472782532877,0.14104906280224766,0,0,8.156765676567657,28.976182743409304,IFI16;FLT3
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),2/26,0.028655472782532877,0.14104906280224766,0,0,8.156765676567657,28.976182743409304,KMT2E;CCND3
positive regulation of histone methylation (GO:0031062),2/26,0.028655472782532877,0.14104906280224766,0,0,8.156765676567657,28.976182743409304,MYB;CTNNB1
cellular response to type I interferon (GO:0071357),3/65,0.02877428416366009,0.14104906280224766,0,0,4.750601829561868,16.856433163813367,IFI27;IRF1;HLA-E
type I interferon signaling pathway (GO:0060337),3/65,0.02877428416366009,0.14104906280224766,0,0,4.750601829561868,16.856433163813367,IFI27;IRF1;HLA-E
mitotic G1 DNA damage checkpoint signaling (GO:0031571),3/65,0.02877428416366009,0.14104906280224766,0,0,4.750601829561868,16.856433163813367,PCNA;MDM2;SOX4
ubiquitin-dependent protein catabolic process (GO:0006511),8/354,0.029234554146341022,0.14296324927411158,0,0,2.294443789076324,8.104902207567818,XBP1;IFI27;UHRF1;UBE2D3;MDM2;CTNNB1;FBXO7;MIB1
response to lipid (GO:0033993),4/114,0.029436747725301284,0.14326816173192952,0,0,3.5792727272727274,12.618767027453668,SOCS2;HMGB2;CTNNB1;SNCA
positive regulation of cellular component organization (GO:0051130),4/114,0.029436747725301284,0.14326816173192952,0,0,3.5792727272727274,12.618767027453668,PPP1R15A;TCL1A;TFRC;SNCA
cellular response to molecule of bacterial origin (GO:0071219),4/115,0.030262398401348988,0.14693756948901437,0,0,3.546846846846847,12.406335809997756,XBP1;HMGB2;HMGB1;RHOA
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),2/27,0.0307436386090805,0.14785906362963738,0,0,7.83009900990099,27.264969933974623,CYLD;UBB
positive regulation of gene silencing by miRNA (GO:2000637),2/27,0.0307436386090805,0.14785906362963738,0,0,7.83009900990099,27.264969933974623,DDX6;DHX9
presynaptic endocytosis (GO:0140238),2/27,0.0307436386090805,0.14785906362963738,0,0,7.83009900990099,27.264969933974623,CANX;SNCA
protein export from nucleus (GO:0006611),2/27,0.0307436386090805,0.14785906362963738,0,0,7.83009900990099,27.264969933974623,XPO1;STRADB
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),5/171,0.031087527472086735,0.14785906362963738,0,0,2.9711812072410244,10.312817210471591,CD74;TFRC;PRKCB;HLA-DRB1;RHOA
regulation of viral genome replication (GO:0045069),3/67,0.031098147439395204,0.14785906362963738,0,0,4.601679104477612,15.970619847210095,IFI16;PABPC1;PPIA
negative regulation of cellular process (GO:0048523),11/566,0.031099192285217913,0.14785906362963738,0,0,1.9759230733323998,6.857586121332378,BNIP3L;CDK6;FTH1;IRF1;ARHGDIB;FHL1;CTNNB1;ADAM10;CD9;ENO1;SOX4
regulation of protein-containing complex assembly (GO:0043254),4/116,0.031101638079245344,0.14785906362963738,0,0,3.515,12.198789186237212,TCL1A;TFRC;HSPA5;RIOK3
positive regulation of angiogenesis (GO:0045766),4/116,0.031101638079245344,0.14785906362963738,0,0,3.515,12.198789186237212,XBP1;PKM;PRKCB;GAB1
regulation of myeloid cell differentiation (GO:0045637),3/68,0.03229598716730943,0.15316362346378828,0,0,4.530654420206659,15.552886188013064,KMT2E;CDK6;PRKCB
positive regulation of protein-containing complex assembly (GO:0031334),4/118,0.03282098714526482,0.15316362346378828,0,0,3.452982456140351,11.797760670429339,TCL1A;TFRC;PARP1;SNCA
cellular response to epidermal growth factor stimulus (GO:0071364),2/28,0.032890187566650485,0.15316362346378828,0,0,7.528560548362528,25.706879173013117,EEF1A1;IQGAP1
regulation of immunoglobulin production (GO:0002637),2/28,0.032890187566650485,0.15316362346378828,0,0,7.528560548362528,25.706879173013117,XBP1;HLA-E
regulation of sodium ion transmembrane transport (GO:1902305),2/28,0.032890187566650485,0.15316362346378828,0,0,7.528560548362528,25.706879173013117,ATP2B4;UTRN
response to interferon-beta (GO:0035456),2/28,0.032890187566650485,0.15316362346378828,0,0,7.528560548362528,25.706879173013117,IFI16;IRF1
mucosal immune response (GO:0002385),2/28,0.032890187566650485,0.15316362346378828,0,0,7.528560548362528,25.706879173013117,H2BC21;H2BC11
negative regulation of oxidative stress-induced cell death (GO:1903202),2/28,0.032890187566650485,0.15316362346378828,0,0,7.528560548362528,25.706879173013117,FBXO7;PPIA
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),2/28,0.032890187566650485,0.15316362346378828,0,0,7.528560548362528,25.706879173013117,CYLD;UBB
cellular response to decreased oxygen levels (GO:0036294),3/69,0.03351767977029721,0.15573180464702716,0,0,4.4617819990954315,15.150793826274809,BNIP3L;MDM2;PMAIP1
defense response to bacterium (GO:0042742),5/176,0.03455742474013089,0.15965113823167532,0,0,2.8835698962649503,9.703595793123066,H2BC21;H2BC11;HMGB2;GBP4;HLA-E
cellular response to lipopolysaccharide (GO:0071222),4/120,0.03459497578080226,0.15965113823167532,0,0,3.393103448275862,11.41455885190288,XBP1;HMGB2;HMGB1;RHOA
cytoskeleton organization (GO:0007010),4/120,0.03459497578080226,0.15965113823167532,0,0,3.393103448275862,11.41455885190288,DPYSL2;ANK1;SYNE3;RHOA
beta-catenin-TCF complex assembly (GO:1904837),2/29,0.035093724013126076,0.15979342333976743,0,0,7.24935826916025,24.283414387731682,LEF1;CTNNB1
mismatch repair (GO:0006298),2/29,0.035093724013126076,0.15979342333976743,0,0,7.24935826916025,24.283414387731682,MSH6;PCNA
negative regulation of interferon-gamma production (GO:0032689),2/29,0.035093724013126076,0.15979342333976743,0,0,7.24935826916025,24.283414387731682,HMGB1;HLA-DRB1
negative regulation of transferase activity (GO:0051348),2/29,0.035093724013126076,0.15979342333976743,0,0,7.24935826916025,24.283414387731682,EIF4A2;HNRNPU
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",2/29,0.035093724013126076,0.15979342333976743,0,0,7.24935826916025,24.283414387731682,UBB;PARP1
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),2/29,0.035093724013126076,0.15979342333976743,0,0,7.24935826916025,24.283414387731682,CYLD;PMAIP1
regulation of mitotic cell cycle (GO:0007346),5/178,0.03600994993838301,0.1633412333148582,0,0,2.84994335841055,9.47309770150218,CYLD;MDM2;HNRNPU;HECA;IQGAP1
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),3/71,0.036032326724409904,0.1633412333148582,0,0,4.330114135206322,14.390436222542569,WIPF1;NCKAP1L;ACTG1
cell junction organization (GO:0034330),3/72,0.03732511690788735,0.16602177819056352,0,0,4.267142548128921,14.030743635020325,RHOA;ACTG1;SNCA
Fc-gamma receptor signaling pathway (GO:0038094),3/72,0.03732511690788735,0.16602177819056352,0,0,4.267142548128921,14.030743635020325,WIPF1;NCKAP1L;ACTG1
negative regulation of supramolecular fiber organization (GO:1902904),3/72,0.03732511690788735,0.16602177819056352,0,0,4.267142548128921,14.030743635020325,STMN1;SSH2;SNCA
positive regulation of protein secretion (GO:0050714),3/72,0.03732511690788735,0.16602177819056352,0,0,4.267142548128921,14.030743635020325,TMED10;PPIA;SOX4
positive regulation of secretion by cell (GO:1903532),3/72,0.03732511690788735,0.16602177819056352,0,0,4.267142548128921,14.030743635020325,TMED10;PPIA;SNCA
regulation of cation transmembrane transport (GO:1904062),2/30,0.037352874448926196,0.16602177819056352,0,0,6.99009900990099,22.97886989951578,WNK1;ATP2B4
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),2/30,0.037352874448926196,0.16602177819056352,0,0,6.99009900990099,22.97886989951578,UBB;UBE2D3
positive regulation of DNA recombination (GO:0045911),2/30,0.037352874448926196,0.16602177819056352,0,0,6.99009900990099,22.97886989951578,TFRC;PARP1
positive regulation of phosphate metabolic process (GO:0045937),2/30,0.037352874448926196,0.16602177819056352,0,0,6.99009900990099,22.97886989951578,NCKAP1L;SNCA
ubiquitin-dependent ERAD pathway (GO:0030433),3/73,0.03864143201371329,0.17100711489438128,0,0,4.205970149253731,13.683830345638446,HSPA5;EDEM1;STT3B
negative regulation of cell adhesion (GO:0007162),3/73,0.03864143201371329,0.17100711489438128,0,0,4.205970149253731,13.683830345638446,ARHGDIB;ADAM10;RHOA
negative regulation of cytokine production (GO:0001818),5/182,0.03902671624324272,0.1723399603069059,0,0,2.7849700479800132,9.033074957230793,CYLD;LEF1;NCKAP1L;HMGB1;HLA-DRB1
regulation of cellular pH (GO:0030641),2/31,0.03966628721748877,0.173562346875092,0,0,6.748719699556163,21.77983021931005,CA2;SLC4A1
regulation of cellular senescence (GO:2000772),2/31,0.03966628721748877,0.173562346875092,0,0,6.748719699556163,21.77983021931005,CDK6;YBX1
MyD88-independent toll-like receptor signaling pathway (GO:0002756),2/31,0.03966628721748877,0.173562346875092,0,0,6.748719699556163,21.77983021931005,UBB;UBE2D3
negative regulation of response to DNA damage stimulus (GO:2001021),2/31,0.03966628721748877,0.173562346875092,0,0,6.748719699556163,21.77983021931005,CD74;MDM2
proteolysis involved in cellular protein catabolic process (GO:0051603),3/74,0.03998117507322763,0.173562346875092,0,0,4.14652091654404,13.349087843731935,UBB;MDM2;PMAIP1
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",3/74,0.03998117507322763,0.173562346875092,0,0,4.14652091654404,13.349087843731935,PCNA;MDM2;SOX4
regulation of stress fiber assembly (GO:0051492),3/74,0.03998117507322763,0.173562346875092,0,0,4.14652091654404,13.349087843731935,STMN1;RHOA;ACTG1
Fc receptor mediated stimulatory signaling pathway (GO:0002431),3/74,0.03998117507322763,0.173562346875092,0,0,4.14652091654404,13.349087843731935,WIPF1;NCKAP1L;ACTG1
positive regulation of DNA-binding transcription factor activity (GO:0051091),6/246,0.04075078409593243,0.17652929516398636,0,0,2.4691919191919194,7.902106003711778,TFRC;UBB;PRKCB;DHX9;CTNNB1;PPIA
nucleic acid phosphodiester bond hydrolysis (GO:0090305),3/75,0.041344243493989505,0.1778861951833347,0,0,4.088723051409619,13.025944181810136,PCNA;PARP1;UBB
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),5/185,0.04138766450308569,0.1778861951833347,0,0,2.7381351200446677,8.72033716165545,TMED10;ANK1;SPTAN1;SPTB;ERGIC1
regulation of cellular amide metabolic process (GO:0034248),2/32,0.04203263221939841,0.1778861951833347,0,0,6.523432343234323,20.674772867416195,RBM3;TMED10
cellular response to glucose stimulus (GO:0071333),2/32,0.04203263221939841,0.1778861951833347,0,0,6.523432343234323,20.674772867416195,XBP1;SOX4
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),2/32,0.04203263221939841,0.1778861951833347,0,0,6.523432343234323,20.674772867416195,ANK1;RHOA
superoxide metabolic process (GO:0006801),2/32,0.04203263221939841,0.1778861951833347,0,0,6.523432343234323,20.674772867416195,PRDX2;PRDX1
negative regulation of microtubule polymerization or depolymerization (GO:0031111),2/32,0.04203263221939841,0.1778861951833347,0,0,6.523432343234323,20.674772867416195,STMN1;SNCA
microtubule cytoskeleton organization involved in mitosis (GO:1902850),4/128,0.04223959942843081,0.1778861951833347,0,0,3.1729032258064516,10.040325838847325,RANBP2;SUN2;XPO1;STMN1
regulation of epithelial to mesenchymal transition (GO:0010717),3/76,0.0427305292274579,0.1778861951833347,0,0,4.032508689429564,12.713861325901654,LEF1;CTNNB1;ADIPOR1
cellular response to hormone stimulus (GO:0032870),3/76,0.0427305292274579,0.1778861951833347,0,0,4.032508689429564,12.713861325901654,SOCS2;XBP1;NCOA4
regulation of RNA splicing (GO:0043484),3/76,0.0427305292274579,0.1778861951833347,0,0,4.032508689429564,12.713861325901654,RBM38;HNRNPK;MBNL3
RNA transport (GO:0050658),3/76,0.0427305292274579,0.1778861951833347,0,0,4.032508689429564,12.713861325901654,YBX1;SRSF5;HNRNPA1
cellular response to insulin stimulus (GO:0032869),4/129,0.043257011653179786,0.1778861951833347,0,0,3.14736,9.884586036445207,XBP1;PKM;PARP1;GAB1
cellular response to UV (GO:0034644),3/77,0.044139918940891816,0.1778861951833347,0,0,3.9778136345300523,12.412332729455924,PCNA;MME;PARP1
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),3/77,0.044139918940891816,0.1778861951833347,0,0,3.9778136345300523,12.412332729455924,FLT3;GAB1;PIK3AP1
positive regulation of tumor necrosis factor production (GO:0032760),3/77,0.044139918940891816,0.1778861951833347,0,0,3.9778136345300523,12.412332729455924,DHX9;HMGB1;HLA-E
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),2/33,0.04445060060490756,0.1778861951833347,0,0,6.31267965506228,19.653750416678832,CANX;HLA-E
regulation of histone acetylation (GO:0035065),2/33,0.04445060060490756,0.1778861951833347,0,0,6.31267965506228,19.653750416678832,SET;SNCA
exonucleolytic catabolism of deadenylated mRNA (GO:0043928),2/33,0.04445060060490756,0.1778861951833347,0,0,6.31267965506228,19.653750416678832,DDX6;DCP2
regulation of sprouting angiogenesis (GO:1903670),2/33,0.04445060060490756,0.1778861951833347,0,0,6.31267965506228,19.653750416678832,PKM;GLUL
signal transduction by p53 class mediator (GO:0072331),2/33,0.04445060060490756,0.1778861951833347,0,0,6.31267965506228,19.653750416678832,IFI16;PMAIP1
neuron projection extension (GO:1990138),2/33,0.04445060060490756,0.1778861951833347,0,0,6.31267965506228,19.653750416678832,CTNNB1;IQGAP1
cellular response to hypoxia (GO:0071456),4/131,0.04533305026575484,0.1778861951833347,0,0,3.09748031496063,9.582733473527458,BNIP3L;UBB;MDM2;PMAIP1
B cell receptor signaling pathway (GO:0050853),2/34,0.04691890447308999,0.1778861951833347,0,0,6.11509900990099,18.708134009682176,PRKCB;NCKAP1L
regulation of glucose metabolic process (GO:0010906),2/34,0.04691890447308999,0.1778861951833347,0,0,6.11509900990099,18.708134009682176,PMAIP1;ADIPOR1
central nervous system neuron differentiation (GO:0021953),2/34,0.04691890447308999,0.1778861951833347,0,0,6.11509900990099,18.708134009682176,CTNNB1;SOX4
regulation of transmembrane transport (GO:0034762),2/34,0.04691890447308999,0.1778861951833347,0,0,6.11509900990099,18.708134009682176,PRKCB;SNCA
synaptic vesicle recycling (GO:0036465),2/34,0.04691890447308999,0.1778861951833347,0,0,6.11509900990099,18.708134009682176,CANX;SNCA
positive regulation of telomerase activity (GO:0051973),2/34,0.04691890447308999,0.1778861951833347,0,0,6.11509900990099,18.708134009682176,XRCC5;CTNNB1
protein destabilization (GO:0031648),2/34,0.04691890447308999,0.1778861951833347,0,0,6.11509900990099,18.708134009682176,MDM2;SNCA
regulation of ion transport (GO:0043269),3/79,0.047027531563970534,0.1778861951833347,0,0,3.8727415553809896,11.839056409366725,CA2;WNK1;SNCA
negative regulation of gene expression (GO:0010629),7/322,0.04760589258082821,0.1778861951833347,0,0,2.197518330513254,6.691001025616005,DDX6;NCL;ATP2B4;ADAM10;YBX1;MACROH2A1;DCP2
regulation of NIK/NF-kappaB signaling (GO:1901222),3/80,0.0485055028998339,0.1778861951833347,0,0,3.8222523744911805,11.566433918832189,CYLD;ADIPOR1;RHOA
negative regulation of cellular component organization (GO:0051129),3/80,0.0485055028998339,0.1778861951833347,0,0,3.8222523744911805,11.566433918832189,HSPA5;RIOK3;XRCC5
"base-excision repair, gap-filling (GO:0006287)",2/35,0.049436276613114706,0.1778861951833347,0,0,5.9294929492949295,17.830404987401263,PCNA;PARP1
negative regulation of cell cycle G1/S phase transition (GO:1902807),2/35,0.049436276613114706,0.1778861951833347,0,0,5.9294929492949295,17.830404987401263,CDK6;FHL1
"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",2/35,0.049436276613114706,0.1778861951833347,0,0,5.9294929492949295,17.830404987401263,DDX6;DCP2
positive regulation of cell cycle G1/S phase transition (GO:1902808),2/35,0.049436276613114706,0.1778861951833347,0,0,5.9294929492949295,17.830404987401263,KMT2E;CCND3
apoptotic chromosome condensation (GO:0030263),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,TOP2A
carbon dioxide transport (GO:0015670),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,CA2
regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,ATP2B4
"CD4-positive, alpha-beta T cell activation (GO:0035710)",1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,HMGB1
cellular response to antibiotic (GO:0071236),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,MDM2
cellular response to indole-3-methanol (GO:0071681),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,CTNNB1
cellular response to nutrient (GO:0031670),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,XBP1
regulation of guanyl-nucleotide exchange factor activity (GO:1905097),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,STMN1
cellular response to sodium arsenite (GO:1903936),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,HNRNPA1
cellular response to testosterone stimulus (GO:0071394),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,NCOA4
regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,MACROH2A1
regulation of natural killer cell mediated immunity (GO:0002715),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,HLA-E
dopamine biosynthetic process (GO:0042416),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,SNCA
embryonic skeletal joint morphogenesis (GO:0060272),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,CTNNB1
regulation of protein monoubiquitination (GO:1902525),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,UBB
regulation of synaptic vesicle recycling (GO:1903421),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,SNCA
glutamate catabolic process (GO:0006538),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,GLUL
response to acetylcholine (GO:1905144),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,ATP2B4
response to fructose (GO:0009750),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,XBP1
response to indole-3-methanol (GO:0071680),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,CTNNB1
response to sodium arsenite (GO:1903935),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,HNRNPA1
histone-threonine phosphorylation (GO:0035405),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,PRKCB
ribosome localization (GO:0033750),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,XPO1
Roundabout signaling pathway (GO:0035385),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,RHOA
kidney morphogenesis (GO:0060993),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,SOX4
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,EDEM1
meiotic mismatch repair (GO:0000710),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,MSH6
tight junction organization (GO:0120193),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,ACTG1
toll-like receptor 2 signaling pathway (GO:0034134),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,PIK3AP1
microtubule nucleation by microtubule organizing center (GO:0051418),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,NIN
mitochondrial DNA repair (GO:0043504),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,PARP1
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,EDEM1
"negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,HMGB1
negative regulation of histone H3-K27 methylation (GO:0061086),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,MACROH2A1
negative regulation of interleukin-13 production (GO:0032696),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,LEF1
negative regulation of interleukin-5 production (GO:0032714),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,LEF1
negative regulation of IRE1-mediated unfolded protein response (GO:1903895),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,HSPA5
negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,NCKAP1L
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,NONO
negative regulation of protein polyubiquitination (GO:1902915),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,PPIA
negative regulation of regulatory T cell differentiation (GO:0045590),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,IRF1
negative regulation of transcription by RNA polymerase I (GO:0016479),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,MACROH2A1
positive regulation by host of viral genome replication (GO:0044829),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,NUCKS1
positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,HNRNPU
positive regulation of cAMP-dependent protein kinase activity (GO:2000481),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,ATP2B4
"positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,NCKAP1L
positive regulation of dendritic cell differentiation (GO:2001200),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,HMGB1
positive regulation of deoxyribonuclease activity (GO:0032077),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,PCNA
positive regulation of DNA ligation (GO:0051106),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,HMGB1
positive regulation of interleukin-18 production (GO:0032741),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,DHX9
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,UBB
positive regulation of low-density lipoprotein receptor activity (GO:1905599),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,HNRNPK
positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,MACROH2A1
positive regulation of maintenance of sister chromatid cohesion (GO:0034093),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,MACROH2A1
positive regulation of MHC class I biosynthetic process (GO:0045345),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,CIITA
positive regulation of natural killer cell proliferation (GO:0032819),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,HLA-E
positive regulation of non-motile cilium assembly (GO:1902857),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,SEPTIN9
positive regulation of nucleobase-containing compound transport (GO:0032241),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,DHX9
positive regulation of prostaglandin biosynthetic process (GO:0031394),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,CD74
positive regulation of protein localization to cell cortex (GO:1904778),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,EPB41
positive regulation of protein monoubiquitination (GO:1902527),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,UBB
positive regulation of RNA export from nucleus (GO:0046833),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,DHX9
positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,HMGB1
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),1/5,0.049974817934996855,0.1778861951833347,0,0,24.374384236453203,73.03140854408878,EDEM1
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),3/81,0.050006075366325425,0.1778861951833347,0,0,3.773057787983161,11.30261255913132,DHX9;HMGB1;HLA-E
"regulation of gene expression, epigenetic (GO:0040029)",3/82,0.05152911166665957,0.18245036372721174,0,0,3.725108634044965,11.047213291905953,IFI16;MACROH2A1;SF3B1
cellular component assembly (GO:0022607),6/261,0.05162473669115031,0.18245036372721174,0,0,2.3221628045157456,6.882320062500237,CD74;WIPF1;MDM2;NCKAP1L;RHOA;ACTG1
regulation of mRNA processing (GO:0050684),2/36,0.05200147018872213,0.18245036372721174,0,0,5.754804892253931,17.01398448930605,HNRNPK;DHX9
regulation of sodium ion transport (GO:0002028),2/36,0.05200147018872213,0.18245036372721174,0,0,5.754804892253931,17.01398448930605,WNK1;ATP2B4
retina homeostasis (GO:0001895),2/36,0.05200147018872213,0.18245036372721174,0,0,5.754804892253931,17.01398448930605,PRDX1;ACTG1
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),2/36,0.05200147018872213,0.18245036372721174,0,0,5.754804892253931,17.01398448930605,IFI16;PMAIP1
transition metal ion transport (GO:0000041),2/36,0.05200147018872213,0.18245036372721174,0,0,5.754804892253931,17.01398448930605,TFRC;FTH1
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",2/36,0.05200147018872213,0.18245036372721174,0,0,5.754804892253931,17.01398448930605,LEF1;CTNNB1
regulation of signal transduction (GO:0009966),5/198,0.05260252264625201,0.18392929846786754,0,0,2.5520087484052385,7.515643309781462,SOCS2;UBASH3B;NUCKS1;PPIA;CDC42SE2
negative regulation of intracellular signal transduction (GO:1902532),5/198,0.05260252264625201,0.18392929846786754,0,0,2.5520087484052385,7.515643309781462,CYLD;RIOK3;MDM2;ATP2B4;ADIPOR1
regulation of defense response (GO:0031347),3/83,0.05307447020423169,0.18526335510812733,0,0,3.678358208955224,10.799877656957179,CYLD;IRF1;PIK3AP1
protein dephosphorylation (GO:0006470),4/139,0.05418509182275143,0.18618521394647183,0,0,2.9127407407407406,8.49165716600708,PPP1R15A;PPP1R15B;UBASH3B;SSH2
regulation of intracellular pH (GO:0051453),2/37,0.05461325848439487,0.18618521394647183,0,0,5.59009900990099,16.253093222624923,CA2;SLC4A1
regulation of microtubule cytoskeleton organization (GO:0070507),2/37,0.05461325848439487,0.18618521394647183,0,0,5.59009900990099,16.253093222624923,CYLD;STMN1
tRNA transport (GO:0051031),2/37,0.05461325848439487,0.18618521394647183,0,0,5.59009900990099,16.253093222624923,RANBP2;YBX1
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),2/37,0.05461325848439487,0.18618521394647183,0,0,5.59009900990099,16.253093222624923,CDK6;FHL1
negative regulation of stress-activated MAPK cascade (GO:0032873),2/37,0.05461325848439487,0.18618521394647183,0,0,5.59009900990099,16.253093222624923,CYLD;PPIA
response to insulin (GO:0032868),3/84,0.05464200517266306,0.18618521394647183,0,0,3.63276211534918,10.560266428159668,XBP1;PKM;PARP1
neuron projection morphogenesis (GO:0048812),4/140,0.05535294711267685,0.18618521394647183,0,0,2.8911764705882352,8.367138072984039,UBB;CTNNB1;NCKAP1L;IQGAP1
regulation of protein phosphorylation (GO:0001932),6/266,0.055608188268137876,0.18618521394647183,0,0,2.276923076923077,6.578998046134878,CD74;PPP1R15B;CCND3;TFRC;PPIA;HLA-DRB1
regulation of cell cycle G2/M phase transition (GO:1902749),3/85,0.056231566767368284,0.18618521394647183,0,0,3.588278121587186,10.32805836370503,TUBA1A;TUBB;MACROH2A1
regulation of small GTPase mediated signal transduction (GO:0051056),4/141,0.056534357509779594,0.18618521394647183,0,0,2.86992700729927,8.245032608506026,ARHGEF12;ARHGDIB;RHOA;ARHGEF6
regulation of apoptotic signaling pathway (GO:2001233),2/38,0.057270434607893016,0.18618521394647183,0,0,5.434543454345435,15.542635394311274,CYLD;PPIA
regulation of cell communication (GO:0010646),2/38,0.057270434607893016,0.18618521394647183,0,0,5.434543454345435,15.542635394311274,SOCS2;CDC42SE2
regulation of phosphoprotein phosphatase activity (GO:0043666),2/38,0.057270434607893016,0.18618521394647183,0,0,5.434543454345435,15.542635394311274,PPP1R15A;PPP1R15B
synaptic vesicle endocytosis (GO:0048488),2/38,0.057270434607893016,0.18618521394647183,0,0,5.434543454345435,15.542635394311274,CANX;SNCA
negative regulation of endothelial cell migration (GO:0010596),2/38,0.057270434607893016,0.18618521394647183,0,0,5.434543454345435,15.542635394311274,ATP2B4;HMGB1
positive regulation of cell development (GO:0010720),2/38,0.057270434607893016,0.18618521394647183,0,0,5.434543454345435,15.542635394311274,MME;NAP1L1
positive regulation of insulin secretion (GO:0032024),2/38,0.057270434607893016,0.18618521394647183,0,0,5.434543454345435,15.542635394311274,SOX4;HLA-DRB1
positive regulation of production of molecular mediator of immune response (GO:0002702),2/38,0.057270434607893016,0.18618521394647183,0,0,5.434543454345435,15.542635394311274,XBP1;HLA-E
protein localization to organelle (GO:0033365),4/142,0.057729294154952475,0.18618521394647183,0,0,2.848985507246377,8.125279705700997,PPP1R15A;DHX9;MDM2;YBX1
negative regulation of cellular amide metabolic process (GO:0034249),3/86,0.05784300126124372,0.18618521394647183,0,0,3.5448660312893363,10.102949059806244,DDX6;NCL;YBX1
negative regulation of phosphorylation (GO:0042326),3/86,0.05784300126124372,0.18618521394647183,0,0,3.5448660312893363,10.102949059806244,PPP1R15B;HNRNPU;PPIA
neuron development (GO:0048666),4/143,0.05893772628897373,0.18618521394647183,0,0,2.828345323741007,8.0078202362455,XBP1;WNK1;STMN1;HMGB1
proteasomal protein catabolic process (GO:0010498),5/205,0.05930745321885344,0.18618521394647183,0,0,2.4618090452261305,6.954660513252739,IFI27;UBE2D3;MDM2;CTNNB1;PMAIP1
ERAD pathway (GO:0036503),3/87,0.05947615120804147,0.18618521394647183,0,0,3.5024875621890548,9.884649881773912,HSPA5;EDEM1;STT3B
positive regulation of gene expression (GO:0010628),9/482,0.05947809418958131,0.18618521394647183,0,0,1.8854773133842901,5.321094518935704,RBM3;CD74;TFRC;IFI16;LEF1;SF3B1;MACROH2A1;SOX4;ACTG1
adiponectin-activated signaling pathway (GO:0033211),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,ADIPOR1
astrocyte development (GO:0014002),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,CDK6
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,ATP2B4
cardiac ventricle formation (GO:0003211),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,SOX4
regulation of digestive system process (GO:0044058),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,EPB41
regulation of hepatocyte proliferation (GO:2000345),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,XBP1
cellular response to salt (GO:1902075),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,HNRNPA1
cellular triglyceride homeostasis (GO:0035356),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,XBP1
COPI coating of Golgi vesicle (GO:0048205),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,TMED10
COPI-coated vesicle budding (GO:0035964),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,TMED10
regulation of nitric oxide mediated signal transduction (GO:0010749),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,ATP2B4
regulation of non-motile cilium assembly (GO:1902855),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,SEPTIN9
regulation of nuclease activity (GO:0032069),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,HMGB2
regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,ATP2B4
"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,UBB
regulation of SNARE complex assembly (GO:0035542),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,SNCA
regulation of t-circle formation (GO:1904429),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,XRCC5
regulation of type 2 immune response (GO:0002828),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,CD74
Golgi transport vesicle coating (GO:0048200),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,TMED10
response to testosterone (GO:0033574),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,NCOA4
spinal cord motor neuron differentiation (GO:0021522),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,SOX4
maintenance of DNA methylation (GO:0010216),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,UHRF1
maintenance of DNA repeat elements (GO:0043570),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,MSH6
mitochondrial protein catabolic process (GO:0035694),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,BNIP3L
valine metabolic process (GO:0006573),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,BCAT1
morphogenesis of an endothelium (GO:0003159),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,CTNNB1
negative regulation of cell size (GO:0045792),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,RHOA
negative regulation of cellular response to hypoxia (GO:1900038),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,ENO1
negative regulation of glial cell proliferation (GO:0060253),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,RNF10
negative regulation of hematopoietic progenitor cell differentiation (GO:1901533),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,MYB
negative regulation of transporter activity (GO:0032410),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,SNCA
negative regulation of trophoblast cell migration (GO:1901164),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,ARHGDIB
neuroepithelial cell differentiation (GO:0060563),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,SOX4
oxygen homeostasis (GO:0032364),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,ALAS2
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,PMAIP1
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,PMAIP1
positive regulation of granulocyte differentiation (GO:0030854),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,LEF1
positive regulation of hemoglobin biosynthetic process (GO:0046985),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,SLC25A37
positive regulation of immune response to tumor cell (GO:0002839),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,HLA-DRB1
positive regulation of plasminogen activation (GO:0010756),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,ENO1
positive regulation of T cell mediated immune response to tumor cell (GO:0002842),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,HLA-DRB1
protection from natural killer cell mediated cytotoxicity (GO:0042270),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,HLA-E
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),1/6,0.05966747583495616,0.18618521394647183,0,0,19.498522167487685,54.965713945366076,PMAIP1
protein monoubiquitination (GO:0006513),2/39,0.05997181122726765,0.18618521394647183,0,0,5.2873963071982875,14.878102105020764,UHRF1;UBE2D3
regulation of ion transmembrane transporter activity (GO:0032412),2/39,0.05997181122726765,0.18618521394647183,0,0,5.2873963071982875,14.878102105020764,FHL1;UTRN
replication fork processing (GO:0031297),2/39,0.05997181122726765,0.18618521394647183,0,0,5.2873963071982875,14.878102105020764,PCNA;NUCKS1
membrane protein proteolysis (GO:0033619),2/39,0.05997181122726765,0.18618521394647183,0,0,5.2873963071982875,14.878102105020764,ADAM10;RBMX
negative regulation of binding (GO:0051100),3/88,0.061130855560929405,0.18922303510662758,0,0,3.4611062335381915,9.672886979402671,JUN;IFI16;LEF1
regulation of microtubule polymerization (GO:0031113),2/40,0.06271622028283748,0.18922303510662758,0,0,5.147993746743095,14.255490529283259,STMN1;SNCA
regulation of sodium ion transmembrane transporter activity (GO:2000649),2/40,0.06271622028283748,0.18922303510662758,0,0,5.147993746743095,14.255490529283259,WNK1;UTRN
nucleocytoplasmic transport (GO:0006913),2/40,0.06271622028283748,0.18922303510662758,0,0,5.147993746743095,14.255490529283259,XPO1;HNRNPA1
positive regulation of catalytic activity (GO:0043085),2/40,0.06271622028283748,0.18922303510662758,0,0,5.147993746743095,14.255490529283259,MSH6;XRCC5
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),2/40,0.06271622028283748,0.18922303510662758,0,0,5.147993746743095,14.255490529283259,UBB;PMAIP1
positive regulation of wound healing (GO:0090303),2/40,0.06271622028283748,0.18922303510662758,0,0,5.147993746743095,14.255490529283259,XBP1;ACTG1
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),3/89,0.06280694976233434,0.18922303510662758,0,0,3.4206872613675805,9.467400375562336,PMAIP1;HMGB1;SNCA
transforming growth factor beta receptor signaling pathway (GO:0007179),3/89,0.06280694976233434,0.18922303510662758,0,0,3.4206872613675805,9.467400375562336,JUN;UBB;RHOA
negative regulation of translation (GO:0017148),3/90,0.06450426593907686,0.18922303510662758,0,0,3.381197460971007,9.267943114630036,DDX6;NCL;YBX1
positive regulation of autophagy (GO:0010508),3/90,0.06450426593907686,0.18922303510662758,0,0,3.381197460971007,9.267943114630036,BNIP3L;HMGB1;FBXO7
protein complex oligomerization (GO:0051259),3/90,0.06450426593907686,0.18922303510662758,0,0,3.381197460971007,9.267943114630036,RBMX;HLA-DRB1;SNCA
regulation of cell development (GO:0060284),2/41,0.06550251276654603,0.18922303510662758,0,0,5.015740035542016,13.671235963045726,HMGB2;CTNNB1
cortical cytoskeleton organization (GO:0030865),2/41,0.06550251276654603,0.18922303510662758,0,0,5.015740035542016,13.671235963045726,NCKAP1L;RHOA
regulation of protein dephosphorylation (GO:0035304),2/41,0.06550251276654603,0.18922303510662758,0,0,5.015740035542016,13.671235963045726,PPP1R15A;PPIA
epithelial cell migration (GO:0010631),2/41,0.06550251276654603,0.18922303510662758,0,0,5.015740035542016,13.671235963045726,ZEB2;RHOA
JNK cascade (GO:0007254),2/41,0.06550251276654603,0.18922303510662758,0,0,5.015740035542016,13.671235963045726,UBB;ARHGEF6
regulation of actin cytoskeleton organization (GO:0032956),3/91,0.06622263298581345,0.18922303510662758,0,0,3.3426051560379917,9.074280477828792,ARHGDIB;IQGAP1;RHOA
positive regulation of hydrolase activity (GO:0051345),4/149,0.06646976937422665,0.18922303510662758,0,0,2.7104827586206897,7.348140525306034,DOCK11;DOCK8;HMGB2;RHOA
regulation of lipid metabolic process (GO:0019216),3/92,0.06796187673057896,0.18922303510662758,0,0,3.3048800939124603,8.886189249555157,CHD9;ADIPOR1;MACROH2A1
Wnt signaling pathway (GO:0016055),3/92,0.06796187673057896,0.18922303510662758,0,0,3.3048800939124603,8.886189249555157,UBB;LEF1;CTNNB1
cellular response to DNA damage stimulus (GO:0006974),7/350,0.06807941629643037,0.18922303510662758,0,0,2.015228426395939,5.415080742698303,TOP2A;MSH6;PPP1R15A;CBX5;PARP1;MCM7;XRCC5
regulation of DNA recombination (GO:0000018),2/42,0.06832955839825983,0.18922303510662758,0,0,4.8900990099009904,13.122154437760411,MSH6;H1-0
regulation of nervous system development (GO:0051960),2/42,0.06832955839825983,0.18922303510662758,0,0,4.8900990099009904,13.122154437760411,HMGB2;CTNNB1
translesion synthesis (GO:0019985),2/42,0.06832955839825983,0.18922303510662758,0,0,4.8900990099009904,13.122154437760411,PCNA;UBB
positive regulation of epithelial to mesenchymal transition (GO:0010718),2/42,0.06832955839825983,0.18922303510662758,0,0,4.8900990099009904,13.122154437760411,LEF1;CTNNB1
positive regulation of protein modification process (GO:0031401),5/214,0.06861262840839141,0.18922303510662758,0,0,2.354716164554832,6.308940802088154,CD74;CCND3;TFRC;PPIA;HLA-DRB1
supramolecular fiber organization (GO:0097435),7/351,0.0688951529582083,0.18922303510662758,0,0,2.0092669106362884,5.375129461001277,TPM4;UBB;STMN1;MDM2;ADAM10;RHOA;SNCA
angiotensin-activated signaling pathway (GO:0038166),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,CA2
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,HLA-E
"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,HLA-E
astrocyte differentiation (GO:0048708),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,CDK6
"regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,NCKAP1L
calcium ion export (GO:1901660),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,ATP2B4
cellular amino acid biosynthetic process (GO:0008652),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,BCAT1
cellular ion homeostasis (GO:0006873),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,SLC4A1
regulation of hemoglobin biosynthetic process (GO:0046984),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,SLC25A37
regulation of histone H3-K27 methylation (GO:0061085),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,MACROH2A1
regulation of inositol phosphate biosynthetic process (GO:0010919),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,SNCA
cleavage furrow formation (GO:0036089),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,RHOA
collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,UBASH3B
regulation of MDA-5 signaling pathway (GO:0039533),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,RIOK3
regulation of MHC class I biosynthetic process (GO:0045343),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,CIITA
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,DCP2
regulation of miRNA mediated inhibition of translation (GO:1905616),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,DDX6
detection of muscle stretch (GO:0035995),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,CTNNB1
regulation of myosin-light-chain-phosphatase activity (GO:0035507),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,NCKAP1L
regulation of natural killer cell cytokine production (GO:0002727),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,HLA-E
regulation of natural killer cell proliferation (GO:0032817),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,HLA-E
DNA ligation (GO:0006266),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,TOP2A
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,NONO
regulation of prostaglandin biosynthetic process (GO:0031392),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,CD74
G-quadruplex DNA unwinding (GO:0044806),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,DHX9
gas homeostasis (GO:0033483),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,ALAS2
glandular epithelial cell development (GO:0002068),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,CDK6
glial cell migration (GO:0008347),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,CD9
glomerular epithelial cell development (GO:0072310),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,IQGAP1
glomerular visceral epithelial cell development (GO:0072015),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,IQGAP1
response to host defenses (GO:0052200),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,UBB
ribosomal large subunit export from nucleus (GO:0000055),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,XPO1
ribosomal small subunit export from nucleus (GO:0000056),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,XPO1
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,XPO1
somatic recombination of immunoglobulin gene segments (GO:0016447),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,MSH6
leucine metabolic process (GO:0006551),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,BCAT1
"synaptic transmission, dopaminergic (GO:0001963)",1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,SNCA
marginal zone B cell differentiation (GO:0002315),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,DOCK11
membrane biogenesis (GO:0044091),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,SERINC1
mitochondrial DNA metabolic process (GO:0032042),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,PARP1
type B pancreatic cell development (GO:0003323),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,CDK6
mitral valve development (GO:0003174),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,SOX4
modulation by symbiont of host defense response (GO:0052031),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,UBB
negative regulation of cell cycle phase transition (GO:1901988),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,MACROH2A1
negative regulation of p38MAPK cascade (GO:1903753),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,CYLD
negative regulation of protein sumoylation (GO:0033234),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,CTNNB1
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,PPIA
noradrenergic neuron differentiation (GO:0003357),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,SOX4
"Notch receptor processing, ligand-dependent (GO:0035333)",1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,ADAM10
nucleobase catabolic process (GO:0046113),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,DPYSL2
oxygen transport (GO:0015671),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,HBA1
polyamine biosynthetic process (GO:0006596),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,SAT1
positive regulation of B cell receptor signaling pathway (GO:0050861),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,PRKCB
positive regulation of helicase activity (GO:0051096),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,MSH6
positive regulation of histone H3-K9 methylation (GO:0051574),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,MYB
positive regulation of miRNA mediated inhibition of translation (GO:1905618),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,DDX6
positive regulation of mitochondrial membrane potential (GO:0010918),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,TCL1A
positive regulation of natural killer cell cytokine production (GO:0002729),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,HLA-E
positive regulation of potassium ion import across plasma membrane (GO:1903288),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,WNK1
positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,CD74
positive regulation of vesicle fusion (GO:0031340),1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,SNCA
"posttranslational protein targeting to membrane, translocation (GO:0031204)",1/7,0.06926172588090321,0.18922303510662758,0,0,16.247947454844006,43.37979083454179,HSPA5
cytoplasmic translation (GO:0002181),3/93,0.06972182000067445,0.19022637707241272,0,0,3.2679933665008294,8.703457039855074,EIF4A2;RPL15;GSPT1
DNA synthesis involved in DNA repair (GO:0000731),2/43,0.07119624540444684,0.19347626901022758,0,0,4.770586814779039,12.605394029939811,PCNA;UBB
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),2/43,0.07119624540444684,0.19347626901022758,0,0,4.770586814779039,12.605394029939811,PCNA;NUCKS1
substantia nigra development (GO:0021762),2/43,0.07119624540444684,0.19347626901022758,0,0,4.770586814779039,12.605394029939811,HSPA5;RHOA
hemopoiesis (GO:0030097),3/94,0.07150228280759627,0.19353788305517142,0,0,3.2319173363949485,8.525881647867097,IFI16;FLT3;AHSP
negative regulation of cell death (GO:0060548),3/94,0.07150228280759627,0.19353788305517142,0,0,3.2319173363949485,8.525881647867097,BNIP3L;SOX4;SNCA
negative regulation of cellular protein metabolic process (GO:0032269),3/94,0.07150228280759627,0.19353788305517142,0,0,3.2319173363949485,8.525881647867097,DDX6;NCL;YBX1
regulation of cell growth (GO:0001558),5/217,0.07188450464474286,0.19431576519403446,0,0,2.321039158054423,6.110587141913152,SOCS2;TFRC;FHL1;ADAM10;ENO1
mRNA metabolic process (GO:0016071),3/95,0.07330308243169056,0.19788934901519625,0,0,3.1966255678131086,8.353270473532973,NONO;SRSF5;DCP2
positive regulation of cell-matrix adhesion (GO:0001954),2/44,0.07410148027067923,0.1989085331554827,0,0,4.656765676567657,12.118393385401305,CDK6;UTRN
"transcription, DNA-templated (GO:0006351)",5/221,0.07637830333450535,0.1989085331554827,0,0,2.2775916620137724,5.858094691236198,XBP1;PARP1;PAX5;PTMA;RBMX
double-strand break repair via homologous recombination (GO:0000724),3/97,0.07696494823790861,0.1989085331554827,0,0,3.1282946967291205,8.022215120044173,MCM7;PARP1;NUCKS1
regulation of DNA repair (GO:0006282),2/45,0.07704418742709425,0.1989085331554827,0,0,4.548238544784711,11.658846251305821,PCNA;DHX9
regulation of insulin receptor signaling pathway (GO:0046626),2/45,0.07704418742709425,0.1989085331554827,0,0,4.548238544784711,11.658846251305821,PRKCB;NUCKS1
negative regulation of T cell activation (GO:0050868),2/45,0.07704418742709425,0.1989085331554827,0,0,4.548238544784711,11.658846251305821,NCKAP1L;HLA-DRB1
positive regulation of nervous system development (GO:0051962),2/45,0.07704418742709425,0.1989085331554827,0,0,4.548238544784711,11.658846251305821,MME;NAP1L1
positive regulation of response to biotic stimulus (GO:0002833),2/45,0.07704418742709425,0.1989085331554827,0,0,4.548238544784711,11.658846251305821,DHX9;RIOK3
alpha-beta T cell activation (GO:0046631),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,HLA-E
pyrimidine nucleobase catabolic process (GO:0006208),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,DPYSL2
regulation of alpha-beta T cell proliferation (GO:0046640),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,IRF1
regulation of anion transport (GO:0044070),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,CA2
regulation of apoptotic cell clearance (GO:2000425),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,HMGB1
carbohydrate phosphorylation (GO:0046835),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,HK1
regulation of dopamine uptake involved in synaptic transmission (GO:0051584),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,SNCA
regulation of endodeoxyribonuclease activity (GO:0032071),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,HMGB1
cellular response to angiotensin (GO:1904385),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,CA2
cellular response to UV-B (GO:0071493),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,MME
regulation of interleukin-18 production (GO:0032661),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,DHX9
regulation of myeloid leukocyte differentiation (GO:0002761),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,UBASH3B
regulation of oxidative stress-induced neuron death (GO:1903203),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,FBXO7
dopamine uptake (GO:0090494),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,SNCA
regulation of potassium ion import (GO:1903286),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,WNK1
regulation of protein localization to cell cortex (GO:1904776),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,EPB41
regulation of protein localization to nucleolus (GO:1904749),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,GLUL
entry of bacterium into host cell (GO:0035635),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,CTNNB1
establishment of protein localization to chromatin (GO:0071169),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,MACROH2A1
fusion of virus membrane with host plasma membrane (GO:0019064),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,PPIA
regulation of translational termination (GO:0006449),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,GSPT1
regulation of vascular wound healing (GO:0061043),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,XBP1
hair cell differentiation (GO:0035315),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,CTNNB1
RNA secondary structure unwinding (GO:0010501),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,DHX9
somatic hypermutation of immunoglobulin genes (GO:0016446),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,MSH6
spermidine metabolic process (GO:0008216),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,SAT1
macromolecule depalmitoylation (GO:0098734),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,ABHD17B
membrane fusion involved in viral entry into host cell (GO:0039663),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,PPIA
myeloid leukocyte mediated immunity (GO:0002444),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,KMT2E
negative regulation of alpha-beta T cell differentiation (GO:0046639),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,HMGB1
negative regulation of chromosome organization (GO:2001251),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,TOP2A
negative regulation of mitochondrial fusion (GO:0010637),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,TFRC
negative regulation of mitochondrial membrane potential (GO:0010917),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,PMAIP1
negative regulation of sodium ion transport (GO:0010766),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,WNK1
negative regulation of T cell mediated cytotoxicity (GO:0001915),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,NCKAP1L
positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,GAB1
positive regulation of melanin biosynthetic process (GO:0048023),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,ZEB2
positive regulation of membrane invagination (GO:1905155),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,NCKAP1L
positive regulation of muscle contraction (GO:0045933),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,ENO1
positive regulation of secondary metabolite biosynthetic process (GO:1900378),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,ZEB2
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,MCM7
protein depalmitoylation (GO:0002084),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,ABHD17B
protein localization to microtubule (GO:0035372),1/8,0.07875856181675209,0.1989085331554827,0,0,13.926108374384237,35.39137016593114,HNRNPU
negative regulation of neuron death (GO:1901215),3/98,0.07882563637005952,0.1989085331554827,0,0,3.0952081696779263,7.86342897479025,SET;FBXO7;SNCA
positive regulation of defense response (GO:0031349),3/98,0.07882563637005952,0.1989085331554827,0,0,3.0952081696779263,7.86342897479025,DHX9;RIOK3;SNCA
regulation of cellular protein localization (GO:1903827),2/46,0.08002330907656921,0.20069493304515337,0,0,4.444644464446444,11.224671019263917,PARP1;CTNNB1
regulation of DNA metabolic process (GO:0051052),2/46,0.08002330907656921,0.20069493304515337,0,0,4.444644464446444,11.224671019263917,XRCC5;NUCKS1
regulation of telomerase activity (GO:0051972),2/46,0.08002330907656921,0.20069493304515337,0,0,4.444644464446444,11.224671019263917,XRCC5;CTNNB1
spliceosomal complex assembly (GO:0000245),2/46,0.08002330907656921,0.20069493304515337,0,0,4.444644464446444,11.224671019263917,SRSF5;SF3B1
postreplication repair (GO:0006301),2/46,0.08002330907656921,0.20069493304515337,0,0,4.444644464446444,11.224671019263917,PCNA;UBB
regulation of protein localization to nucleus (GO:1900180),2/47,0.083037804906241,0.2069883969013234,0,0,4.345654565456545,10.813984492303446,TFRC;GLUL
epidermal growth factor receptor signaling pathway (GO:0007173),2/47,0.083037804906241,0.2069883969013234,0,0,4.345654565456545,10.813984492303446,GAB1;IQGAP1
epithelial to mesenchymal transition (GO:0001837),2/47,0.083037804906241,0.2069883969013234,0,0,4.345654565456545,10.813984492303446,LEF1;CTNNB1
regulation of T cell activation (GO:0050863),2/47,0.083037804906241,0.2069883969013234,0,0,4.345654565456545,10.813984492303446,HLA-DPB1;HLA-DPA1
positive regulation of neuron death (GO:1901216),2/47,0.083037804906241,0.2069883969013234,0,0,4.345654565456545,10.813984492303446,CTNNB1;SNCA
DNA repair (GO:0006281),6/298,0.08539540838010504,0.2097999123479472,0,0,2.0240763802407638,4.980164932796322,MSH6;PCNA;PARP1;UBB;XRCC5;NUCKS1
base-excision repair (GO:0006284),2/48,0.0860866518338643,0.2097999123479472,0,0,4.250968575118382,10.425079204265643,PCNA;PARP1
regulation of interleukin-10 production (GO:0032653),2/48,0.0860866518338643,0.2097999123479472,0,0,4.250968575118382,10.425079204265643,HMGB1;HLA-DRB1
establishment of protein localization to mitochondrion (GO:0072655),2/48,0.0860866518338643,0.2097999123479472,0,0,4.250968575118382,10.425079204265643,FBXO7;HK1
negative regulation of mitotic cell cycle (GO:0045930),2/48,0.0860866518338643,0.2097999123479472,0,0,4.250968575118382,10.425079204265643,CTNNB1;HECA
positive regulation of cellular protein metabolic process (GO:0032270),3/102,0.08646224100602967,0.2097999123479472,0,0,2.9695462083521784,7.269590113610033,RBM3;UHRF1;SOX4
positive regulation of vasculature development (GO:1904018),3/102,0.08646224100602967,0.2097999123479472,0,0,2.9695462083521784,7.269590113610033,XBP1;PRKCB;GAB1
regulation of DNA-directed DNA polymerase activity (GO:1900262),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,PCNA
regulation of helicase activity (GO:0051095),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,MSH6
collagen-activated signaling pathway (GO:0038065),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,UBASH3B
regulation of nephron tubule epithelial cell differentiation (GO:0072182),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,CTNNB1
regulation of transmembrane transporter activity (GO:0022898),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,SNCA
response to magnesium ion (GO:0032026),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,SNCA
small RNA loading onto RISC (GO:0070922),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,DHX9
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,MSH6
sympathetic ganglion development (GO:0061549),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,CTNNB1
maintenance of apical/basal cell polarity (GO:0035090),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,ANK1
maintenance of epithelial cell apical/basal polarity (GO:0045199),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,ANK1
type B pancreatic cell differentiation (GO:0003309),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,CDK6
mitral valve morphogenesis (GO:0003183),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,SOX4
negative regulation of bone resorption (GO:0045779),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,UBASH3B
negative regulation of exocytosis (GO:0045920),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,SNCA
negative regulation of leukocyte degranulation (GO:0043301),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,NCKAP1L
negative regulation of membrane potential (GO:0045837),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,PMAIP1
negative regulation of necroptotic process (GO:0060546),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,YBX3
negative regulation of nitric oxide biosynthetic process (GO:0045019),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,ATP2B4
negative regulation of nitric oxide metabolic process (GO:1904406),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,ATP2B4
negative regulation of platelet aggregation (GO:0090331),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,CD9
Notch receptor processing (GO:0007220),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,ADAM10
one-carbon compound transport (GO:0019755),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,CA2
positive regulation of ATP biosynthetic process (GO:2001171),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,ENO1
positive regulation of autophagy of mitochondrion (GO:1903599),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,FBXO7
positive regulation of DNA-directed DNA polymerase activity (GO:1900264),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,PCNA
positive regulation of inositol phosphate biosynthetic process (GO:0060732),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,SNCA
positive regulation of macrophage cytokine production (GO:0060907),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,CD74
positive regulation of megakaryocyte differentiation (GO:0045654),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,HMGB2
positive regulation of membrane potential (GO:0045838),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,TCL1A
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,BNIP3L
"positive regulation of phagocytosis, engulfment (GO:0060100)",1/9,0.0881589675605576,0.2097999123479472,0,0,12.18472906403941,29.59199926092177,NCKAP1L
regulation of cellular protein metabolic process (GO:0032268),2/49,0.08916884380813203,0.2107346723908449,0,0,4.160311775858437,10.056403745859729,RBM3;UHRF1
regulation of smooth muscle cell proliferation (GO:0048660),2/49,0.08916884380813203,0.2107346723908449,0,0,4.160311775858437,10.056403745859729,XRCC5;CTNNB1
response to glucose (GO:0009749),2/49,0.08916884380813203,0.2107346723908449,0,0,4.160311775858437,10.056403745859729,XBP1;SOX4
response to hydrogen peroxide (GO:0042542),2/49,0.08916884380813203,0.2107346723908449,0,0,4.160311775858437,10.056403745859729,CAT;HBA1
response to unfolded protein (GO:0006986),2/49,0.08916884380813203,0.2107346723908449,0,0,4.160311775858437,10.056403745859729,HSPA5;STT3B
mitotic cytokinesis (GO:0000281),2/49,0.08916884380813203,0.2107346723908449,0,0,4.160311775858437,10.056403745859729,STMN1;SEPTIN6
iron ion transport (GO:0006826),2/50,0.09228339151793027,0.2178392999407322,0,0,4.073432343234323,9.706545652223769,TFRC;FTH1
nucleotide-excision repair (GO:0006289),3/105,0.09238767772010555,0.2178392999407322,0,0,2.881767632426105,6.863683680791012,PCNA;UBB;PARP1
cellular response to peptide hormone stimulus (GO:0071375),3/106,0.09439945330565676,0.21801699386941192,0,0,2.853644399362411,6.735228575990684,XBP1;PKM;PARP1
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),3/106,0.09439945330565676,0.21801699386941192,0,0,2.853644399362411,6.735228575990684,FLT3;GAB1;PIK3AP1
RNA export from nucleus (GO:0006405),3/106,0.09439945330565676,0.21801699386941192,0,0,2.853644399362411,6.735228575990684,RANBP2;SRSF5;HNRNPA1
regulation of epithelial cell migration (GO:0010632),2/51,0.09542932219954067,0.21801699386941192,0,0,3.99009900990099,9.374216465643885,ADIPOR1;GLUL
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),2/51,0.09542932219954067,0.21801699386941192,0,0,3.99009900990099,9.374216465643885,MSH6;IFI16
mesenchymal cell differentiation (GO:0048762),2/51,0.09542932219954067,0.21801699386941192,0,0,3.99009900990099,9.374216465643885,LEF1;CTNNB1
positive regulation of fat cell differentiation (GO:0045600),2/51,0.09542932219954067,0.21801699386941192,0,0,3.99009900990099,9.374216465643885,XBP1;HNRNPU
protein poly-ADP-ribosylation (GO:0070212),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,PARP1
adherens junction assembly (GO:0034333),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,CTNNB1
regulation of cell-cell adhesion involved in gastrulation (GO:0070587),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,WNK1
regulation of cell-cell adhesion mediated by integrin (GO:0033632),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,WNK1
cellular response to acetylcholine (GO:1905145),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,ATP2B4
regulation of granulocyte differentiation (GO:0030852),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,LEF1
regulation of histone phosphorylation (GO:0033127),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,MACROH2A1
regulation of low-density lipoprotein particle clearance (GO:0010988),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,HNRNPK
defense response to tumor cell (GO:0002357),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,PRDX2
DNA replication-dependent nucleosome assembly (GO:0006335),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,NASP
DNA replication-dependent nucleosome organization (GO:0034723),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,NASP
"regulation of phagocytosis, engulfment (GO:0060099)",1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,NCKAP1L
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,HMGB1
regulation of store-operated calcium entry (GO:2001256),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,SARAF
fructose 6-phosphate metabolic process (GO:0006002),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,HK1
granulocyte activation (GO:0036230),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,KMT2E
immunoglobulin mediated immune response (GO:0016064),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,CD74
sequestering of actin monomers (GO:0042989),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,TMSB10
iron ion transmembrane transport (GO:0034755),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,SLC25A37
SNARE complex assembly (GO:0035493),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,SNCA
lipoprotein transport (GO:0042953),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,PRKCB
toxin transport (GO:1901998),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,ADAM10
methylguanosine-cap decapping (GO:0110156),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,DCP2
microtubule anchoring at centrosome (GO:0034454),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,NIN
UV protection (GO:0009650),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,CAT
modification-dependent macromolecule catabolic process (GO:0043632),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,UBB
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,CTNNB1
monocyte activation (GO:0042117),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,ADAM10
myelin assembly (GO:0032288),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,CD9
negative regulation of cell adhesion mediated by integrin (GO:0033629),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,WNK1
negative regulation of heterotypic cell-cell adhesion (GO:0034115),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,WNK1
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,JUN
negative regulation of transmembrane transport (GO:0034763),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,PRKCB
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,RIOK3
nucleic acid transport (GO:0050657),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,YBX1
positive regulation of lipase activity (GO:0060193),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,RHOA
positive regulation of myoblast fusion (GO:1901741),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,CD53
positive regulation of receptor recycling (GO:0001921),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,SNCA
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,NCL
positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),1/10,0.09746391722029348,0.21801699386941192,0,0,10.83032293377121,25.21594900155374,PRKCB
neuron projection development (GO:0031175),4/171,0.09807360963388885,0.21889819832845564,0,0,2.3507784431137724,5.45859443801941,UBB;STMN1;NCKAP1L;HMGB1
nuclear-transcribed mRNA catabolic process (GO:0000956),4/171,0.09807360963388885,0.21889819832845564,0,0,2.3507784431137724,5.45859443801941,PABPC1;RPL15;GSPT1;DCP2
DNA replication (GO:0006260),3/108,0.09847670926372197,0.21889819832845564,0,0,2.799004975124378,6.487912193032809,SET;MCM7;NAP1L1
regulation of intrinsic apoptotic signaling pathway (GO:2001242),2/52,0.09860567938368206,0.21889819832845564,0,0,3.91009900990099,9.058238666429835,CYLD;PMAIP1
regulation of release of sequestered calcium ion into cytosol (GO:0051279),2/52,0.09860567938368206,0.21889819832845564,0,0,3.91009900990099,9.058238666429835,UBASH3B;SNCA
plasma membrane bounded cell projection morphogenesis (GO:0120039),2/52,0.09860567938368206,0.21889819832845564,0,0,3.91009900990099,9.058238666429835,UBB;NCKAP1L
positive regulation of protein localization to cell periphery (GO:1904377),2/52,0.09860567938368206,0.21889819832845564,0,0,3.91009900990099,9.058238666429835,EPB41;ATP2B4
regulation of immune effector process (GO:0002697),2/53,0.10181152270043903,0.22528273219567987,0,0,3.833236264802951,8.7575342022346,HLA-DRA;HLA-DRB1
negative regulation of cysteine-type endopeptidase activity (GO:2000117),2/53,0.10181152270043903,0.22528273219567987,0,0,3.833236264802951,8.7575342022346,IFI16;SNCA
positive regulation of chemokine production (GO:0032722),2/53,0.10181152270043903,0.22528273219567987,0,0,3.833236264802951,8.7575342022346,CD74;HMGB1
neuron differentiation (GO:0030182),4/174,0.10284545191683153,0.22580144091099952,0,0,2.3089411764705883,5.251751089337969,XBP1;WNK1;CTNNB1;SOX4
regulation of focal adhesion assembly (GO:0051893),2/54,0.10504592758167294,0.22580144091099952,0,0,3.7593297791317593,8.471114399834835,RHOA;ACTG1
regulation of megakaryocyte differentiation (GO:0045652),2/54,0.10504592758167294,0.22580144091099952,0,0,3.7593297791317593,8.471114399834835,KMT2E;HMGB2
regulation of proteasomal protein catabolic process (GO:0061136),2/54,0.10504592758167294,0.22580144091099952,0,0,3.7593297791317593,8.471114399834835,XPO1;UBB
inorganic anion transport (GO:0015698),2/54,0.10504592758167294,0.22580144091099952,0,0,3.7593297791317593,8.471114399834835,SLC4A1;CLIC1
atrial septum morphogenesis (GO:0060413),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,SOX4
regulation of biosynthetic process (GO:0009889),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,SNCA
B cell mediated immunity (GO:0019724),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,CD74
cell differentiation in spinal cord (GO:0021515),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,SOX4
cellular response to UV-A (GO:0071492),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,MME
columnar/cuboidal epithelial cell differentiation (GO:0002065),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,SOX4
regulation of melanin biosynthetic process (GO:0048021),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,ZEB2
regulation of mitochondrial fusion (GO:0010635),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,TFRC
regulation of phospholipase activity (GO:0010517),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,SNCA
establishment of epithelial cell apical/basal polarity (GO:0045198),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,RHOA
fatty acid homeostasis (GO:0055089),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,XBP1
regulation of T cell mediated immunity (GO:0002709),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,HMGB1
regulation of toll-like receptor 9 signaling pathway (GO:0034163),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,HMGB1
glutamine family amino acid biosynthetic process (GO:0009084),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,GLUL
hepatocyte growth factor receptor signaling pathway (GO:0048012),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,STMN1
interleukin-35-mediated signaling pathway (GO:0070757),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,CANX
isotype switching (GO:0045190),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,MSH6
lipoprotein catabolic process (GO:0042159),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,ABHD17B
lipoprotein localization (GO:0044872),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,PRKCB
midbrain dopaminergic neuron differentiation (GO:1904948),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,CTNNB1
monocyte differentiation (GO:0030224),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,IFI16
negative regulation of bone remodeling (GO:0046851),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,UBASH3B
negative regulation of homotypic cell-cell adhesion (GO:0034111),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,CD9
negative regulation of interleukin-17 production (GO:0032700),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,NCKAP1L
negative regulation of natural killer cell mediated immunity (GO:0002716),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,HLA-E
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,SNCA
negative regulation of programmed necrotic cell death (GO:0062099),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,YBX3
negative regulation of receptor signaling pathway via STAT (GO:1904893),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,ADIPOR1
nuclear DNA replication (GO:0033260),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,MCM7
PERK-mediated unfolded protein response (GO:0036499),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,HSPA5
positive regulation by host of viral process (GO:0044794),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,NUCKS1
positive regulation of alcohol biosynthetic process (GO:1902932),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,SNCA
positive regulation of interleukin-13 production (GO:0032736),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,HLA-E
positive regulation of myelination (GO:0031643),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,RNF10
positive regulation of neuroblast proliferation (GO:0002052),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,CTNNB1
positive regulation of posttranscriptional gene silencing (GO:0060148),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,DHX9
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/11,0.10667437520831993,0.22580144091099952,0,0,9.74679802955665,21.81308356459046,HSPA5
regulation of cytoskeleton organization (GO:0051493),3/112,0.10684015767387674,0.22591897118036475,0,0,2.69574147610571,6.028813966323748,CYLD;IQGAP1;RHOA
positive regulation of cellular process (GO:0048522),10/625,0.10763209194388894,0.22735892411652417,0,0,1.6076607157824157,3.583534292038659,RNF10;TCL1A;XBP1;FLT3;LEF1;MDM2;ADAM10;NAP1L1;HBA1;SOX4
regulation of blood vessel endothelial cell migration (GO:0043535),2/55,0.10830798512229418,0.2283159069090337,0,0,3.68821221744816,8.198071061066498,ATP2B4;HMGB1
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),2/55,0.10830798512229418,0.2283159069090337,0,0,3.68821221744816,8.198071061066498,CTNNB1;SOX4
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",3/113,0.10897330904363366,0.2294823332275492,0,0,2.671099050203528,5.92089784754723,PABPC1;RPL15;GSPT1
regulation of immune response (GO:0050776),4/179,0.11103072546049544,0.23101885689760887,0,0,2.2424,4.928679290395782,IRF1;HLA-DRA;HLA-DRB1;HLA-E
cellular response to transforming growth factor beta stimulus (GO:0071560),3/114,0.11112294716819258,0.23101885689760887,0,0,2.646900631975259,5.815553177556838,JUN;UBB;RHOA
Rho protein signal transduction (GO:0007266),2/56,0.11159680181676472,0.23101885689760887,0,0,3.61972863953062,7.9375685946428876,ARHGDIB;RHOA
mitochondrial transport (GO:0006839),2/56,0.11159680181676472,0.23101885689760887,0,0,3.61972863953062,7.9375685946428876,PMAIP1;FBXO7
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",2/56,0.11159680181676472,0.23101885689760887,0,0,3.61972863953062,7.9375685946428876,DDX6;DCP2
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),2/56,0.11159680181676472,0.23101885689760887,0,0,3.61972863953062,7.9375685946428876,UBE2D3;PMAIP1
cellular response to peptide (GO:1901653),2/57,0.11491149931147912,0.23101885689760887,0,0,3.5537353735373536,7.688837042343878,XBP1;MDM2
negative regulation of cell cycle G2/M phase transition (GO:1902750),2/57,0.11491149931147912,0.23101885689760887,0,0,3.5537353735373536,7.688837042343878,FHL1;MACROH2A1
negative regulation of DNA recombination (GO:0045910),2/57,0.11491149931147912,0.23101885689760887,0,0,3.5537353735373536,7.688837042343878,MSH6;H1-0
positive regulation of interferon-gamma production (GO:0032729),2/57,0.11491149931147912,0.23101885689760887,0,0,3.5537353735373536,7.688837042343878,HLA-DPB1;HLA-DPA1
protein K48-linked ubiquitination (GO:0070936),2/57,0.11491149931147912,0.23101885689760887,0,0,3.5537353735373536,7.688837042343878,IFI27;UBE2D3
adipose tissue development (GO:0060612),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,XBP1
pyrimidine nucleobase metabolic process (GO:0006206),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,DPYSL2
angiotensin maturation (GO:0002003),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,MME
regulation of amyloid precursor protein catabolic process (GO:1902991),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,TMED10
regulation of angiotensin levels in blood (GO:0002002),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,MME
catecholamine biosynthetic process (GO:0042423),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,SNCA
regulation of dendritic cell differentiation (GO:2001198),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,HMGB1
cellular response to growth hormone stimulus (GO:0071378),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,SOCS2
regulation of hemopoiesis (GO:1903706),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,PRKCB
regulation of histone H3-K9 methylation (GO:0051570),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,MYB
regulation of leukocyte cell-cell adhesion (GO:1903037),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,WNK1
regulation of myoblast fusion (GO:1901739),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,CD53
dosage compensation by inactivation of X chromosome (GO:0009048),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,HNRNPU
double-strand break repair via break-induced replication (GO:0000727),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,MCM7
regulation of plasminogen activation (GO:0010755),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,ENO1
regulation of response to oxidative stress (GO:1902882),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,MACROH2A1
regulation of RNA export from nucleus (GO:0046831),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,DHX9
regulation of sequestering of calcium ion (GO:0051282),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,UBASH3B
regulation of sister chromatid cohesion (GO:0007063),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,CTNNB1
ganglion development (GO:0061548),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,CTNNB1
glomerular visceral epithelial cell differentiation (GO:0072112),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,IQGAP1
glutamine metabolic process (GO:0006541),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,GLUL
replicative senescence (GO:0090399),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,MME
maintenance of protein localization in endoplasmic reticulum (GO:0035437),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,HSPA5
microtubule anchoring at microtubule organizing center (GO:0072393),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,NIN
mitochondrial genome maintenance (GO:0000002),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,PARP1
mitotic nuclear membrane disassembly (GO:0007077),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,PRKCB
modulation by host of viral process (GO:0044788),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,IFI27
morphogenesis of a polarized epithelium (GO:0001738),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,ACTG1
negative regulation of calcineurin-mediated signaling (GO:0106057),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,ATP2B4
negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,ATP2B4
negative regulation of cardiac muscle hypertrophy (GO:0010614),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,ATP2B4
negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,ATP2B4
negative regulation of glucose transmembrane transport (GO:0010829),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,PRKCB
negative regulation of oxidoreductase activity (GO:0051354),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,SNCA
negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,HNRNPU
neurotransmitter uptake (GO:0001504),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,GLUL
P-body assembly (GO:0033962),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,DDX6
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,XBP1
positive regulation of protein maturation (GO:1903319),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,SOX4
positive regulation of sodium ion transmembrane transport (GO:1902307),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,WNK1
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,HSPA5
protein auto-ADP-ribosylation (GO:0070213),1/12,0.11579129625858678,0.23101885689760887,0,0,8.860277653381102,19.102456294823007,PARP1
phosphorylation (GO:0016310),7/400,0.11599086032905981,0.23119189962475054,0,0,1.7543173040906215,3.7792273181022775,CDK6;PRKCB;WNK1;STRADB;ADAM10;ERG;HK1
regulation of canonical Wnt signaling pathway (GO:0060828),5/253,0.11755001436974427,0.23407189450301846,0,0,1.9804668503809368,4.239964411826845,CYLD;ZEB2;WNK1;CTNNB1;SOX4
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),2/58,0.11825121427848563,0.2345563775959507,0,0,3.49009900990099,7.451165880993574,CYLD;H2BC11
muscle organ development (GO:0007517),2/58,0.11825121427848563,0.2345563775959507,0,0,3.49009900990099,7.451165880993574,FHL1;UTRN
positive regulation of mitochondrion organization (GO:0010822),2/58,0.11825121427848563,0.2345563775959507,0,0,3.49009900990099,7.451165880993574,PMAIP1;FBXO7
positive regulation of mitotic cell cycle phase transition (GO:1901992),2/58,0.11825121427848563,0.2345563775959507,0,0,3.49009900990099,7.451165880993574,KMT2E;CCND3
positive regulation of apoptotic signaling pathway (GO:2001235),2/59,0.12161509810928037,0.23870433090357648,0,0,3.4286955011290603,7.223898510859551,CYLD;PMAIP1
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),3/119,0.1221108533743568,0.23870433090357648,0,0,2.5321667524446734,5.324706115258784,PMAIP1;HMGB1;SNCA
positive regulation of cell differentiation (GO:0045597),5/258,0.12478048502896999,0.23870433090357648,0,0,1.9408306353903906,4.039255175868363,XBP1;LEF1;CTNNB1;MACROH2A1;RHOA
regulation of actomyosin structure organization (GO:0110020),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,ACTG1
regulation of antigen receptor-mediated signaling pathway (GO:0050854),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,PAX5
cardiac right ventricle morphogenesis (GO:0003215),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,SOX4
regulation of interleukin-5 production (GO:0032674),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,LEF1
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,RHOA
regulation of mRNA metabolic process (GO:1903311),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,DHX9
regulation of nucleocytoplasmic transport (GO:0046822),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,IFI27
DNA replication-independent nucleosome organization (GO:0034724),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,NASP
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,SNCA
regulation of response to stress (GO:0080134),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,MACROH2A1
"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,EDEM1
establishment of protein localization to chromosome (GO:0070199),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,MACROH2A1
response to iron ion (GO:0010039),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,SNCA
response to UV-B (GO:0010224),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,MME
ribosomal subunit export from nucleus (GO:0000054),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,XPO1
spinal cord development (GO:0021510),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,SOX4
lipid oxidation (GO:0034440),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,ADIPOR1
mature B cell differentiation involved in immune response (GO:0002313),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,DOCK11
toll-like receptor 9 signaling pathway (GO:0034162),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,PIK3AP1
mitochondrion transport along microtubule (GO:0047497),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,UBB
negative regulation by host of viral transcription (GO:0043922),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,JUN
"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,HMGB1
negative regulation of chromatin organization (GO:1905268),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,H1-0
negative regulation of chromatin silencing (GO:0031936),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,H1-0
negative regulation of gene silencing (GO:0060969),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,H1-0
negative regulation of histone methylation (GO:0031061),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,MACROH2A1
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,CD74
negative regulation of myotube differentiation (GO:0010832),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,XBP1
negative regulation of stem cell differentiation (GO:2000737),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,HNRNPU
polyamine metabolic process (GO:0006595),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,SAT1
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,PABPC1
positive regulation of protein exit from endoplasmic reticulum (GO:0070863),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,EDEM1
positive regulation of purine nucleotide biosynthetic process (GO:1900373),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,ENO1
positive regulation of vascular endothelial cell proliferation (GO:1905564),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,HMGB1
protein localization to mitochondrion (GO:0070585),1/13,0.12481562554868265,0.23870433090357648,0,0,8.12151067323481,16.900194711039827,HK1
cellular protein catabolic process (GO:0044257),2/60,0.12500231676893,0.23870433090357648,0,0,3.3694093547285764,7.006427334582721,BNIP3L;MDM2
ribonucleoprotein complex biogenesis (GO:0022613),2/60,0.12500231676893,0.23870433090357648,0,0,3.3694093547285764,7.006427334582721,XPO1;GLUL
response to light stimulus (GO:0009416),2/61,0.12841205056805619,0.24453186952969064,0,0,3.312132908206075,6.798189361212573,MSH6;FECH
pattern recognition receptor signaling pathway (GO:0002221),2/61,0.12841205056805619,0.24453186952969064,0,0,3.312132908206075,6.798189361212573,UBB;HMGB1
positive regulation of interleukin-8 production (GO:0032757),2/61,0.12841205056805619,0.24453186952969064,0,0,3.312132908206075,6.798189361212573,CD74;HMGB1
negative regulation of cell differentiation (GO:0045596),4/191,0.13180319657011833,0.24578499029160353,0,0,2.0972192513368983,4.249900313094531,CDK6;MYB;HNRNPU;ADIPOR1
stress-activated MAPK cascade (GO:0051403),2/62,0.13184349398019252,0.24578499029160353,0,0,3.2567656765676567,6.598662268350372,UBB;ARHGEF6
regulation of tumor necrosis factor production (GO:0032680),3/124,0.13347825374235606,0.24578499029160353,0,0,2.4269150117182683,4.887361998829472,DHX9;HMGB1;HLA-E
non-canonical Wnt signaling pathway (GO:0035567),3/124,0.13347825374235606,0.24578499029160353,0,0,2.4269150117182683,4.887361998829472,LEF1;CTNNB1;RHOA
activation of cysteine-type endopeptidase activity (GO:0097202),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,IFI16
amyloid precursor protein catabolic process (GO:0042987),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,ADAM10
regulation of cAMP-dependent protein kinase activity (GO:2000479),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,ATP2B4
branching involved in blood vessel morphogenesis (GO:0001569),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,CTNNB1
calcium ion import across plasma membrane (GO:0098703),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,ATP2B4
regulation of chromatin organization (GO:1902275),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,HNRNPU
cellular response to low-density lipoprotein particle stimulus (GO:0071404),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,CD9
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,CD74
regulation of IRE1-mediated unfolded protein response (GO:1903894),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,HSPA5
regulation of macrophage cytokine production (GO:0010935),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,CD74
covalent chromatin modification (GO:0016569),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,CHD1
defense response to protozoan (GO:0042832),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,GBP4
detection of bacterium (GO:0016045),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,HLA-DRB1
dicarboxylic acid catabolic process (GO:0043649),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,GLUL
regulation of trophoblast cell migration (GO:1901163),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,ARHGDIB
response to UV-A (GO:0070141),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,MME
secondary palate development (GO:0062009),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,LEF1
vascular endothelial growth factor signaling pathway (GO:0038084),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,GAB1
myeloid dendritic cell activation (GO:0001773),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,HMGB1
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,RHOA
"negative regulation of DNA-templated transcription, elongation (GO:0032785)",1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,HNRNPU
"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,RBMX
negative regulation of secretion (GO:0051048),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,CD74
negative regulation of T cell differentiation (GO:0045581),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,IRF1
nuclear membrane disassembly (GO:0051081),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,PRKCB
peptidyl-serine dephosphorylation (GO:0070262),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,PPP1R15B
polarized epithelial cell differentiation (GO:0030859),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,RHOA
positive regulation of alpha-beta T cell differentiation (GO:0046638),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,NCKAP1L
positive regulation of brown fat cell differentiation (GO:0090336),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,HNRNPU
positive regulation of glucose metabolic process (GO:0010907),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,PMAIP1
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,HLA-DRB1
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,WNK1
positive regulation of T-helper cell differentiation (GO:0045624),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,MYB
positive regulation of transmembrane transport (GO:0034764),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,CA2
positive regulation of type 2 immune response (GO:0002830),1/14,0.13374829876775887,0.24578499029160353,0,0,7.496400151572566,15.08122493657931,CD74
actin cytoskeleton reorganization (GO:0031532),2/63,0.13529585534312058,0.24840609999825633,0,0,3.2032137639993508,6.4073608719788195,GAB1;RHOA
regulation of phosphorylation (GO:0042325),3/125,0.13579485533617197,0.24909906766680068,0,0,2.4068999265965254,4.8056403389621645,RANBP2;MCM7;NCKAP1L
regulation of programmed cell death (GO:0043067),4/194,0.13723190269650445,0.2515099898257045,0,0,2.0637894736842104,4.098857320887728,PRDX2;BNIP3L;FLT3;PMAIP1
protein deubiquitination (GO:0016579),5/267,0.13829887248660622,0.2529587933862486,0,0,1.8732977866431393,3.7060165581941993,CYLD;UBB;MDM2;EIF3F;RHOA
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),2/64,0.13876835684009844,0.2529587933862486,0,0,3.151389332481635,6.223833946822459,LEF1;CTNNB1
pre-replicative complex assembly (GO:0036388),2/64,0.13876835684009844,0.2529587933862486,0,0,3.151389332481635,6.223833946822459,MCM7;UBB
protein catabolic process (GO:0030163),2/64,0.13876835684009844,0.2529587933862486,0,0,3.151389332481635,6.223833946822459,PMAIP1;STT3B
regulation of cellular catabolic process (GO:0031329),2/65,0.14226023416837882,0.2529587933862486,0,0,3.1012101210121013,6.0476613708930715,IFI16;DCAF12
chemical homeostasis (GO:0048878),2/65,0.14226023416837882,0.2529587933862486,0,0,3.1012101210121013,6.0476613708930715,WNK1;SLC4A1
regulation of RNA metabolic process (GO:0051252),2/65,0.14226023416837882,0.2529587933862486,0,0,3.1012101210121013,6.0476613708930715,RBM38;MBNL3
calcium ion import into cytosol (GO:1902656),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,ATP2B4
cellular response to arsenic-containing substance (GO:0071243),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,HNRNPA1
cellular response to estrogen stimulus (GO:0071391),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,NCOA4
cellular response to exogenous dsRNA (GO:0071360),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,DHX9
contractile actin filament bundle assembly (GO:0030038),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,RHOA
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,PABPC1
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,PABPC1
establishment of apical/basal cell polarity (GO:0035089),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,RHOA
response to muscle stretch (GO:0035994),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,CTNNB1
histone mRNA catabolic process (GO:0071044),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,DCP2
integrated stress response signaling (GO:0140467),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,HSPA5
interleukin-27-mediated signaling pathway (GO:0070106),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,CANX
stress fiber assembly (GO:0043149),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,RHOA
T cell proliferation (GO:0042098),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,DOCK8
myoblast fusion (GO:0007520),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,CD9
negative regulation of cellular component movement (GO:0051271),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,CD9
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,XBP1
negative regulation of leukocyte mediated cytotoxicity (GO:0001911),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,HLA-E
negative regulation of mRNA processing (GO:0050686),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,RBMX
nucleosome positioning (GO:0016584),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,H1-0
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,PMAIP1
positive regulation of double-strand break repair via homologous recombination (GO:1905168),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,PARP1
positive regulation of keratinocyte differentiation (GO:0045618),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,MACROH2A1
positive regulation of natural killer cell activation (GO:0032816),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,HLA-E
"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,PABPC1
positive regulation of secretion (GO:0051047),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,XBP1
positive regulation of sprouting angiogenesis (GO:1903672),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,PKM
prostanoid biosynthetic process (GO:0046457),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,CD74
protein localization to cell-cell junction (GO:0150105),1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,ACTG1
"protein localization to chromosome, telomeric region (GO:0070198)",1/15,0.14259024224554276,0.2529587933862486,0,0,6.960591133004926,13.557701594688005,XRCC5
ERBB signaling pathway (GO:0038127),2/66,0.14577073630627355,0.2579311214952975,0,0,3.05259900990099,5.878451547654295,GAB1;IQGAP1
positive regulation of cell cycle (GO:0045787),2/66,0.14577073630627355,0.2579311214952975,0,0,3.05259900990099,5.878451547654295,CCND3;MDM2
positive regulation of cell death (GO:0010942),2/66,0.14577073630627355,0.2579311214952975,0,0,3.05259900990099,5.878451547654295,HBA1;SNCA
regulation of primary metabolic process (GO:0080090),3/130,0.14758133467109766,0.2594983448991095,0,0,2.3115524738512163,4.422868641750747,CHD9;ADIPOR1;MACROH2A1
regulation of response to external stimulus (GO:0032101),3/130,0.14758133467109766,0.2594983448991095,0,0,2.3115524738512163,4.422868641750747,CYLD;IRF1;PIK3AP1
positive regulation of canonical Wnt signaling pathway (GO:0090263),3/130,0.14758133467109766,0.2594983448991095,0,0,2.3115524738512163,4.422868641750747,ZEB2;WNK1;SOX4
positive regulation of MAPK cascade (GO:0043410),5/274,0.1492417298497981,0.2594983448991095,0,0,1.823896433842073,3.469393799600104,CD74;FLT3;IQGAP1;HMGB1;HLA-DRB1
regulation of gene silencing by miRNA (GO:0060964),2/67,0.1492991255135835,0.2594983448991095,0,0,3.0054836252856054,5.71583907247848,RANBP2;DHX9
vascular endothelial growth factor receptor signaling pathway (GO:0048010),2/67,0.1492991255135835,0.2594983448991095,0,0,3.0054836252856054,5.71583907247848,NCKAP1L;RHOA
cellular response to metal ion (GO:0071248),3/131,0.14997777981218033,0.2594983448991095,0,0,2.293376865671642,4.351150838337175,JUN;IQGAP1;SNCA
B cell activation involved in immune response (GO:0002312),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,MSH6
regulation of cellular carbohydrate metabolic process (GO:0010675),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,ADIPOR1
regulation of chromatin silencing (GO:0031935),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,H1-0
regulation of defense response to virus (GO:0050688),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,DHX9
cellular response to corticosteroid stimulus (GO:0071384),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,HNRNPU
regulation of isotype switching (GO:0045191),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,TFRC
regulation of leukocyte activation (GO:0002694),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,CD74
dendritic cell chemotaxis (GO:0002407),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,HMGB1
DNA unwinding involved in DNA replication (GO:0006268),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,MCM7
regulation of phosphate metabolic process (GO:0019220),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,MCM7
epiboly involved in wound healing (GO:0090505),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,RHOA
glutamine family amino acid catabolic process (GO:0009065),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,GLUL
resolution of meiotic recombination intermediates (GO:0000712),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,TOP2A
heme catabolic process (GO:0042167),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,BLVRB
necroptotic process (GO:0070266),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,CYLD
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,HLA-E
negative regulation of platelet activation (GO:0010544),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,CD9
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,ADIPOR1
negative regulation of telomere maintenance (GO:0032205),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,PARP1
neural tube development (GO:0021915),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,SOX4
neutrophil activation (GO:0042119),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,KMT2E
nuclear transport (GO:0051169),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,XPO1
porphyrin-containing compound catabolic process (GO:0006787),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,BLVRB
positive regulation of alpha-beta T cell proliferation (GO:0046641),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,HLA-E
positive regulation of immunoglobulin mediated immune response (GO:0002891),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,TFRC
positive regulation of isotype switching (GO:0045830),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,TFRC
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,RHOA
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,CD74
positive regulation of small molecule metabolic process (GO:0062013),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,PMAIP1
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),1/16,0.15134237294018343,0.2594983448991095,0,0,6.496223316912972,12.266237975819138,CD53
generation of neurons (GO:0048699),4/202,0.15213776824981295,0.2606440527958752,0,0,1.9795959595959596,3.7275174257075374,CDK6;HMGB2;CTNNB1;NAV1
protein modification by small protein removal (GO:0070646),5/276,0.15243436481678277,0.2609340129570492,0,0,1.810250514565447,3.405119541308445,CYLD;UBB;MDM2;EIF3F;RHOA
canonical Wnt signaling pathway (GO:0060070),2/68,0.1528446769600423,0.26141798254685034,0,0,2.95979597959796,5.559482628989288,LEF1;CTNNB1
regulation of cell motility (GO:2000145),3/133,0.1548080559153002,0.2643347554753751,0,0,2.257864523536165,4.2122026898623615,CDK6;TMSB10;RHOA
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),3/133,0.1548080559153002,0.2643347554753751,0,0,2.257864523536165,4.2122026898623615,JUN;UBB;RHOA
cell chemotaxis (GO:0060326),2/69,0.15640667859273272,0.26662003696880976,0,0,2.9154721442293483,5.409063077799617,LEF1;HMGB2
positive regulation of protein transport (GO:0051222),2/69,0.15640667859273272,0.26662003696880976,0,0,2.9154721442293483,5.409063077799617,TMED10;PPIA
regulation of inflammatory response (GO:0050727),4/206,0.1598132294382127,0.2671976134098581,0,0,1.94,3.5574739555107624,CYLD;DHX9;PIK3AP1;SNCA
carbohydrate homeostasis (GO:0033500),2/70,0.1599844310262211,0.2671976134098581,0,0,2.8724519510774607,5.264281721708895,ADIPOR1;SOX4
cellular response to light stimulus (GO:0071482),2/70,0.1599844310262211,0.2671976134098581,0,0,2.8724519510774607,5.264281721708895,PCNA;PARP1
kidney development (GO:0001822),2/70,0.1599844310262211,0.2671976134098581,0,0,2.8724519510774607,5.264281721708895,MME;SOX4
negative regulation of viral process (GO:0048525),2/70,0.1599844310262211,0.2671976134098581,0,0,2.8724519510774607,5.264281721708895,IFI16;PPIA
neutrophil chemotaxis (GO:0030593),2/70,0.1599844310262211,0.2671976134098581,0,0,2.8724519510774607,5.264281721708895,NCKAP1L;PPIA
positive regulation of cell-substrate adhesion (GO:0010811),2/70,0.1599844310262211,0.2671976134098581,0,0,2.8724519510774607,5.264281721708895,CDK6;UTRN
pyrimidine-containing compound catabolic process (GO:0072529),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,DPYSL2
amyloid-beta metabolic process (GO:0050435),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,MME
cellular biogenic amine biosynthetic process (GO:0042401),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,SAT1
regulation of leukocyte migration (GO:0002685),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,NCKAP1L
regulation of metal ion transport (GO:0010959),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,EPB41
regulation of neuroblast proliferation (GO:1902692),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,CTNNB1
DNA biosynthetic process (GO:0071897),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,PPIA
regulation of osteoblast proliferation (GO:0033688),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,RHOA
regulation of receptor recycling (GO:0001919),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,SNCA
establishment of protein localization to endoplasmic reticulum (GO:0072599),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,EDEM1
ribosomal small subunit assembly (GO:0000028),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,XRCC5
RNA interference (GO:0016246),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,DHX9
negative regulation of ATP metabolic process (GO:1903579),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,PARP1
negative regulation of phagocytosis (GO:0050765),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,HMGB1
negative regulation of viral entry into host cell (GO:0046597),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,CIITA
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,CCND3
positive regulation of muscle hypertrophy (GO:0014742),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,PARP1
positive regulation of stem cell proliferation (GO:2000648),1/17,0.16000559865978323,0.2671976134098581,0,0,6.0899014778325125,11.160027472516946,HNRNPU
protein tetramerization (GO:0051262),2/71,0.16357724725585454,0.272717477320786,0,0,2.830678720045918,5.1248587322669765,HLA-DRB1;SNCA
negative regulation of neuron apoptotic process (GO:0043524),2/71,0.16357724725585454,0.272717477320786,0,0,2.830678720045918,5.1248587322669765,SET;NONO
3'-UTR-mediated mRNA stabilization (GO:0070935),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,YBX3
"alternative mRNA splicing, via spliceosome (GO:0000380)",1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,DHX9
amyloid precursor protein metabolic process (GO:0042982),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,ADAM10
regulation of adaptive immune response (GO:0002819),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,IRF1
regulation of brown fat cell differentiation (GO:0090335),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,HNRNPU
regulation of catabolic process (GO:0009894),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,MDM2
cellular response to glucocorticoid stimulus (GO:0071385),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,HNRNPU
regulation of fatty acid metabolic process (GO:0019217),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,ADIPOR1
chromatin disassembly (GO:0031498),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,SET
regulation of membrane depolarization (GO:0003254),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,FHL1
dendritic cell migration (GO:0036336),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,HMGB1
DNA strand elongation (GO:0022616),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,MCM7
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,PPIA
regulation of platelet aggregation (GO:0090330),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,CD9
regulation of presynapse assembly (GO:1905606),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,SNCA
regulation of presynapse organization (GO:0099174),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,SNCA
regulation of protein sumoylation (GO:0033233),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,CTNNB1
regulation of protein-containing complex disassembly (GO:0043244),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,GSPT1
regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,TOP2A
regulation of telomerase RNA localization to Cajal body (GO:1904872),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,DCP2
regulation of telomere maintenance via telomere lengthening (GO:1904356),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,PARP1
regulation of vascular endothelial cell proliferation (GO:1905562),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,HMGB1
intracellular estrogen receptor signaling pathway (GO:0030520),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,NCOA4
microtubule depolymerization (GO:0007019),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,STMN1
negative regulation of biosynthetic process (GO:0009890),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,CIITA
negative regulation of fibroblast proliferation (GO:0048147),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,FTH1
negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,WNK1
negative regulation of Rho protein signal transduction (GO:0035024),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,STMN1
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,H2BC11
nucleosome disassembly (GO:0006337),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,SET
positive regulation of cardiac muscle hypertrophy (GO:0010613),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,PARP1
positive regulation of cell adhesion mediated by integrin (GO:0033630),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,NCKAP1L
positive regulation of interleukin-4 production (GO:0032753),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,HLA-E
positive regulation of nervous system process (GO:0031646),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,RNF10
programmed necrotic cell death (GO:0097300),1/18,0.16858081808691658,0.27327697488931335,0,0,5.731382208055636,10.203809066850313,CYLD
regulation of cellular component organization (GO:0051128),3/139,0.1695821685966086,0.2744659268992504,0,0,2.1575943810359965,3.828473657282654,SOCS2;TFRC;HNRNPU
positive regulation of response to external stimulus (GO:0032103),3/139,0.1695821685966086,0.2744659268992504,0,0,2.1575943810359965,3.828473657282654,DHX9;RIOK3;SNCA
regulation of actin filament polymerization (GO:0030833),2/73,0.17080538418063307,0.27492555552719333,0,0,2.75066239018268,4.8610544018684845,NCKAP1L;SSH2
regulation of actin filament-based process (GO:0032970),2/73,0.17080538418063307,0.27492555552719333,0,0,2.75066239018268,4.8610544018684845,IQGAP1;RHOA
defense response to Gram-negative bacterium (GO:0050829),2/73,0.17080538418063307,0.27492555552719333,0,0,2.75066239018268,4.8610544018684845,H2BC11;HMGB2
regulation of Rho protein signal transduction (GO:0035023),2/73,0.17080538418063307,0.27492555552719333,0,0,2.75066239018268,4.8610544018684845,ARHGDIB;STMN1
granulocyte chemotaxis (GO:0071621),2/73,0.17080538418063307,0.27492555552719333,0,0,2.75066239018268,4.8610544018684845,NCKAP1L;PPIA
response to molecule of bacterial origin (GO:0002237),2/73,0.17080538418063307,0.27492555552719333,0,0,2.75066239018268,4.8610544018684845,HMGB2;SNCA
transcription-coupled nucleotide-excision repair (GO:0006283),2/73,0.17080538418063307,0.27492555552719333,0,0,2.75066239018268,4.8610544018684845,PCNA;UBB
regulation of cytokine-mediated signaling pathway (GO:0001959),2/74,0.17443939140464484,0.2791648562314633,0,0,2.7123212321232124,4.736195460678165,CD74;CYLD
negative regulation of multicellular organismal process (GO:0051241),4/214,0.17557733519851115,0.2791648562314633,0,0,1.8653333333333333,3.2450750290029515,ARHGDIB;ATP2B4;LNPEP;ADIPOR1
pyroptosis (GO:0070269),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,DHX9
atrioventricular valve morphogenesis (GO:0003181),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,SOX4
regulation of autophagy of mitochondrion (GO:1903146),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,FBXO7
regulation of collagen biosynthetic process (GO:0032965),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,CIITA
cellular response to copper ion (GO:0071280),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,SNCA
cellular response to interleukin-7 (GO:0098761),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,SOCS2
regulation of glucose transmembrane transport (GO:0010827),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,PRKCB
regulation of mitochondrial membrane permeability (GO:0046902),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,PMAIP1
regulation of mitotic spindle assembly (GO:1901673),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,HNRNPU
detection of mechanical stimulus (GO:0050982),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,CTNNB1
DNA alkylation (GO:0006305),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,KMT2E
DNA methylation or demethylation (GO:0044728),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,KMT2E
dopamine metabolic process (GO:0042417),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,SNCA
endoplasmic reticulum mannose trimming (GO:1904380),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,UBB
establishment of skin barrier (GO:0061436),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,STMN1
regulation of water loss via skin (GO:0033561),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,STMN1
interleukin-7-mediated signaling pathway (GO:0038111),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,SOCS2
negative regulation of RNA splicing (GO:0033119),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,RBMX
negative regulation of striated muscle cell differentiation (GO:0051154),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,XBP1
NLS-bearing protein import into nucleus (GO:0006607),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,RANBP2
pore complex assembly (GO:0046931),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,ADAM10
positive regulation of cilium assembly (GO:0045724),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,SEPTIN9
positive regulation of monocyte chemotaxis (GO:0090026),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,HMGB1
prostaglandin biosynthetic process (GO:0001516),1/19,0.17706892083125947,0.2791648562314633,0,0,5.412698412698413,9.37055138871512,CD74
Ras protein signal transduction (GO:0007265),3/142,0.17711777115710214,0.2791648562314633,0,0,2.1107054654783637,3.653505349826967,JUN;ARHGDIB;RHOA
actomyosin structure organization (GO:0031032),2/76,0.18174408805529324,0.28530754032130434,0,0,2.6387476585496388,4.499475587066146,EPB41;RHOA
chloride transport (GO:0006821),2/76,0.18174408805529324,0.28530754032130434,0,0,2.6387476585496388,4.499475587066146,SLC4A1;CLIC1
negative regulation of cell migration (GO:0030336),3/144,0.18219255486042157,0.28530754032130434,0,0,2.0805546734413043,3.5425420450549847,CD74;ARHGDIB;ADIPOR1
negative regulation of developmental process (GO:0051093),2/77,0.1854135338318932,0.28530754032130434,0,0,2.6034323432343234,4.387217309583115,CDK6;TFRC
neutrophil migration (GO:1990266),2/77,0.1854135338318932,0.28530754032130434,0,0,2.6034323432343234,4.387217309583115,NCKAP1L;PPIA
positive regulation of endothelial cell proliferation (GO:0001938),2/77,0.1854135338318932,0.28530754032130434,0,0,2.6034323432343234,4.387217309583115,HMGB2;HMGB1
protein targeting to lysosome (GO:0006622),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,NCOA4
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,HLA-DRB1
protein-DNA complex disassembly (GO:0032986),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,SET
branched-chain amino acid catabolic process (GO:0009083),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,BCAT1
branched-chain amino acid metabolic process (GO:0009081),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,BCAT1
regulation of granulocyte chemotaxis (GO:0071622),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,MPP1
regulation of lymphocyte differentiation (GO:0045619),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,NCKAP1L
cortical actin cytoskeleton organization (GO:0030866),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,NCKAP1L
dopaminergic neuron differentiation (GO:0071542),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,CTNNB1
regulation of programmed necrotic cell death (GO:0062098),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,CYLD
establishment of epithelial cell polarity (GO:0090162),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,RHOA
granulocyte differentiation (GO:0030851),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,LEF1
growth hormone receptor signaling pathway (GO:0060396),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,SOCS2
hepaticobiliary system development (GO:0061008),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,XBP1
skeletal muscle contraction (GO:0003009),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,RCSD1
toll-like receptor 4 signaling pathway (GO:0034142),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,PIK3AP1
mitotic cytokinetic process (GO:1902410),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,RHOA
natural killer cell mediated immunity (GO:0002228),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,TUBB
negative regulation of dephosphorylation (GO:0035305),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,PPP1R15A
positive regulation of activated T cell proliferation (GO:0042104),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,HMGB1
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,CCND3
positive regulation of epidermal cell differentiation (GO:0045606),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,MACROH2A1
positive regulation of interferon-alpha production (GO:0032727),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,DHX9
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,HLA-E
positive regulation of peptidyl-lysine acetylation (GO:2000758),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,SOX4
positive regulation of protein processing (GO:0010954),1/20,0.18547078755879814,0.28530754032130434,0,0,5.12756028001037,8.639210388089602,ENO1
protein modification process (GO:0036211),2/78,0.18909356766741553,0.290226756667067,0,0,2.5690463783220427,4.278780961262947,PARP1;UBE2D3
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),2/78,0.18909356766741553,0.290226756667067,0,0,2.5690463783220427,4.278780961262947,LNPEP;HLA-E
negative regulation of blood vessel morphogenesis (GO:2000181),2/78,0.18909356766741553,0.290226756667067,0,0,2.5690463783220427,4.278780961262947,ATP2B4;CTNNB1
recombinational repair (GO:0000725),2/79,0.19278359572492712,0.2928245999017725,0,0,2.5355535553555355,4.173995262190702,PARP1;NUCKS1
mRNA 3'-end processing (GO:0031124),2/79,0.19278359572492712,0.2928245999017725,0,0,2.5355535553555355,4.173995262190702,PABPC1;SRSF5
actin filament-based transport (GO:0099515),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,SUN2
autonomic nervous system development (GO:0048483),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,SOX4
beta-catenin destruction complex disassembly (GO:1904886),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,CTNNB1
calcium ion transport into cytosol (GO:0060402),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,ATP2B4
histone ubiquitination (GO:0016574),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,UHRF1
sensory perception of pain (GO:0019233),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,MME
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,IFI16
stress granule assembly (GO:0034063),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,DDX6
negative regulation of cell communication (GO:0010648),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,UBASH3B
negative regulation of reproductive process (GO:2000242),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,ARHGDIB
nuclear envelope organization (GO:0006998),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,SUN2
"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,PARP1
"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,PARP1
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,PRKCB
positive regulation of immune system process (GO:0002684),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,NCKAP1L
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,XBP1
positive regulation of transcription regulatory region DNA binding (GO:2000679),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,H1-0
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,JUN
protein localization to chromatin (GO:0071168),1/21,0.19378729012533114,0.2928245999017725,0,0,4.870935960591133,7.99317748505789,MACROH2A1
regulation of G2/M transition of mitotic cell cycle (GO:0010389),3/149,0.19504571407466167,0.294508966941033,0,0,2.008791658147618,3.283412786133717,TUBA1A;TUBB;FHL1
negative regulation of cell cycle (GO:0045786),2/80,0.19648303512983445,0.29624263354012564,0,0,2.502919522721503,4.072698553149905,CDK6;HECA
negative regulation of cellular response to growth factor stimulus (GO:0090288),2/80,0.19648303512983445,0.29624263354012564,0,0,2.502919522721503,4.072698553149905,UBE2D3;ATP2B4
MAPK cascade (GO:0000165),5/303,0.19814869218565975,0.2985343163885418,0,0,1.6439580452598563,2.661136634088403,UBB;ABHD17B;FLT3;SPTAN1;SPTB
regulation of interleukin-8 production (GO:0032677),2/81,0.20019131363271056,0.30104547523476566,0,0,2.471111668128838,3.974738147635628,CD74;HMGB1
positive regulation of cellular amide metabolic process (GO:0034250),2/81,0.20019131363271056,0.30104547523476566,0,0,2.471111668128838,3.974738147635628,RBM3;SOX4
regulation of chromosome organization (GO:0033044),1/22,0.2020192915801868,0.30104547523476566,0,0,4.638752052545156,7.419183309087755,XRCC5
cell projection assembly (GO:0030031),1/22,0.2020192915801868,0.30104547523476566,0,0,4.638752052545156,7.419183309087755,NCKAP1L
regulation of response to cytokine stimulus (GO:0060759),1/22,0.2020192915801868,0.30104547523476566,0,0,4.638752052545156,7.419183309087755,DHX9
regulation of vacuole organization (GO:0044088),1/22,0.2020192915801868,0.30104547523476566,0,0,4.638752052545156,7.419183309087755,ENO1
glutamate metabolic process (GO:0006536),1/22,0.2020192915801868,0.30104547523476566,0,0,4.638752052545156,7.419183309087755,GLUL
lipid droplet organization (GO:0034389),1/22,0.2020192915801868,0.30104547523476566,0,0,4.638752052545156,7.419183309087755,PPIA
membrane lipid metabolic process (GO:0006643),1/22,0.2020192915801868,0.30104547523476566,0,0,4.638752052545156,7.419183309087755,SERINC1
membrane protein intracellular domain proteolysis (GO:0031293),1/22,0.2020192915801868,0.30104547523476566,0,0,4.638752052545156,7.419183309087755,ADAM10
microglial cell activation (GO:0001774),1/22,0.2020192915801868,0.30104547523476566,0,0,4.638752052545156,7.419183309087755,SNCA
natural killer cell mediated cytotoxicity (GO:0042267),1/22,0.2020192915801868,0.30104547523476566,0,0,4.638752052545156,7.419183309087755,TUBB
negative regulation of myeloid cell differentiation (GO:0045638),1/22,0.2020192915801868,0.30104547523476566,0,0,4.638752052545156,7.419183309087755,CDK6
negative regulation of protein dephosphorylation (GO:0035308),1/22,0.2020192915801868,0.30104547523476566,0,0,4.638752052545156,7.419183309087755,PPP1R15A
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/22,0.2020192915801868,0.30104547523476566,0,0,4.638752052545156,7.419183309087755,JUN
regulation of cellular macromolecule biosynthetic process (GO:2000112),7/468,0.2025852318601201,0.3016694331986817,0,0,1.4903046786394618,2.379412376806594,RBM3;NONO;MYB;NUCKS1;YBX1;SSBP2;SOX4
ephrin receptor signaling pathway (GO:0048013),2/82,0.20390786966622554,0.3034184640131417,0,0,2.4400990099009903,3.879969730050742,RHOA;ACTG1
positive regulation of Wnt signaling pathway (GO:0030177),3/153,0.20548526647673238,0.30554376706155634,0,0,1.9548258706467663,3.0932792057542304,ZEB2;WNK1;SOX4
regulation of osteoblast differentiation (GO:0045667),2/83,0.20763215208744065,0.3080653726482013,0,0,2.4098520963207433,3.7882568047495977,HEMGN;CDK6
epidermis development (GO:0008544),2/83,0.20763215208744065,0.3080653726482013,0,0,2.4098520963207433,3.7882568047495977,YBX1;HLA-DRB1
peptide metabolic process (GO:0006518),2/83,0.20763215208744065,0.3080653726482013,0,0,2.4098520963207433,3.7882568047495977,MME;LNPEP
regulation of calcium ion transmembrane transport (GO:1903169),1/23,0.21016764632504312,0.30914106770998806,0,0,4.427675772503359,6.906508950874955,UBASH3B
regulation of cysteine-type endopeptidase activity (GO:2000116),1/23,0.21016764632504312,0.30914106770998806,0,0,4.427675772503359,6.906508950874955,IFI16
regulation of neural precursor cell proliferation (GO:2000177),1/23,0.21016764632504312,0.30914106770998806,0,0,4.427675772503359,6.906508950874955,NAP1L1
DNA methylation (GO:0006306),1/23,0.21016764632504312,0.30914106770998806,0,0,4.427675772503359,6.906508950874955,KMT2E
regulation of protein export from nucleus (GO:0046825),1/23,0.21016764632504312,0.30914106770998806,0,0,4.427675772503359,6.906508950874955,IFI27
glucose 6-phosphate metabolic process (GO:0051156),1/23,0.21016764632504312,0.30914106770998806,0,0,4.427675772503359,6.906508950874955,HK1
response to copper ion (GO:0046688),1/23,0.21016764632504312,0.30914106770998806,0,0,4.427675772503359,6.906508950874955,SNCA
negative regulation of GTPase activity (GO:0034260),1/23,0.21016764632504312,0.30914106770998806,0,0,4.427675772503359,6.906508950874955,WNK1
positive regulation of natural killer cell mediated immunity (GO:0002717),1/23,0.21016764632504312,0.30914106770998806,0,0,4.427675772503359,6.906508950874955,HLA-E
positive regulation of transcription by RNA polymerase I (GO:0045943),1/23,0.21016764632504312,0.30914106770998806,0,0,4.427675772503359,6.906508950874955,NCL
protein alkylation (GO:0008213),1/23,0.21016764632504312,0.30914106770998806,0,0,4.427675772503359,6.906508950874955,GSPT1
protein deacylation (GO:0035601),1/23,0.21016764632504312,0.30914106770998806,0,0,4.427675772503359,6.906508950874955,ABHD17B
regulation of autophagy (GO:0010506),4/231,0.21069497420109004,0.3096944061248447,0,0,1.7241409691629956,2.6850802681738886,EEF1A1;IFI16;HMGB1;DCAF12
lymphocyte differentiation (GO:0030098),2/84,0.2113636199843776,0.3102321327707663,0,0,2.3803429123400144,3.6994701866732984,FLT3;SOX4
vascular transport (GO:0010232),2/84,0.2113636199843776,0.3102321327707663,0,0,2.3803429123400144,3.6994701866732984,TFRC;ATP2B4
regulation of cell differentiation (GO:0045595),3/156,0.21339780131300784,0.31299362554785476,0,0,1.9162032972392937,2.959762330504982,HEMGN;CDK6;PRKCB
B cell activation (GO:0042113),2/85,0.21510174262060974,0.3150417945887272,0,0,2.3515447930335203,3.613487529213,FLT3;PRKCB
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",2/85,0.21510174262060974,0.3150417945887272,0,0,2.3515447930335203,3.613487529213,TMED10;ERGIC1
regulation of cardiac muscle hypertrophy (GO:0010611),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,PARP1
regulation of cell size (GO:0008361),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,RHOA
dendritic cell differentiation (GO:0097028),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,FLT3
regulation of monooxygenase activity (GO:0032768),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,SNCA
DNA packaging (GO:0006323),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,H1-0
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,PRKCB
histone monoubiquitination (GO:0010390),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,UHRF1
lymphocyte activation involved in immune response (GO:0002285),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,CD74
"wound healing, spreading of cells (GO:0044319)",1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,RHOA
negative regulation of stress fiber assembly (GO:0051497),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,STMN1
peptidyl-glutamic acid modification (GO:0018200),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,PARP1
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,ZEB2
positive regulation of neuron apoptotic process (GO:0043525),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,CTNNB1
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,HSPA5
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,ZEB2
protein insertion into mitochondrial membrane (GO:0051204),1/24,0.21823320016139572,0.31600807066031256,0,0,4.234953951595631,6.446409054924387,PMAIP1
cellular response to growth factor stimulus (GO:0071363),3/158,0.2187092217964444,0.31600807066031256,0,0,1.8912855079441502,2.874777018838898,EEF1A1;CTNNB1;IQGAP1
regulation of neuron death (GO:1901214),2/86,0.21884599915421354,0.31600807066031256,0,0,2.3234323432343236,3.530192890105955,UBB;SNCA
response to interleukin-1 (GO:0070555),2/86,0.21884599915421354,0.31600807066031256,0,0,2.3234323432343236,3.530192890105955,RBMX;SNCA
transport across blood-brain barrier (GO:0150104),2/86,0.21884599915421354,0.31600807066031256,0,0,2.3234323432343236,3.530192890105955,TFRC;ATP2B4
negative regulation of angiogenesis (GO:0016525),2/87,0.22259587866918998,0.32119644745997905,0,0,2.2959813628421664,3.4494763262640022,ATP2B4;CTNNB1
receptor signaling pathway via STAT (GO:0097696),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,SOCS2
regulation of calcium ion import (GO:0090279),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,CTNNB1
regulation of dopamine secretion (GO:0014059),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,SNCA
regulation of heterotypic cell-cell adhesion (GO:0034114),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,WNK1
regulation of interferon-alpha production (GO:0032647),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,DHX9
regulation of myotube differentiation (GO:0010830),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,XBP1
divalent inorganic cation homeostasis (GO:0072507),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,SNCA
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,UBB
regulation of spindle assembly (GO:0090169),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,HNRNPU
in utero embryonic development (GO:0001701),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,ADAM10
"RNA splicing, via transesterification reactions (GO:0000375)",1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,SF3B1
negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,XBP1
negative regulation of signaling (GO:0023057),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,UBASH3B
peptide catabolic process (GO:0043171),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,LNPEP
positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/25,0.22621679031560463,0.3230092009454173,0,0,4.058292282430213,6.031683535803371,PMAIP1
positive regulation of protein kinase B signaling (GO:0051897),3/161,0.2267269260200037,0.32351216672352895,0,0,1.8550916304553184,2.7529725914287106,FLT3;GAB1;PIK3AP1
peptide biosynthetic process (GO:0043043),3/162,0.2294121860857475,0.32711591460660866,0,0,1.8433305172251948,2.7138156194887166,EEF1A1;RPL15;GSPT1
positive regulation of inflammatory response (GO:0050729),2/89,0.23011051113142425,0.327655620089151,0,0,2.242972573119381,3.2953654404480064,DHX9;SNCA
post-Golgi vesicle-mediated transport (GO:0006892),2/89,0.23011051113142425,0.327655620089151,0,0,2.242972573119381,3.2953654404480064,FTH1;FTL
cellular amino acid catabolic process (GO:0009063),2/90,0.2338742900222665,0.32834382916379035,0,0,2.217371737173717,3.221778005777338,BCAT1;GLUL
regulation of actin filament bundle assembly (GO:0032231),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,ACTG1
cellular response to drug (GO:0035690),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,TFRC
chaperone cofactor-dependent protein refolding (GO:0051085),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,HSPA5
clathrin-dependent endocytosis (GO:0072583),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,CANX
regulation of monocyte chemotaxis (GO:0090025),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,HMGB1
regulation of myelination (GO:0031641),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,RNF10
DNA modification (GO:0006304),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,PARP1
regulation of potassium ion transmembrane transporter activity (GO:1901016),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,FHL1
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,PMAIP1
regulation of regulatory T cell differentiation (GO:0045589),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,IRF1
regulation of synapse organization (GO:0050807),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,ABHD17B
regulation of telomere maintenance (GO:0032204),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,XRCC5
regulation of viral life cycle (GO:1903900),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,PPIA
RNA polyadenylation (GO:0043631),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,PABPC1
lamellipodium assembly (GO:0030032),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,ARHGEF6
mRNA polyadenylation (GO:0006378),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,PABPC1
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,CD74
positive regulation of filopodium assembly (GO:0051491),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,DOCK11
positive regulation of ion transmembrane transporter activity (GO:0032414),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,WNK1
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,PMAIP1
positive regulation of viral transcription (GO:0050434),1/26,0.23411924568486955,0.32834382916379035,0,0,3.8957635467980296,5.656355305246379,DHX9
membrane organization (GO:0061024),4/242,0.23439966776988555,0.3285122566761255,0,0,1.643529411764706,2.3843135425717907,SUN2;TFRC;UBB;ACTG1
regulation of stem cell differentiation (GO:2000736),2/91,0.23764174355578846,0.33282838861641184,0,0,2.192346200912226,3.1503818002826556,MYB;HNRNPU
T cell activation (GO:0042110),2/92,0.24141240778197534,0.3342804461030021,0,0,2.1678767876787677,3.0810917895778376,CD74;SOX4
negative regulation of mitotic cell cycle phase transition (GO:1901991),2/92,0.24141240778197534,0.3342804461030021,0,0,2.1678767876787677,3.0810917895778376,CDK6;FHL1
positive regulation of cellular component biogenesis (GO:0044089),2/92,0.24141240778197534,0.3342804461030021,0,0,2.1678767876787677,3.0810917895778376,TCL1A;TFRC
protein peptidyl-prolyl isomerization (GO:0000413),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,PPIA
cellular response to cadmium ion (GO:0071276),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,JUN
cellular response to unfolded protein (GO:0034620),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,HSPA5
regulation of toll-like receptor signaling pathway (GO:0034121),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,IRF1
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,HNRNPU
regulation of transcription regulatory region DNA binding (GO:2000677),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,H1-0
regulation of vasculature development (GO:1901342),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,CTNNB1
response to glucocorticoid (GO:0051384),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,HNRNPU
stress-activated protein kinase signaling cascade (GO:0031098),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,UBB
microtubule polymerization or depolymerization (GO:0031109),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,STMN1
mitotic chromosome condensation (GO:0007076),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,SET
negative regulation of actin filament bundle assembly (GO:0032232),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,STMN1
negative regulation of insulin receptor signaling pathway (GO:0046627),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,PRKCB
positive regulation of calcium ion transmembrane transport (GO:1904427),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,SNCA
positive regulation of mitotic cell cycle (GO:0045931),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,MDM2
positive regulation of muscle cell differentiation (GO:0051149),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,CTNNB1
positive regulation of toll-like receptor signaling pathway (GO:0034123),1/27,0.2419413868085662,0.3342804461030021,0,0,3.7457370215990906,5.315424774154307,HMGB1
protein phosphorylation (GO:0006468),7/496,0.24401494990992434,0.33691821587967313,0,0,1.402935650296368,1.9788769100605956,CDK6;PRKCB;WNK1;FLT3;STRADB;ADAM10;ERG
regulation of epithelial cell proliferation (GO:0050678),2/93,0.24518582775054884,0.33830690980530276,0,0,2.143945163747144,3.013827063242195,CDK6;UHRF1
cellular protein-containing complex assembly (GO:0034622),3/168,0.2456433610590566,0.33871012571332904,0,0,1.7757575757575759,2.4929408618030346,DHX9;EIF4B;SNCA
cellular protein localization (GO:0034613),5/329,0.24601213893127086,0.3388096483548625,0,0,1.5100192319622805,2.1176123129289404,CD74;TMED10;SEPTIN6;CTNNB1;SEPTIN9
cellular protein modification process (GO:0006464),13/1025,0.24830796105690683,0.3388096483548625,0,0,1.2633321606688326,1.7599297459549712,PARP1;PRKCB;STRADB;UBE2D3;ADAM10;SSH2;PDIA6;SOCS2;CDK6;WNK1;ERG;STT3B;FBXO7
peptidyl-serine modification (GO:0018209),3/169,0.24836670406189526,0.3388096483548625,0,0,1.764970329077504,2.4583371217492225,PARP1;PRKCB;WNK1
regulation of calcineurin-NFAT signaling cascade (GO:0070884),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,ATP2B4
cellular response to acid chemical (GO:0071229),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,XBP1
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,HLA-DRB1
regulation of microtubule polymerization or depolymerization (GO:0031110),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,STMN1
regulation of muscle contraction (GO:0006937),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,ENO1
regulation of plasma membrane bounded cell projection organization (GO:0120035),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,FBXO7
regulation of postsynapse organization (GO:0099175),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,ABHD17B
regulation of reactive oxygen species biosynthetic process (GO:1903426),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,SNCA
regulation of small molecule metabolic process (GO:0062012),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,ADIPOR1
histone mRNA metabolic process (GO:0008334),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,DCP2
T cell activation involved in immune response (GO:0002286),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,CD74
ventricular septum morphogenesis (GO:0060412),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,SOX4
negative regulation of axonogenesis (GO:0050771),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,RHOA
negative regulation of cellular response to insulin stimulus (GO:1900077),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,PRKCB
negative regulation of phosphatase activity (GO:0010923),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,PPP1R15A
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,FLT3
positive regulation of response to wounding (GO:1903036),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,ACTG1
protein depolymerization (GO:0051261),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,STMN1
protein localization to cell surface (GO:0034394),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,CTNNB1
protein localization to Golgi apparatus (GO:0034067),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,TMED10
protein localization to lysosome (GO:0061462),1/28,0.24968402587400798,0.3388096483548625,0,0,3.6068235723408137,5.004680714855542,NCOA4
ciliary basal body-plasma membrane docking (GO:0097711),2/95,0.25273915940609565,0.3427283505116413,0,0,2.09762589162142,2.8850690141356474,TUBA1A;TUBB
cellular protein metabolic process (GO:0044267),6/417,0.2536531070403726,0.3437402224376478,0,0,1.4292560642925607,1.9606358401564232,EEF1A1;UBE2D3;ADAM10;RPL15;PDIA6;GSPT1
positive regulation of ERK1 and ERK2 cascade (GO:0070374),3/172,0.25656407986893764,0.3450955395969192,0,0,1.733374547381436,2.3580425572733823,CD74;HMGB1;HLA-DRB1
aggrephagy (GO:0035973),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,UBB
regulation of fatty acid biosynthetic process (GO:0042304),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,ADIPOR1
regulation of response to biotic stimulus (GO:0002831),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,IRF1
glial cell differentiation (GO:0010001),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,SOX4
response to cadmium ion (GO:0046686),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,JUN
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,PPP1R15A
lamellipodium organization (GO:0097581),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,ARHGEF6
transition metal ion homeostasis (GO:0055076),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,FTL
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,UBB
negative regulation of epithelial to mesenchymal transition (GO:0010719),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,ADIPOR1
negative regulation of myeloid leukocyte differentiation (GO:0002762),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,CDK6
positive regulation of dephosphorylation (GO:0035306),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,PPIA
positive regulation of leukocyte migration (GO:0002687),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,NCKAP1L
protein ADP-ribosylation (GO:0006471),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,PARP1
protein K11-linked ubiquitination (GO:0070979),1/29,0.25734796705909835,0.3450955395969192,0,0,3.477832512315271,4.72055302274505,UBE2D3
organelle organization (GO:0006996),6/420,0.2587730181487006,0.3467795383823986,0,0,1.4186795491143318,1.917776659887388,TMED10;PARP1;DPYSL2;ANK1;PPIA;SYNE3
protein maturation (GO:0051604),2/97,0.2602982738390255,0.34836784003668403,0,0,2.0532569046378324,2.763534107995956,MME;ADAM10
calcium ion homeostasis (GO:0055074),2/97,0.2602982738390255,0.34836784003668403,0,0,2.0532569046378324,2.763534107995956,ATP2B4;SNCA
regulation of neuron apoptotic process (GO:0043523),2/98,0.26407895401970416,0.3499998574496269,0,0,2.0317656765676566,2.7053105301299336,SET;CTNNB1
RNA splicing (GO:0008380),2/98,0.26407895401970416,0.3499998574496269,0,0,2.0317656765676566,2.7053105301299336,NONO;SF3B1
mitochondrion organization (GO:0007005),3/175,0.2647986146707939,0.3499998574496269,0,0,1.7028809441166262,2.262763824421735,BNIP3L;PARP1;FBXO7
protein N-linked glycosylation via asparagine (GO:0018279),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,STT3B
regulation of catecholamine secretion (GO:0050433),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,SNCA
cell projection organization (GO:0030030),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,NCKAP1L
CENP-A containing chromatin organization (GO:0061641),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,NASP
CENP-A containing nucleosome assembly (GO:0034080),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,NASP
regulation of macrophage activation (GO:0043030),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,CD74
regulation of natural killer cell mediated cytotoxicity (GO:0042269),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,HLA-E
respiratory tube development (GO:0030323),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,HECA
RNA-dependent DNA biosynthetic process (GO:0006278),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,PPIA
synaptic vesicle cycle (GO:0099504),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,SNCA
maintenance of blood-brain barrier (GO:0035633),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,ACTG1
morphogenesis of an epithelium (GO:0002009),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,ACTG1
mRNA splice site selection (GO:0006376),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,SRSF5
negative regulation of cytoskeleton organization (GO:0051494),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,SSH2
"negative regulation of gene expression, epigenetic (GO:0045814)",1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,MACROH2A1
plasma membrane invagination (GO:0099024),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,RHOA
positive regulation of lipid kinase activity (GO:0090218),1/30,0.26493400629788744,0.3499998574496269,0,0,3.3577373874639034,4.459997006035752,FLT3
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),2/99,0.2678598418417319,0.3536371236686267,0,0,2.010717566602021,2.648700985407327,RANBP2;SRSF5
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),2/100,0.2716405416203822,0.3560175808474115,0,0,1.99009900990099,2.5936475306384104,ZEB2;UBB
'de novo' posttranslational protein folding (GO:0051084),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,HSPA5
protein palmitoylation (GO:0018345),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,GLUL
activation of protein kinase B activity (GO:0032148),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,PPIA
receptor signaling pathway via JAK-STAT (GO:0007259),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,SOCS2
regulation of cellular component size (GO:0032535),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,PPP1R15A
regulation of potassium ion transport (GO:0043266),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,FHL1
triglyceride homeostasis (GO:0070328),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,XBP1
negative regulation of interleukin-6 production (GO:0032715),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,NCKAP1L
negative regulation of osteoblast differentiation (GO:0045668),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,CDK6
negative regulation of response to biotic stimulus (GO:0002832),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,IFI16
organelle transport along microtubule (GO:0072384),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,UBB
peptidyl-asparagine modification (GO:0018196),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,STT3B
positive regulation of mononuclear cell migration (GO:0071677),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,HMGB1
positive regulation of protein targeting to mitochondrion (GO:1903955),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,UBE2D3
prostaglandin metabolic process (GO:0006693),1/31,0.2724429315611231,0.3560175808474115,0,0,3.245648604269294,4.2204016314008594,CD74
positive regulation of protein localization to membrane (GO:1905477),2/101,0.275420665709409,0.3596793779723257,0,0,1.96989698969897,2.540094816318396,ATP2B4;PMAIP1
post-translational protein modification (GO:0043687),5/345,0.2768553202320168,0.36089675681443245,0,0,1.4377771208986108,1.8464799599825958,SOCS2;ADAM10;STT3B;FBXO7;PDIA6
regulated exocytosis (GO:0045055),3/180,0.27859222964441865,0.36089675681443245,0,0,1.6543553419343957,2.114276233033593,TMED10;CD9;SNCA
cell junction assembly (GO:0034329),2/102,0.27919983429990936,0.36089675681443245,0,0,1.95009900990099,2.487989947627413,RHOA;ACTG1
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),2/102,0.27919983429990936,0.36089675681443245,0,0,1.95009900990099,2.487989947627413,XPO1;MDM2
regulation of protein catabolic process (GO:0042176),2/102,0.27919983429990936,0.36089675681443245,0,0,1.95009900990099,2.487989947627413,EEF1A1;MDM2
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,RHOA
regulation of cellular biosynthetic process (GO:0031326),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,ADIPOR1
cellular response to topologically incorrect protein (GO:0035967),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,HSPA5
regulation of intracellular protein transport (GO:0033157),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,IFI27
chromatin remodeling at centromere (GO:0031055),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,NASP
ERBB2 signaling pathway (GO:0038128),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,GAB1
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,PCNA
response to amino acid (GO:0043200),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,XBP1
hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,FLT3
liver development (GO:0001889),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,XBP1
metal ion export (GO:0070839),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,ATP2B4
mitochondrial membrane organization (GO:0007006),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,PMAIP1
peptidyl-proline modification (GO:0018208),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,PPIA
positive regulation of interleukin-10 production (GO:0032733),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,HMGB1
protein K63-linked deubiquitination (GO:0070536),1/32,0.27987552297615087,0.36089675681443245,0,0,3.1407913554743367,3.999516173580666,CYLD
protein targeting to ER (GO:0045047),2/103,0.2829776752879234,0.3644382505750817,0,0,1.9306930693069306,2.4372823536633272,EDEM1;RPL15
cellular response to organonitrogen compound (GO:0071417),2/103,0.2829776752879234,0.3644382505750817,0,0,1.9306930693069306,2.4372823536633272,XBP1;CTNNB1
mRNA transport (GO:0051028),2/104,0.28675382422498863,0.3680672298287448,0,0,1.9116676373519705,2.3879236642660944,RANBP2;SRSF5
apoptotic cell clearance (GO:0043277),1/33,0.28723255270676573,0.3680672298287448,0,0,3.042487684729064,3.7953911284934607,HMGB1
regulation of interleukin-17 production (GO:0032660),1/33,0.28723255270676573,0.3680672298287448,0,0,3.042487684729064,3.7953911284934607,NCKAP1L
regulation of protein localization to cell surface (GO:2000008),1/33,0.28723255270676573,0.3680672298287448,0,0,3.042487684729064,3.7953911284934607,CTNNB1
negative chemotaxis (GO:0050919),1/33,0.28723255270676573,0.3680672298287448,0,0,3.042487684729064,3.7953911284934607,RHOA
negative regulation of JNK cascade (GO:0046329),1/33,0.28723255270676573,0.3680672298287448,0,0,3.042487684729064,3.7953911284934607,CYLD
positive regulation of ATP metabolic process (GO:1903580),1/33,0.28723255270676573,0.3680672298287448,0,0,3.042487684729064,3.7953911284934607,ENO1
positive regulation of cytokine production involved in immune response (GO:0002720),1/33,0.28723255270676573,0.3680672298287448,0,0,3.042487684729064,3.7953911284934607,HLA-E
regulation of intracellular signal transduction (GO:1902531),6/437,0.28827786783801373,0.3691758445000563,0,0,1.3615271039865007,1.6935088637710247,CYLD;ARHGEF12;ARHGDIB;MDM2;RHOA;ARHGEF6
regulation of JNK cascade (GO:0046328),2/105,0.2905279241463263,0.37159283182011393,0,0,1.8930116312602134,2.339867595279473,CYLD;HMGB1
positive regulation of cellular metabolic process (GO:0031325),2/105,0.2905279241463263,0.37159283182011393,0,0,1.8930116312602134,2.339867595279473,UHRF1;SNCA
protein processing (GO:0016485),2/106,0.29429962543872495,0.3720473457129449,0,0,1.8747143945163747,2.293069840550728,MME;ADAM10
protein localization to nucleus (GO:0034504),2/106,0.29429962543872495,0.3720473457129449,0,0,1.8747143945163747,2.293069840550728,MDM2;HNRNPU
regulation of activated T cell proliferation (GO:0046006),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,HMGB1
regulation of amyloid-beta formation (GO:1902003),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,TMED10
regulation of cell adhesion mediated by integrin (GO:0033628),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,NCKAP1L
cellular response to amino acid stimulus (GO:0071230),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,XBP1
cellular response to vascular endothelial growth factor stimulus (GO:0035924),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,GAB1
regulation of keratinocyte differentiation (GO:0045616),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,MACROH2A1
epithelial tube morphogenesis (GO:0060562),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,CTNNB1
sister chromatid segregation (GO:0000819),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,TOP2A
tRNA export from nucleus (GO:0006409),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,RANBP2
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,RANBP2
negative regulation of mitochondrion organization (GO:0010823),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,TFRC
phosphatidylserine metabolic process (GO:0006658),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,SERINC1
positive regulation of calcium ion transport into cytosol (GO:0010524),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,SNCA
positive regulation of interleukin-12 production (GO:0032735),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,HMGB1
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,PMAIP1
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,JUN
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,SNCA
protein localization to chromosome (GO:0034502),1/34,0.29451478513733365,0.3720473457129449,0,0,2.9501418122107776,3.6063302701440927,XRCC5
mRNA export from nucleus (GO:0006406),2/107,0.29806858580424994,0.3763047025957536,0,0,1.8567656765676568,2.247487969871468,RANBP2;SRSF5
regulation of mitotic cell cycle phase transition (GO:1901990),3/188,0.3007943980482763,0.37733912709417045,0,0,1.582170229931424,1.9007058893886635,TUBA1A;UBB;TUBB
cellular response to virus (GO:0098586),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,RIOK3
regulation of ion transmembrane transport (GO:0034765),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,WNK1
regulation of lipid biosynthetic process (GO:0046890),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,ADIPOR1
regulation of mitotic spindle organization (GO:0060236),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,HNRNPU
regulation of muscle cell differentiation (GO:0051147),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,CTNNB1
regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,FLT3
response to estrogen (GO:0043627),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,NCOA4
response to exogenous dsRNA (GO:0043330),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,DHX9
maturation of SSU-rRNA (GO:0030490),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,RIOK3
negative regulation of epithelial cell migration (GO:0010633),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,ADIPOR1
negative regulation of neurogenesis (GO:0050768),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,RHOA
negative regulation of Ras protein signal transduction (GO:0046580),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,STMN1
negative regulation of T cell proliferation (GO:0042130),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,HLA-DRB1
peptidyl-tyrosine dephosphorylation (GO:0035335),1/35,0.3017229770910228,0.37733912709417045,0,0,2.8632280498406257,3.4308514918973034,UBASH3B
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),2/108,0.30183447013535647,0.37733912709417045,0,0,1.839155613674575,2.2030813336223765,UBB;UBE2D3
regulation of GTPase activity (GO:0043087),3/189,0.30357761559891155,0.37928691119644503,0,0,1.5735836944310704,1.8758973932778769,DOCK11;WNK1;DOCK8
regulation of protein ubiquitination (GO:0031396),2/109,0.3055969503100625,0.3815771792719793,0,0,1.8218747108355695,2.159810973562475,UBB;SOX4
regulation of cell cycle G1/S phase transition (GO:1902806),1/36,0.3088578776207369,0.3833130171077468,0,0,2.78128078817734,3.26765462620049,ATP2B4
regulation of defense response to virus by host (GO:0050691),1/36,0.3088578776207369,0.3833130171077468,0,0,2.78128078817734,3.26765462620049,DHX9
regulation of microtubule-based process (GO:0032886),1/36,0.3088578776207369,0.3833130171077468,0,0,2.78128078817734,3.26765462620049,CYLD
regulation of osteoclast differentiation (GO:0045670),1/36,0.3088578776207369,0.3833130171077468,0,0,2.78128078817734,3.26765462620049,UBASH3B
embryonic limb morphogenesis (GO:0030326),1/36,0.3088578776207369,0.3833130171077468,0,0,2.78128078817734,3.26765462620049,CTNNB1
macrophage activation (GO:0042116),1/36,0.3088578776207369,0.3833130171077468,0,0,2.78128078817734,3.26765462620049,SNCA
transferrin transport (GO:0033572),1/36,0.3088578776207369,0.3833130171077468,0,0,2.78128078817734,3.26765462620049,TFRC
mitochondrion disassembly (GO:0061726),1/36,0.3088578776207369,0.3833130171077468,0,0,2.78128078817734,3.26765462620049,FBXO7
negative regulation of cellular protein localization (GO:1903828),1/36,0.3088578776207369,0.3833130171077468,0,0,2.78128078817734,3.26765462620049,MACROH2A1
positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/36,0.3088578776207369,0.3833130171077468,0,0,2.78128078817734,3.26765462620049,CD74
ribosome biogenesis (GO:0042254),3/192,0.31193400000157323,0.3868963474595784,0,0,1.5483692647871752,1.8037939133611889,XPO1;RPL15;GLUL
regulation of actin cytoskeleton reorganization (GO:2000249),1/37,0.31592022831414535,0.390187189762317,0,0,2.7038861521620143,3.115594835348194,ARHGDIB
centromere complex assembly (GO:0034508),1/37,0.31592022831414535,0.390187189762317,0,0,2.7038861521620143,3.115594835348194,NASP
regulation of p38MAPK cascade (GO:1900744),1/37,0.31592022831414535,0.390187189762317,0,0,2.7038861521620143,3.115594835348194,CYLD
regulation of vascular associated smooth muscle cell proliferation (GO:1904705),1/37,0.31592022831414535,0.390187189762317,0,0,2.7038861521620143,3.115594835348194,JUN
glutamine family amino acid metabolic process (GO:0009064),1/37,0.31592022831414535,0.390187189762317,0,0,2.7038861521620143,3.115594835348194,GLUL
positive regulation of cytokinesis (GO:0032467),1/37,0.31592022831414535,0.390187189762317,0,0,2.7038861521620143,3.115594835348194,RHOA
positive regulation of exocytosis (GO:0045921),1/37,0.31592022831414535,0.390187189762317,0,0,2.7038861521620143,3.115594835348194,SNCA
cellular response to tumor necrosis factor (GO:0071356),3/194,0.31750897411475226,0.3919131855187515,0,0,1.5319996874267408,1.757585409857159,TCL1A;DHX9;YBX3
actin-myosin filament sliding (GO:0033275),1/38,0.32291076325299056,0.39572018774245077,0,0,2.630675009985355,2.9736604939454767,TPM4
connective tissue development (GO:0061448),1/38,0.32291076325299056,0.39572018774245077,0,0,2.630675009985355,2.9736604939454767,XBP1
DNA replication initiation (GO:0006270),1/38,0.32291076325299056,0.39572018774245077,0,0,2.630675009985355,2.9736604939454767,MCM7
histone exchange (GO:0043486),1/38,0.32291076325299056,0.39572018774245077,0,0,2.630675009985355,2.9736604939454767,NASP
lymphocyte proliferation (GO:0046651),1/38,0.32291076325299056,0.39572018774245077,0,0,2.630675009985355,2.9736604939454767,FLT3
ventricular septum development (GO:0003281),1/38,0.32291076325299056,0.39572018774245077,0,0,2.630675009985355,2.9736604939454767,SOX4
muscle filament sliding (GO:0030049),1/38,0.32291076325299056,0.39572018774245077,0,0,2.630675009985355,2.9736604939454767,TPM4
ncRNA export from nucleus (GO:0097064),1/38,0.32291076325299056,0.39572018774245077,0,0,2.630675009985355,2.9736604939454767,RANBP2
negative regulation of G0 to G1 transition (GO:0070317),1/38,0.32291076325299056,0.39572018774245077,0,0,2.630675009985355,2.9736604939454767,CBX5
negative regulation of innate immune response (GO:0045824),1/38,0.32291076325299056,0.39572018774245077,0,0,2.630675009985355,2.9736604939454767,IFI16
positive regulation of potassium ion transport (GO:0043268),1/38,0.32291076325299056,0.39572018774245077,0,0,2.630675009985355,2.9736604939454767,FHL1
positive regulation of signaling (GO:0023056),1/38,0.32291076325299056,0.39572018774245077,0,0,2.630675009985355,2.9736604939454767,SNCA
activation of protein kinase activity (GO:0032147),2/114,0.32434728621973025,0.3971123370069025,0,0,1.74009900990099,1.9592478904157444,STRADB;PPIA
protein transport (GO:0015031),5/369,0.32443438367474614,0.3971123370069025,0,0,1.3413219945883263,1.5098885730699603,CD74;TMED10;TFRC;PRKCB;CANX
positive regulation of protein metabolic process (GO:0051247),2/115,0.32808283331044463,0.4006058676369614,0,0,1.7246122842372733,1.9220616992626884,SLC25A37;UHRF1
regulation of exit from mitosis (GO:0007096),1/39,0.3298302092257462,0.4006058676369614,0,0,2.5613170858179934,2.840954704195769,UBB
cellular response to ketone (GO:1901655),1/39,0.3298302092257462,0.4006058676369614,0,0,2.5613170858179934,2.840954704195769,NCOA4
regulation of nitric-oxide synthase activity (GO:0050999),1/39,0.3298302092257462,0.4006058676369614,0,0,2.5613170858179934,2.840954704195769,ATP2B4
DNA recombination (GO:0006310),1/39,0.3298302092257462,0.4006058676369614,0,0,2.5613170858179934,2.840954704195769,HMGB1
DNA replication-independent nucleosome assembly (GO:0006336),1/39,0.3298302092257462,0.4006058676369614,0,0,2.5613170858179934,2.840954704195769,NASP
endothelial cell migration (GO:0043542),1/39,0.3298302092257462,0.4006058676369614,0,0,2.5613170858179934,2.840954704195769,RHOA
regulation of protein targeting to mitochondrion (GO:1903214),1/39,0.3298302092257462,0.4006058676369614,0,0,2.5613170858179934,2.840954704195769,UBE2D3
regulation of receptor-mediated endocytosis (GO:0048259),1/39,0.3298302092257462,0.4006058676369614,0,0,2.5613170858179934,2.840954704195769,HNRNPK
regulation of T cell differentiation (GO:0045580),1/39,0.3298302092257462,0.4006058676369614,0,0,2.5613170858179934,2.840954704195769,XBP1
negative regulation of lymphocyte proliferation (GO:0050672),1/39,0.3298302092257462,0.4006058676369614,0,0,2.5613170858179934,2.840954704195769,HLA-DRB1
negative regulation of secretion by cell (GO:1903531),1/39,0.3298302092257462,0.4006058676369614,0,0,2.5613170858179934,2.840954704195769,SNCA
protein acylation (GO:0043543),1/39,0.3298302092257462,0.4006058676369614,0,0,2.5613170858179934,2.840954704195769,GLUL
ion transport (GO:0006811),2/116,0.3318128682072214,0.4025367477540536,0,0,1.7093972555150252,1.8857799052681772,WNK1;SLC4A1
sphingolipid metabolic process (GO:0006665),2/116,0.3318128682072214,0.4025367477540536,0,0,1.7093972555150252,1.8857799052681772,SERINC1;ESYT2
proteolysis (GO:0006508),4/287,0.33628193389041633,0.40651494173245206,0,0,1.3790106007067138,1.502853174344156,MME;MDM2;ADAM10;LNPEP
autophagy of mitochondrion (GO:0000422),1/40,0.33667928556367555,0.40651494173245206,0,0,2.495515978274599,2.7166797758085846,FBXO7
regulation of nitric oxide biosynthetic process (GO:0045428),1/40,0.33667928556367555,0.40651494173245206,0,0,2.495515978274599,2.7166797758085846,ATP2B4
ribosomal small subunit biogenesis (GO:0042274),1/40,0.33667928556367555,0.40651494173245206,0,0,2.495515978274599,2.7166797758085846,RIOK3
synaptic vesicle exocytosis (GO:0016079),1/40,0.33667928556367555,0.40651494173245206,0,0,2.495515978274599,2.7166797758085846,SNCA
negative regulation of cell-substrate adhesion (GO:0010812),1/40,0.33667928556367555,0.40651494173245206,0,0,2.495515978274599,2.7166797758085846,RHOA
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/40,0.33667928556367555,0.40651494173245206,0,0,2.495515978274599,2.7166797758085846,RIOK3
positive regulation of double-strand break repair (GO:2000781),1/40,0.33667928556367555,0.40651494173245206,0,0,2.495515978274599,2.7166797758085846,PARP1
axon guidance (GO:0007411),3/203,0.34260173828409796,0.4115478862345621,0,0,1.4623880597014924,1.566490521782694,GAB1;SPTAN1;SPTB
protein methylation (GO:0006479),1/41,0.34345870447101084,0.4115478862345621,0,0,2.4330049261083744,2.6001241281165455,GSPT1
regulation of filopodium assembly (GO:0051489),1/41,0.34345870447101084,0.4115478862345621,0,0,2.4330049261083744,2.6001241281165455,DOCK11
regulation of G0 to G1 transition (GO:0070316),1/41,0.34345870447101084,0.4115478862345621,0,0,2.4330049261083744,2.6001241281165455,CBX5
regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,0.34345870447101084,0.4115478862345621,0,0,2.4330049261083744,2.6001241281165455,PMAIP1
gluconeogenesis (GO:0006094),1/41,0.34345870447101084,0.4115478862345621,0,0,2.4330049261083744,2.6001241281165455,ENO1
regulation of viral transcription (GO:0046782),1/41,0.34345870447101084,0.4115478862345621,0,0,2.4330049261083744,2.6001241281165455,DHX9
response to growth factor (GO:0070848),1/41,0.34345870447101084,0.4115478862345621,0,0,2.4330049261083744,2.6001241281165455,CTNNB1
hexose metabolic process (GO:0019318),1/41,0.34345870447101084,0.4115478862345621,0,0,2.4330049261083744,2.6001241281165455,HK1
import into cell (GO:0098657),1/41,0.34345870447101084,0.4115478862345621,0,0,2.4330049261083744,2.6001241281165455,GLUL
T cell differentiation (GO:0030217),1/41,0.34345870447101084,0.4115478862345621,0,0,2.4330049261083744,2.6001241281165455,SOX4
negative regulation of cell-cell adhesion (GO:0022408),1/41,0.34345870447101084,0.4115478862345621,0,0,2.4330049261083744,2.6001241281165455,WNK1
positive regulation of TOR signaling (GO:0032008),1/41,0.34345870447101084,0.4115478862345621,0,0,2.4330049261083744,2.6001241281165455,NCKAP1L
negative regulation of cell population proliferation (GO:0008285),5/379,0.3445496057214376,0.4126137592771629,0,0,1.3047859618950366,1.390271891905238,CDK6;FTH1;IRF1;CTNNB1;SOX4
ATP-dependent chromatin remodeling (GO:0043044),1/42,0.35016917090840655,0.4171492041810029,0,0,2.3735431935600144,2.490651193911044,NASP
calcium ion transmembrane import into cytosol (GO:0097553),1/42,0.35016917090840655,0.4171492041810029,0,0,2.3735431935600144,2.490651193911044,ATP2B4
regulation of chemokine production (GO:0032642),1/42,0.35016917090840655,0.4171492041810029,0,0,2.3735431935600144,2.490651193911044,CD74
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/42,0.35016917090840655,0.4171492041810029,0,0,2.3735431935600144,2.490651193911044,PMAIP1
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),1/42,0.35016917090840655,0.4171492041810029,0,0,2.3735431935600144,2.490651193911044,XPO1
histone H3 acetylation (GO:0043966),1/42,0.35016917090840655,0.4171492041810029,0,0,2.3735431935600144,2.490651193911044,LEF1
negative regulation of protein catabolic process (GO:0042177),1/42,0.35016917090840655,0.4171492041810029,0,0,2.3735431935600144,2.490651193911044,SNCA
nucleic acid-templated transcription (GO:0097659),1/42,0.35016917090840655,0.4171492041810029,0,0,2.3735431935600144,2.490651193911044,PTMA
phosphatidylinositol phosphate biosynthetic process (GO:0046854),1/42,0.35016917090840655,0.4171492041810029,0,0,2.3735431935600144,2.490651193911044,SOCS2
regulation of protein kinase B signaling (GO:0051896),3/207,0.3537382268168497,0.4211560875930999,0,0,1.4334211296458883,1.4896085311438843,FLT3;GAB1;PIK3AP1
positive regulation of macromolecule metabolic process (GO:0010604),5/384,0.354642335458426,0.4216300595559861,0,0,1.287240954110924,1.3344125465273438,CD74;TFRC;LEF1;ACTG1;SNCA
anion transport (GO:0006820),1/43,0.35681138275748164,0.4216300595559861,0,0,2.316912972085386,2.3876899749654306,SLC4A1
regulation of carbohydrate catabolic process (GO:0043470),1/43,0.35681138275748164,0.4216300595559861,0,0,2.316912972085386,2.3876899749654306,RANBP2
regulation of cell-substrate adhesion (GO:0010810),1/43,0.35681138275748164,0.4216300595559861,0,0,2.316912972085386,2.3876899749654306,RHOA
development of primary male sexual characteristics (GO:0046546),1/43,0.35681138275748164,0.4216300595559861,0,0,2.316912972085386,2.3876899749654306,NCOA4
regulation of purine nucleotide metabolic process (GO:1900542),1/43,0.35681138275748164,0.4216300595559861,0,0,2.316912972085386,2.3876899749654306,RANBP2
signal release from synapse (GO:0099643),1/43,0.35681138275748164,0.4216300595559861,0,0,2.316912972085386,2.3876899749654306,SNCA
male gonad development (GO:0008584),1/43,0.35681138275748164,0.4216300595559861,0,0,2.316912972085386,2.3876899749654306,NCOA4
natural killer cell activation (GO:0030101),1/43,0.35681138275748164,0.4216300595559861,0,0,2.316912972085386,2.3876899749654306,PRDX1
negative regulation of type I interferon production (GO:0032480),1/43,0.35681138275748164,0.4216300595559861,0,0,2.316912972085386,2.3876899749654306,CYLD
positive regulation of axonogenesis (GO:0050772),1/43,0.35681138275748164,0.4216300595559861,0,0,2.316912972085386,2.3876899749654306,RHOA
positive regulation of neuron differentiation (GO:0045666),1/43,0.35681138275748164,0.4216300595559861,0,0,2.316912972085386,2.3876899749654306,RHOA
positive regulation of peptide hormone secretion (GO:0090277),1/43,0.35681138275748164,0.4216300595559861,0,0,2.316912972085386,2.3876899749654306,SOX4
positive regulation of epithelial cell proliferation (GO:0050679),2/123,0.3577463991080235,0.4224912805604267,0,0,1.6099337206447917,1.6549006602330298,XBP1;HMGB2
fatty acid metabolic process (GO:0006631),2/124,0.3614229254253939,0.42523014124599723,0,0,1.5966563869501704,1.624927531838302,XBP1;ADIPOR1
branching morphogenesis of an epithelial tube (GO:0048754),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,CTNNB1
cardiac ventricle morphogenesis (GO:0003208),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,SOX4
hexose biosynthetic process (GO:0019319),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,ENO1
intracellular protein transmembrane transport (GO:0065002),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,HSPA5
intracellular steroid hormone receptor signaling pathway (GO:0030518),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,NCOA4
metal ion homeostasis (GO:0055065),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,SNCA
mitotic spindle assembly (GO:0090307),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,RHOA
mRNA catabolic process (GO:0006402),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,DCP2
neurogenesis (GO:0022008),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,CDK6
neurotransmitter secretion (GO:0007269),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,SNCA
positive regulation of cell division (GO:0051781),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,RHOA
positive regulation of mRNA catabolic process (GO:0061014),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,PABPC1
positive regulation of potassium ion transmembrane transport (GO:1901381),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,WNK1
positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,HNRNPK
positive regulation of stress fiber assembly (GO:0051496),1/44,0.3633860309037292,0.42523014124599723,0,0,2.262916714400275,2.2907269736446687,RHOA
protein targeting (GO:0006605),2/125,0.3650916738685975,0.4267386421886801,0,0,1.5835949448603397,1.595641028000691,EDEM1;FBXO7
regulation of protein secretion (GO:0050708),2/125,0.3650916738685975,0.4267386421886801,0,0,1.5835949448603397,1.595641028000691,TMED10;PPIA
negative regulation of cell growth (GO:0030308),2/126,0.36875242086300924,0.43052633068279544,0,0,1.5707441711913126,1.5670212032484048,FHL1;ENO1
negative regulation of growth (GO:0045926),2/126,0.36875242086300924,0.43052633068279544,0,0,1.5707441711913126,1.5670212032484048,FHL1;ENO1
cellular response to radiation (GO:0071478),1/45,0.36989379914368115,0.43063204229852425,0,0,2.2113748320644873,2.199299274567594,IFI16
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.36989379914368115,0.43063204229852425,0,0,2.2113748320644873,2.199299274567594,JUN
regulation of receptor signaling pathway via JAK-STAT (GO:0046425),1/45,0.36989379914368115,0.43063204229852425,0,0,2.2113748320644873,2.199299274567594,ADIPOR1
microtubule bundle formation (GO:0001578),1/45,0.36989379914368115,0.43063204229852425,0,0,2.2113748320644873,2.199299274567594,NAV1
zymogen activation (GO:0031638),1/45,0.36989379914368115,0.43063204229852425,0,0,2.2113748320644873,2.199299274567594,IFI16
translation (GO:0006412),3/214,0.37316881964291754,0.43419813256577966,0,0,1.3853717196010469,1.3655946546468143,EEF1A1;RPL15;GSPT1
plasma membrane bounded cell projection organization (GO:0120036),2/128,0.3760490429649353,0.4359022962524422,0,0,1.5456545654565457,1.5117053613929448,STMN1;HMGB1
alpha-amino acid metabolic process (GO:1901605),1/46,0.3763353646025233,0.4359022962524422,0,0,2.1621237000547344,2.1129885870694256,GLUL
regulation of double-strand break repair via homologous recombination (GO:0010569),1/46,0.3763353646025233,0.4359022962524422,0,0,2.1621237000547344,2.1129885870694256,PARP1
establishment of protein localization to extracellular region (GO:0035592),1/46,0.3763353646025233,0.4359022962524422,0,0,2.1621237000547344,2.1129885870694256,CANX
positive regulation of nucleocytoplasmic transport (GO:0046824),1/46,0.3763353646025233,0.4359022962524422,0,0,2.1621237000547344,2.1129885870694256,DHX9
positive regulation of response to stimulus (GO:0048584),1/46,0.3763353646025233,0.4359022962524422,0,0,2.1621237000547344,2.1129885870694256,DHX9
positive regulation of smooth muscle cell proliferation (GO:0048661),1/46,0.3763353646025233,0.4359022962524422,0,0,2.1621237000547344,2.1129885870694256,JUN
posttranscriptional regulation of gene expression (GO:0010608),1/46,0.3763353646025233,0.4359022962524422,0,0,2.1621237000547344,2.1129885870694256,RBM3
DNA-dependent DNA replication (GO:0006261),2/129,0.37968449727154474,0.43928488701829205,0,0,1.5334060965151632,1.4849729151770747,UBB;MCM7
muscle contraction (GO:0006936),2/129,0.37968449727154474,0.43928488701829205,0,0,1.5334060965151632,1.4849729151770747,TPM4;UTRN
regulation of synapse assembly (GO:0051963),1/47,0.38271139744846433,0.44178910049121317,0,0,2.115013921610623,2.03141610408811,SNCA
regulation of wound healing (GO:0061041),1/47,0.38271139744846433,0.44178910049121317,0,0,2.115013921610623,2.03141610408811,ACTG1
glycosphingolipid metabolic process (GO:0006687),1/47,0.38271139744846433,0.44178910049121317,0,0,2.115013921610623,2.03141610408811,ESYT2
negative regulation of cold-induced thermogenesis (GO:0120163),1/47,0.38271139744846433,0.44178910049121317,0,0,2.115013921610623,2.03141610408811,LNPEP
G2/M transition of mitotic cell cycle (GO:0000086),2/130,0.3833111083630269,0.4422322415742354,0,0,1.52134900990099,1.4588342325850094,TUBA1A;TUBB
cell cycle G2/M phase transition (GO:0044839),2/131,0.3869286785220949,0.44615467771062034,0,0,1.5094788548622304,1.4332726581317348,TUBA1A;TUBB
cellular response to alcohol (GO:0097306),1/48,0.38902256101362515,0.44680898403414676,0,0,2.069908814589666,1.9542380451512489,CTNNB1
cognition (GO:0050890),1/48,0.38902256101362515,0.44680898403414676,0,0,2.069908814589666,1.9542380451512489,HLA-DRA
regulation of protein metabolic process (GO:0051246),1/48,0.38902256101362515,0.44680898403414676,0,0,2.069908814589666,1.9542380451512489,MDM2
histone H4 acetylation (GO:0043967),1/48,0.38902256101362515,0.44680898403414676,0,0,2.069908814589666,1.9542380451512489,LEF1
substrate adhesion-dependent cell spreading (GO:0034446),1/48,0.38902256101362515,0.44680898403414676,0,0,2.069908814589666,1.9542380451512489,RHOA
nucleus organization (GO:0006997),1/48,0.38902256101362515,0.44680898403414676,0,0,2.069908814589666,1.9542380451512489,SUN2
positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.38902256101362515,0.44680898403414676,0,0,2.069908814589666,1.9542380451512489,HMGB1
regulation of cell adhesion (GO:0030155),2/133,0.3941359293586575,0.45220950896838563,0,0,1.4862822160078604,1.3838170740596463,ARHGDIB;ADAM10
adherens junction organization (GO:0034332),1/49,0.39526951223151713,0.45220950896838563,0,0,2.0266830870279144,1.881141780770528,CTNNB1
regulation of cellular localization (GO:0060341),1/49,0.39526951223151713,0.45220950896838563,0,0,2.0266830870279144,1.881141780770528,PARP1
cellular response to mechanical stimulus (GO:0071260),1/49,0.39526951223151713,0.45220950896838563,0,0,2.0266830870279144,1.881141780770528,IRF1
regulation of stress-activated MAPK cascade (GO:0032872),1/49,0.39526951223151713,0.45220950896838563,0,0,2.0266830870279144,1.881141780770528,PPIA
RNA catabolic process (GO:0006401),1/49,0.39526951223151713,0.45220950896838563,0,0,2.0266830870279144,1.881141780770528,DCP2
positive regulation of actin filament polymerization (GO:0030838),1/49,0.39526951223151713,0.45220950896838563,0,0,2.0266830870279144,1.881141780770528,NCKAP1L
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),2/134,0.3977252387788016,0.4547650749206275,0,0,1.474947494749475,1.3598925442019782,CD74;FLT3
regulation of generation of precursor metabolites and energy (GO:0043467),1/50,0.4014529010595411,0.4582601639392756,0,0,1.9852216748768472,1.8118424588650803,RANBP2
neuron migration (GO:0001764),1/50,0.4014529010595411,0.4582601639392756,0,0,1.9852216748768472,1.8118424588650803,NAV1
positive regulation of ion transport (GO:0043270),1/50,0.4014529010595411,0.4582601639392756,0,0,1.9852216748768472,1.8118424588650803,FHL1
regulation of axonogenesis (GO:0050770),1/51,0.40757337122395215,0.4631823836039257,0,0,1.9454187192118226,1.7460800486363166,RHOA
regulation of interleukin-12 production (GO:0032655),1/51,0.40757337122395215,0.4631823836039257,0,0,1.9454187192118226,1.7460800486363166,HMGB1
gonad development (GO:0008406),1/51,0.40757337122395215,0.4631823836039257,0,0,1.9454187192118226,1.7460800486363166,NCOA4
inositol lipid-mediated signaling (GO:0048017),1/51,0.40757337122395215,0.4631823836039257,0,0,1.9454187192118226,1.7460800486363166,RHOA
sensory perception (GO:0007600),1/51,0.40757337122395215,0.4631823836039257,0,0,1.9454187192118226,1.7460800486363166,MME
negative regulation of protein ubiquitination (GO:0031397),1/51,0.40757337122395215,0.4631823836039257,0,0,1.9454187192118226,1.7460800486363166,SOX4
negative regulation of transport (GO:0051051),1/51,0.40757337122395215,0.4631823836039257,0,0,1.9454187192118226,1.7460800486363166,SNCA
positive regulation of actin filament bundle assembly (GO:0032233),1/51,0.40757337122395215,0.4631823836039257,0,0,1.9454187192118226,1.7460800486363166,RHOA
transcription by RNA polymerase II (GO:0006366),4/320,0.4124475853723287,0.4682492076729235,0,0,1.2329113924050632,1.0919232243314194,XBP1;PARP1;PAX5;RBMX
regulation of exocytosis (GO:0017157),1/52,0.4136315597305962,0.4682492076729235,0,0,1.9071766637689558,1.6836167548650114,SNCA
glycolipid metabolic process (GO:0006664),1/52,0.4136315597305962,0.4682492076729235,0,0,1.9071766637689558,1.6836167548650114,ESYT2
response to peptide hormone (GO:0043434),1/52,0.4136315597305962,0.4682492076729235,0,0,1.9071766637689558,1.6836167548650114,XBP1
negative regulation of BMP signaling pathway (GO:0030514),1/52,0.4136315597305962,0.4682492076729235,0,0,1.9071766637689558,1.6836167548650114,UBE2D3
negative regulation of cellular biosynthetic process (GO:0031327),1/52,0.4136315597305962,0.4682492076729235,0,0,1.9071766637689558,1.6836167548650114,ATP2B4
positive regulation of protein localization to plasma membrane (GO:1903078),1/52,0.4136315597305962,0.4682492076729235,0,0,1.9071766637689558,1.6836167548650114,ATP2B4
cellular macromolecule catabolic process (GO:0044265),1/53,0.41962809730553535,0.47372890985071187,0,0,1.8704054566123531,1.6242347406533706,STT3B
epidermal cell differentiation (GO:0009913),1/53,0.41962809730553535,0.47372890985071187,0,0,1.8704054566123531,1.6242347406533706,CTNNB1
positive regulation of macroautophagy (GO:0016239),1/53,0.41962809730553535,0.47372890985071187,0,0,1.8704054566123531,1.6242347406533706,BNIP3L
positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.41962809730553535,0.47372890985071187,0,0,1.8704054566123531,1.6242347406533706,RHOA
positive regulation of phagocytosis (GO:0050766),1/53,0.41962809730553535,0.47372890985071187,0,0,1.8704054566123531,1.6242347406533706,NCKAP1L
positive regulation of cellular catabolic process (GO:0031331),2/141,0.4225670314560217,0.47678405696772497,0,0,1.4001709523470334,1.2061173261905123,HMGB1;SNCA
regulation of cyclin-dependent protein kinase activity (GO:1904029),1/54,0.42556360830808415,0.4785838822301122,0,0,1.835021842178641,1.5677341229946478,CCND3
cytoplasmic microtubule organization (GO:0031122),1/54,0.42556360830808415,0.4785838822301122,0,0,1.835021842178641,1.5677341229946478,RHOA
regulation of potassium ion transmembrane transport (GO:1901379),1/54,0.42556360830808415,0.4785838822301122,0,0,1.835021842178641,1.5677341229946478,FHL1
striated muscle contraction (GO:0006941),1/54,0.42556360830808415,0.4785838822301122,0,0,1.835021842178641,1.5677341229946478,RCSD1
negative regulation of viral genome replication (GO:0045071),1/54,0.42556360830808415,0.4785838822301122,0,0,1.835021842178641,1.5677341229946478,IFI16
positive regulation of leukocyte chemotaxis (GO:0002690),1/54,0.42556360830808415,0.4785838822301122,0,0,1.835021842178641,1.5677341229946478,HMGB1
protein sumoylation (GO:0016925),1/55,0.4314387106959538,0.483069900664486,0,0,1.8009487319832147,1.5139312017895978,RANBP2
protein targeting to mitochondrion (GO:0006626),1/55,0.4314387106959538,0.483069900664486,0,0,1.8009487319832147,1.5139312017895978,FBXO7
regulation of cardiac conduction (GO:1903779),1/55,0.4314387106959538,0.483069900664486,0,0,1.8009487319832147,1.5139312017895978,ATP2B4
regulation of gene silencing by RNA (GO:0060966),1/55,0.4314387106959538,0.483069900664486,0,0,1.8009487319832147,1.5139312017895978,RANBP2
regulation of posttranscriptional gene silencing (GO:0060147),1/55,0.4314387106959538,0.483069900664486,0,0,1.8009487319832147,1.5139312017895978,RANBP2
glycoprotein metabolic process (GO:0009100),1/55,0.4314387106959538,0.483069900664486,0,0,1.8009487319832147,1.5139312017895978,STT3B
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/55,0.4314387106959538,0.483069900664486,0,0,1.8009487319832147,1.5139312017895978,SNCA
negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/55,0.4314387106959538,0.483069900664486,0,0,1.8009487319832147,1.5139312017895978,H2BC11
protein-containing complex disassembly (GO:0032984),1/56,0.4372540163040096,0.4877155576521044,0,0,1.768114643976713,1.462656890399588,CTNNB1
regulation of ATP metabolic process (GO:1903578),1/56,0.4372540163040096,0.4877155576521044,0,0,1.768114643976713,1.462656890399588,RANBP2
chemokine-mediated signaling pathway (GO:0070098),1/56,0.4372540163040096,0.4877155576521044,0,0,1.768114643976713,1.462656890399588,WNK1
tight junction assembly (GO:0120192),1/56,0.4372540163040096,0.4877155576521044,0,0,1.768114643976713,1.462656890399588,ACTG1
negative regulation of metabolic process (GO:0009892),1/56,0.4372540163040096,0.4877155576521044,0,0,1.768114643976713,1.462656890399588,LNPEP
peptidyl-tyrosine modification (GO:0018212),1/56,0.4372540163040096,0.4877155576521044,0,0,1.768114643976713,1.462656890399588,FLT3
positive regulation of interleukin-1 beta production (GO:0032731),1/56,0.4372540163040096,0.4877155576521044,0,0,1.768114643976713,1.462656890399588,IFI16
regulation of ERK1 and ERK2 cascade (GO:0070372),3/238,0.43870622723485225,0.4890691292732385,0,0,1.2423626548110511,1.0236139934625388,CD74;HMGB1;HLA-DRB1
regulation of reactive oxygen species metabolic process (GO:2000377),1/57,0.4430101308617841,0.49333030333467154,0,0,1.7364532019704433,1.4137553239097946,SNCA
renal system development (GO:0072001),1/57,0.4430101308617841,0.49333030333467154,0,0,1.7364532019704433,1.4137553239097946,MME
axonogenesis (GO:0007409),3/240,0.44406162842614355,0.49423263261551775,0,0,1.2317526292587695,0.9999268360842835,GAB1;SPTAN1;SPTB
regulation of cytosolic calcium ion concentration (GO:0051480),2/148,0.4468750863045864,0.4968242278014636,0,0,1.3325647633256477,1.0733491650449698,ATP2B4;HMGB1
positive regulation of intracellular protein transport (GO:0090316),2/148,0.4468750863045864,0.4968242278014636,0,0,1.3325647633256477,1.0733491650449698,UBE2D3;PMAIP1
regulation of nucleic acid-templated transcription (GO:1903506),5/430,0.44729366013767635,0.4970199076041751,0,0,1.145196571090748,0.9213563831914012,NONO;MYB;YBX1;SSBP2;SOX4
chordate embryonic development (GO:0043009),1/58,0.4487076537970958,0.4973756637981038,0,0,1.7059026877538674,1.3670826221326327,ADAM10
negative regulation of hydrolase activity (GO:0051346),1/58,0.4487076537970958,0.4973756637981038,0,0,1.7059026877538674,1.3670826221326327,WNK1
negative regulation of neuron projection development (GO:0010977),1/58,0.4487076537970958,0.4973756637981038,0,0,1.7059026877538674,1.3670826221326327,RHOA
positive regulation of protein binding (GO:0032092),1/58,0.4487076537970958,0.4973756637981038,0,0,1.7059026877538674,1.3670826221326327,EPB41
intracellular protein transport (GO:0006886),4/336,0.4488275267753508,0.4973756637981038,0,0,1.1725301204819276,0.9393333347063175,CD74;XPO1;TMED10;STRADB
regulation of cytokine production (GO:0001817),2/150,0.4537156335924866,0.5021345032609067,0,0,1.3144233342253144,1.0387685648061473,IFI16;HLA-DRB1
fatty acid oxidation (GO:0019395),1/59,0.4543471786460327,0.5021345032609067,0,0,1.6764056395447597,1.3225057848311041,ADIPOR1
selective autophagy (GO:0061912),1/59,0.4543471786460327,0.5021345032609067,0,0,1.6764056395447597,1.3225057848311041,UBB
negative regulation of autophagy (GO:0010507),1/59,0.4543471786460327,0.5021345032609067,0,0,1.6764056395447597,1.3225057848311041,SNCA
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/59,0.4543471786460327,0.5021345032609067,0,0,1.6764056395447597,1.3225057848311041,FLT3
apical junction assembly (GO:0043297),1/60,0.4599292929145131,0.5077559920160762,0,0,1.6479084912749435,1.2799017071578913,RHOA
peptidyl-threonine phosphorylation (GO:0018107),1/60,0.4599292929145131,0.5077559920160762,0,0,1.6479084912749435,1.2799017071578913,WNK1
actin filament organization (GO:0007015),2/152,0.46050793067617574,0.5081210285166851,0,0,1.2967656765676567,1.0055447861209454,TPM4;RHOA
B cell differentiation (GO:0030183),1/61,0.46545457817068164,0.5127507691783476,0,0,1.620361247947455,1.2391562978337145,FLT3
regulation of endocytosis (GO:0030100),1/61,0.46545457817068164,0.5127507691783476,0,0,1.620361247947455,1.2391562978337145,SNCA
protein lipidation (GO:0006497),1/61,0.46545457817068164,0.5127507691783476,0,0,1.620361247947455,1.2391562978337145,GLUL
cellular response to interleukin-1 (GO:0071347),2/155,0.47060403040494064,0.51794013816753,0,0,1.2711447615349771,0.9581104132207141,UBB;RBMX
glucose metabolic process (GO:0006006),1/62,0.47092361025188306,0.51794013816753,0,0,1.5937171929257854,1.2001636882459743,ENO1
I-kappaB kinase/NF-kappaB signaling (GO:0007249),1/62,0.47092361025188306,0.51794013816753,0,0,1.5937171929257854,1.2001636882459743,UBB
peptidyl-serine phosphorylation (GO:0018105),2/156,0.4739443696345963,0.5209828397968281,0,0,1.2628262826282628,0.9429086002917817,PRKCB;WNK1
positive regulation of signal transduction (GO:0009967),3/252,0.47575444295055397,0.5213752291015488,0,0,1.17167176167356,0.8703803916974908,CD74;XBP1;PRKCB
cellular response to reactive oxygen species (GO:0034614),1/63,0.4763369589448996,0.5213752291015488,0,0,1.5679326235499762,1.16282552391197,JUN
COPII vesicle coating (GO:0048208),1/63,0.4763369589448996,0.5213752291015488,0,0,1.5679326235499762,1.16282552391197,TMED10
vesicle coating (GO:0006901),1/63,0.4763369589448996,0.5213752291015488,0,0,1.5679326235499762,1.16282552391197,TMED10
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/63,0.4763369589448996,0.5213752291015488,0,0,1.5679326235499762,1.16282552391197,TMED10
monocarboxylic acid biosynthetic process (GO:0072330),1/63,0.4763369589448996,0.5213752291015488,0,0,1.5679326235499762,1.16282552391197,XBP1
negative regulation of endopeptidase activity (GO:0010951),1/63,0.4763369589448996,0.5213752291015488,0,0,1.5679326235499762,1.16282552391197,IFI16
organonitrogen compound catabolic process (GO:1901565),1/63,0.4763369589448996,0.5213752291015488,0,0,1.5679326235499762,1.16282552391197,LNPEP
skeletal system development (GO:0001501),2/158,0.4805869439518958,0.525555612985012,0,0,1.2465092663112465,0.9133760776743718,PRDX1;SOX4
protein secretion (GO:0009306),1/64,0.48169518847528187,0.525555612985012,0,0,1.5429666119321293,1.1270503243615253,CANX
regulation of cilium assembly (GO:1902017),1/64,0.48169518847528187,0.525555612985012,0,0,1.5429666119321293,1.1270503243615253,CYLD
regulation of extrinsic apoptotic signaling pathway (GO:2001236),1/64,0.48169518847528187,0.525555612985012,0,0,1.5429666119321293,1.1270503243615253,CYLD
lipid homeostasis (GO:0055088),1/64,0.48169518847528187,0.525555612985012,0,0,1.5429666119321293,1.1270503243615253,XBP1
negative regulation of cell cycle process (GO:0010948),1/64,0.48169518847528187,0.525555612985012,0,0,1.5429666119321293,1.1270503243615253,CBX5
cellular component disassembly (GO:0022411),1/66,0.49224851847187423,0.5356437675777325,0,0,1.4953391436150056,1.0598538742581958,ADAM10
cellular response to nutrient levels (GO:0031669),1/66,0.49224851847187423,0.5356437675777325,0,0,1.4953391436150056,1.0598538742581958,XBP1
regulation of protein localization (GO:0032880),1/66,0.49224851847187423,0.5356437675777325,0,0,1.4953391436150056,1.0598538742581958,PARP1
extracellular matrix disassembly (GO:0022617),1/66,0.49224851847187423,0.5356437675777325,0,0,1.4953391436150056,1.0598538742581958,ADAM10
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),1/66,0.49224851847187423,0.5356437675777325,0,0,1.4953391436150056,1.0598538742581958,FHL1
protein N-linked glycosylation (GO:0006487),1/67,0.49744471908584614,0.5407237291283282,0,0,1.4726078519181967,1.0282791305452124,STT3B
peptidyl-threonine modification (GO:0018210),1/67,0.49744471908584614,0.5407237291283282,0,0,1.4726078519181967,1.0282791305452124,WNK1
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/68,0.5025880008538223,0.5454464055876493,0,0,1.450555106242188,0.9979594705476131,FLT3
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1/68,0.5025880008538223,0.5454464055876493,0,0,1.450555106242188,0.9979594705476131,UBB
positive regulation of protein localization to nucleus (GO:1900182),1/68,0.5025880008538223,0.5454464055876493,0,0,1.450555106242188,0.9979594705476131,TFRC
cellular response to calcium ion (GO:0071277),1/69,0.5076789002266886,0.549516147155037,0,0,1.429150970733121,0.9688301857799617,IQGAP1
RNA 3'-end processing (GO:0031123),1/69,0.5076789002266886,0.549516147155037,0,0,1.429150970733121,0.9688301857799617,SRSF5
peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.5076789002266886,0.549516147155037,0,0,1.429150970733121,0.9688301857799617,FLT3
positive regulation of MAP kinase activity (GO:0043406),1/69,0.5076789002266886,0.549516147155037,0,0,1.429150970733121,0.9688301857799617,FLT3
positive regulation of protein polymerization (GO:0032273),1/69,0.5076789002266886,0.549516147155037,0,0,1.429150970733121,0.9688301857799617,NCKAP1L
COPII-coated vesicle budding (GO:0090114),1/70,0.5127179480188168,0.5540923393937529,0,0,1.4083672449489542,0.9408307170908768,TMED10
regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/70,0.5127179480188168,0.5540923393937529,0,0,1.4083672449489542,0.9408307170908768,CYLD
establishment of protein localization to membrane (GO:0090150),1/70,0.5127179480188168,0.5540923393937529,0,0,1.4083672449489542,0.9408307170908768,SYNE3
negative regulation of signal transduction (GO:0009968),3/267,0.5141654250832649,0.5553637090119187,0,0,1.1042514699231116,0.7345593705558227,UBASH3B;PRKCB;SNCA
regulation of glycolytic process (GO:0006110),1/71,0.5177056697987945,0.5565471759799212,0,0,1.3881773399014778,0.9139043351296697,RANBP2
regulation of hematopoietic stem cell differentiation (GO:1902036),1/71,0.5177056697987945,0.5565471759799212,0,0,1.3881773399014778,0.9139043351296697,MYB
cholesterol homeostasis (GO:0042632),1/71,0.5177056697987945,0.5565471759799212,0,0,1.3881773399014778,0.9139043351296697,XBP1
fatty acid biosynthetic process (GO:0006633),1/71,0.5177056697987945,0.5565471759799212,0,0,1.3881773399014778,0.9139043351296697,XBP1
gland development (GO:0048732),1/71,0.5177056697987945,0.5565471759799212,0,0,1.3881773399014778,0.9139043351296697,XBP1
histone acetylation (GO:0016573),1/71,0.5177056697987945,0.5565471759799212,0,0,1.3881773399014778,0.9139043351296697,LEF1
response to metal ion (GO:0010038),1/71,0.5177056697987945,0.5565471759799212,0,0,1.3881773399014778,0.9139043351296697,SNCA
phosphatidylinositol-mediated signaling (GO:0048015),1/71,0.5177056697987945,0.5565471759799212,0,0,1.3881773399014778,0.9139043351296697,RHOA
positive regulation of cellular protein localization (GO:1903829),1/71,0.5177056697987945,0.5565471759799212,0,0,1.3881773399014778,0.9139043351296697,TFRC
cell morphogenesis involved in differentiation (GO:0000904),1/72,0.5226425858065477,0.5603844365869263,0,0,1.3685561645736488,0.8879978506396441,RHOA
extrinsic apoptotic signaling pathway (GO:0097191),1/72,0.5226425858065477,0.5603844365869263,0,0,1.3685561645736488,0.8879978506396441,IFI27
response to ionizing radiation (GO:0010212),1/72,0.5226425858065477,0.5603844365869263,0,0,1.3685561645736488,0.8879978506396441,IFI16
sterol homeostasis (GO:0055092),1/72,0.5226425858065477,0.5603844365869263,0,0,1.3685561645736488,0.8879978506396441,XBP1
negative regulation of epithelial cell proliferation (GO:0050680),1/72,0.5226425858065477,0.5603844365869263,0,0,1.3685561645736488,0.8879978506396441,CDK6
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",1/73,0.5275292110242672,0.564442482187323,0,0,1.349480021893815,0.8630613498633677,HLA-E
insulin receptor signaling pathway (GO:0008286),1/73,0.5275292110242672,0.564442482187323,0,0,1.349480021893815,0.8630613498633677,GAB1
neurotransmitter transport (GO:0006836),1/73,0.5275292110242672,0.564442482187323,0,0,1.349480021893815,0.8630613498633677,GLUL
positive regulation of JNK cascade (GO:0046330),1/73,0.5275292110242672,0.564442482187323,0,0,1.349480021893815,0.8630613498633677,HMGB1
rRNA processing (GO:0006364),2/173,0.5287271931923327,0.5654290286279173,0,0,1.1362978403103468,0.7241429363536288,RIOK3;RPL15
mitotic nuclear division (GO:0140014),1/74,0.5323660552540482,0.5690234988083176,0,0,1.330926513260004,0.8390479529350536,RHOA
regulation of hematopoietic progenitor cell differentiation (GO:1901532),1/75,0.5371536231783908,0.5729452232652382,0,0,1.3128744508054853,0.8159135930450523,MYB
fibroblast growth factor receptor signaling pathway (GO:0008543),1/75,0.5371536231783908,0.5729452232652382,0,0,1.3128744508054853,0.8159135930450523,HNRNPA1
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),1/75,0.5371536231783908,0.5729452232652382,0,0,1.3128744508054853,0.8159135930450523,UBB
integrin-mediated signaling pathway (GO:0007229),1/75,0.5371536231783908,0.5729452232652382,0,0,1.3128744508054853,0.8159135930450523,ADAM10
positive regulation of developmental process (GO:0051094),2/177,0.5410475030372192,0.5764992507420426,0,0,1.1100990099009902,0.6818763164406008,XBP1;TFRC
regulation of BMP signaling pathway (GO:0030510),1/76,0.5418924143138966,0.5764992507420426,0,0,1.295303776683087,0.7936168145600232,UBE2D3
establishment of protein localization to organelle (GO:0072594),1/76,0.5418924143138966,0.5764992507420426,0,0,1.295303776683087,0.7936168145600232,HK1
positive regulation of growth (GO:0045927),1/76,0.5418924143138966,0.5764992507420426,0,0,1.295303776683087,0.7936168145600232,ADAM10
protein import into nucleus (GO:0006606),1/76,0.5418924143138966,0.5764992507420426,0,0,1.295303776683087,0.7936168145600232,RANBP2
negative regulation of immune response (GO:0050777),2/178,0.5440927520490011,0.5785397244153624,0,0,1.1037353735373536,0.6717725823411169,IFI16;HLA-DRB1
regulation of organelle assembly (GO:1902115),1/77,0.546582923190177,0.5799836404022126,0,0,1.2781954887218046,0.7721185874812032,CYLD
import into nucleus (GO:0051170),1/77,0.546582923190177,0.5799836404022126,0,0,1.2781954887218046,0.7721185874812032,HNRNPA1
inorganic cation import across plasma membrane (GO:0098659),1/77,0.546582923190177,0.5799836404022126,0,0,1.2781954887218046,0.7721185874812032,ATP2B4
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/77,0.546582923190177,0.5799836404022126,0,0,1.2781954887218046,0.7721185874812032,UBB
protein stabilization (GO:0050821),2/179,0.5471239973414388,0.5802572828947247,0,0,1.0974436426693517,0.6618461101658054,AHSP;SOX4
negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.5512256393643044,0.5843048810436936,0,0,1.2615315718763995,0.7513821376074742,MACROH2A1
regulation of cellular response to heat (GO:1900034),1/79,0.5558210474474341,0.5876559990814203,0,0,1.2452949349501075,0.7313727905105102,RANBP2
regulation of neuron differentiation (GO:0045664),1/79,0.5558210474474341,0.5876559990814203,0,0,1.2452949349501075,0.7313727905105102,RHOA
negative regulation of NF-kappaB transcription factor activity (GO:0032088),1/79,0.5558210474474341,0.5876559990814203,0,0,1.2452949349501075,0.7313727905105102,CYLD
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/79,0.5558210474474341,0.5876559990814203,0,0,1.2452949349501075,0.7313727905105102,MDM2
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.5558210474474341,0.5876559990814203,0,0,1.2452949349501075,0.7313727905105102,MDM2
regulation of fat cell differentiation (GO:0045598),1/80,0.5603696271317814,0.5903328359861285,0,0,1.2294693521232152,0.7120578280679314,XBP1
regulation of organelle organization (GO:0033043),1/80,0.5603696271317814,0.5903328359861285,0,0,1.2294693521232152,0.7120578280679314,ZEB2
regulation of protein localization to plasma membrane (GO:1903076),1/80,0.5603696271317814,0.5903328359861285,0,0,1.2294693521232152,0.7120578280679314,ATP2B4
glycerophospholipid metabolic process (GO:0006650),1/80,0.5603696271317814,0.5903328359861285,0,0,1.2294693521232152,0.7120578280679314,SERINC1
skin development (GO:0043588),1/80,0.5603696271317814,0.5903328359861285,0,0,1.2294693521232152,0.7120578280679314,STMN1
lipid biosynthetic process (GO:0008610),1/80,0.5603696271317814,0.5903328359861285,0,0,1.2294693521232152,0.7120578280679314,XBP1
positive regulation of cell adhesion (GO:0045785),1/80,0.5603696271317814,0.5903328359861285,0,0,1.2294693521232152,0.7120578280679314,NCKAP1L
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),1/81,0.5648718532398892,0.5947700037453921,0,0,1.214039408866995,0.6934063563563992,SNCA
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/82,0.5693281958757586,0.598539493765741,0,0,1.198990451864015,0.6753891837108899,CCND3
positive regulation of cytoskeleton organization (GO:0051495),1/82,0.5693281958757586,0.598539493765741,0,0,1.198990451864015,0.6753891837108899,NCKAP1L
positive regulation of protein ubiquitination (GO:0031398),1/82,0.5693281958757586,0.598539493765741,0,0,1.198990451864015,0.6753891837108899,UBB
regulation of interleukin-1 beta production (GO:0032651),1/83,0.5737391203654282,0.6025584098558495,0,0,1.184308542592815,0.6579787086959046,IFI16
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),1/83,0.5737391203654282,0.6025584098558495,0,0,1.184308542592815,0.6579787086959046,DOCK11
anaphase-promoting complex-dependent catabolic process (GO:0031145),1/84,0.5781050874123935,0.6062115271791169,0,0,1.169980414267909,0.6411488162293543,UBB
regulation of cytokinesis (GO:0032465),1/84,0.5781050874123935,0.6062115271791169,0,0,1.169980414267909,0.6411488162293543,RHOA
spindle assembly (GO:0051225),1/84,0.5781050874123935,0.6062115271791169,0,0,1.169980414267909,0.6411488162293543,RHOA
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",1/85,0.5824265529590874,0.6101186129924183,0,0,1.1559934318555007,0.6248747821778563,RHOA
negative regulation of defense response (GO:0031348),1/85,0.5824265529590874,0.6101186129924183,0,0,1.1559934318555007,0.6248747821778563,IFI16
regulation of Ras protein signal transduction (GO:0046578),1/86,0.5867039682621468,0.6136582087642362,0,0,1.1423355549116199,0.6091331846749747,ARHGDIB
positive regulation of endothelial cell migration (GO:0010595),1/86,0.5867039682621468,0.6136582087642362,0,0,1.1423355549116199,0.6091331846749747,HMGB1
positive regulation of proteasomal protein catabolic process (GO:1901800),1/86,0.5867039682621468,0.6136582087642362,0,0,1.1423355549116199,0.6091331846749747,MDM2
negative regulation of macromolecule metabolic process (GO:0010605),2/194,0.5908949655405661,0.6171414433567081,0,0,1.0109323432343233,0.5318686922848505,ATP2B4;ADAM10
calcium ion transmembrane transport (GO:0070588),1/87,0.590937780315208,0.6171414433567081,0,0,1.1289953030129454,0.5939018213529518,ATP2B4
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/87,0.590937780315208,0.6171414433567081,0,0,1.1289953030129454,0.5939018213529518,UBB
protein localization to membrane (GO:0072657),2/195,0.5936990853521114,0.6197093356528152,0,0,1.0056430513517673,0.5243248675235763,ANK1;SYNE3
regulation of establishment of planar polarity (GO:0090175),1/88,0.5951284313607962,0.6208850080744762,0,0,1.1159617235717116,0.5791596343779737,RHOA
regulation of endothelial cell migration (GO:0010594),1/89,0.5992763593423178,0.6248942800470275,0,0,1.1032243618450515,0.5648866391518002,GLUL
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),1/90,0.6033819975315803,0.6288553982412045,0,0,1.0907732329661814,0.5510638596451592,RPL15
endomembrane system organization (GO:0010256),2/199,0.6047726195311269,0.6299842894861611,0,0,0.9850228677690104,0.4953706864380774,SUN2;TMED10
positive regulation of supramolecular fiber organization (GO:1902905),1/91,0.6074457751178958,0.6321261519637219,0,0,1.078598795840175,0.5376732665837451,NCKAP1L
positive regulation of transport (GO:0051050),1/91,0.6074457751178958,0.6321261519637219,0,0,1.078598795840175,0.5376732665837451,SNCA
regulation of endothelial cell proliferation (GO:0001936),1/92,0.6114681168037448,0.635021881059743,0,0,1.0666919287608942,0.5246977217405681,HMGB2
cellular response to fibroblast growth factor stimulus (GO:0044344),1/92,0.6114681168037448,0.635021881059743,0,0,1.0666919287608942,0.5246977217405681,HNRNPA1
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.6114681168037448,0.635021881059743,0,0,1.0666919287608942,0.5246977217405681,CD74
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),1/92,0.6114681168037448,0.635021881059743,0,0,1.0666919287608942,0.5246977217405681,ZEB2
regulation of heart contraction (GO:0008016),1/93,0.6154494429425392,0.6388327804403561,0,0,1.0550439066181194,0.512120925139783,ATP2B4
cotranslational protein targeting to membrane (GO:0006613),1/94,0.6193901697982895,0.641947626664995,0,0,1.0436463795751894,0.4999273656894242,RPL15
interleukin-1-mediated signaling pathway (GO:0070498),1/94,0.6193901697982895,0.641947626664995,0,0,1.0436463795751894,0.4999273656894242,UBB
negative regulation of MAPK cascade (GO:0043409),1/94,0.6193901697982895,0.641947626664995,0,0,1.0436463795751894,0.4999273656894242,PPIA
regulation of cell cycle phase transition (GO:1901987),1/95,0.6232907094449534,0.6456636317758895,0,0,1.0324913531076407,0.48810227578104776,ATP2B4
cilium assembly (GO:0060271),3/314,0.6239419467944713,0.6460116467821485,0,0,0.9351154196861352,0.4410920254730225,TUBA1A;TUBB;SEPTIN6
translational termination (GO:0006415),1/96,0.6271514694656477,0.6490067479470264,0,0,1.0215711693025669,0.4766315892635776,GSPT1
regulation of MAP kinase activity (GO:0043405),1/97,0.630972853879322,0.6523024104938098,0,0,1.0108784893267653,0.4655019002333899,FLT3
positive regulation of cold-induced thermogenesis (GO:0120162),1/97,0.630972853879322,0.6523024104938098,0,0,1.0108784893267653,0.4655019002333899,ADIPOR1
positive regulation of stress-activated MAPK cascade (GO:0032874),1/99,0.6384990897421888,0.659750194090643,0,0,0.9901477832512315,0.4442149795816084,HMGB1
positive regulation of GTPase activity (GO:0043547),2/214,0.6442666337785419,0.6653741595827783,0,0,0.9146273117877826,0.402109139407083,DOCK11;DOCK8
epithelial cell differentiation (GO:0030855),1/101,0.6458725659307989,0.6663609705902351,0,0,0.9702463054187193,0.42414614235723147,PCNA
positive regulation of cell cycle process (GO:0090068),1/101,0.6458725659307989,0.6663609705902351,0,0,0.9702463054187193,0.42414614235723147,RHOA
mitotic sister chromatid segregation (GO:0000070),1/102,0.6495029858079479,0.6694324033805258,0,0,0.9605911330049262,0.41454103413818844,SET
positive regulation of cell growth (GO:0030307),1/102,0.6495029858079479,0.6694324033805258,0,0,0.9605911330049262,0.41454103413818844,ADAM10
chromatin remodeling (GO:0006338),1/103,0.6530963680326702,0.6727976159371247,0,0,0.9511252776972858,0.40520845676197886,MYB
cellular metal ion homeostasis (GO:0006875),1/104,0.6566530885378662,0.6754428606496424,0,0,0.9418432254053278,0.3961387176192002,ATP2B4
regulation of insulin secretion (GO:0050796),1/104,0.6566530885378662,0.6754428606496424,0,0,0.9418432254053278,0.3961387176192002,SOX4
translational elongation (GO:0006414),1/104,0.6566530885378662,0.6754428606496424,0,0,0.9418432254053278,0.3961387176192002,EEF1A1
regulation of cell cycle process (GO:0010564),1/106,0.6636580296214016,0.6816217056111539,0,0,0.9238095238095239,0.37875107568395955,CTNNB1
small GTPase mediated signal transduction (GO:0007264),1/106,0.6636580296214016,0.6816217056111539,0,0,0.9238095238095239,0.37875107568395955,JUN
peptidyl-lysine modification (GO:0018205),1/106,0.6636580296214016,0.6816217056111539,0,0,0.9238095238095239,0.37875107568395955,RANBP2
response to calcium ion (GO:0051592),1/107,0.6671069833804473,0.6848207459651987,0,0,0.9150478669021285,0.3704158154696593,IQGAP1
cellular divalent inorganic cation homeostasis (GO:0072503),1/111,0.6805544022142898,0.6975767734552675,0,0,0.8815942678011643,0.3392793637414093,ATP2B4
Fc-epsilon receptor signaling pathway (GO:0038095),1/111,0.6805544022142898,0.6975767734552675,0,0,0.8815942678011643,0.3392793637414093,JUN
regulation of Wnt signaling pathway (GO:0030111),1/111,0.6805544022142898,0.6975767734552675,0,0,0.8815942678011643,0.3392793637414093,CTNNB1
inflammatory response (GO:0006954),2/230,0.6829054345415613,0.6996366176878295,0,0,0.8497481327080076,0.3240929903563301,CIITA;HMGB1
regulation of macroautophagy (GO:0016241),1/112,0.6838309179378819,0.6998848905368231,0,0,0.8736075977455288,0.33200983948443946,BNIP3L
Fc receptor signaling pathway (GO:0038093),1/112,0.6838309179378819,0.6998848905368231,0,0,0.8736075977455288,0.33200983948443946,JUN
positive regulation of metabolic process (GO:0009893),1/113,0.6870739896988246,0.7028530229120777,0,0,0.8657635467980296,0.32493256757983624,ADIPOR1
histone modification (GO:0016570),1/114,0.6902839571136331,0.7054323332298426,0,0,0.8580583286106631,0.3180412364002841,UHRF1
negative regulation of cell motility (GO:2000146),1/114,0.6902839571136331,0.7054323332298426,0,0,0.8580583286106631,0.3180412364002841,CD74
calcium ion transport (GO:0006816),1/115,0.6934611567050838,0.7079730493715579,0,0,0.85048828968974155,0.3113297869665344,ATP2B4
cellular amide metabolic process (GO:0043603),1/115,0.6934611567050838,0.7079730493715579,0,0,0.85048828968974155,0.3113297869665344,MME
positive regulation of cell projection organization (GO:0031346),1/117,0.6997185798066738,0.7140056623624875,0,0,0.8357397655851877,0.2984234930895692,RHOA
regulation of cellular response to stress (GO:0080135),1/118,0.7027994590817185,0.7160796079853015,0,0,0.8285545871752769,0.2922176911029681,RANBP2
regulation of protein binding (GO:0043393),1/118,0.7027994590817185,0.7160796079853015,0,0,0.8285545871752769,0.2922176911029681,EPB41
negative regulation of response to external stimulus (GO:0032102),1/118,0.7027994590817185,0.7160796079853015,0,0,0.8285545871752769,0.2922176911029681,IFI16
protein homooligomerization (GO:0051260),1/121,0.7118546328511061,0.724945398962185,0,0,0.8077175697865353,0.2745283042330094,RBMX
epithelium development (GO:0060429),1/122,0.7148115906560267,0.7275951064352703,0,0,0.8010015063306599,0.26892526647833204,PCNA
regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.7177383510950146,0.7302114604735278,0,0,0.7943955422757005,0.26346143242392106,CTNNB1
platelet degranulation (GO:0002576),1/125,0.7235025043008155,0.735710487003658,0,0,0.7815032575877959,0.25293452303650155,CD9
circulatory system development (GO:0072359),1/126,0.726340501524213,0.7374983585842976,0,0,0.7752118226600985,0.24786340930900425,SOX4
synapse organization (GO:0050808),1/126,0.726340501524213,0.7374983585842976,0,0,0.7752118226600985,0.24786340930900425,SNCA
phosphatidylinositol biosynthetic process (GO:0006661),1/126,0.726340501524213,0.7374983585842976,0,0,0.7752118226600985,0.24786340930900425,SOCS2
Golgi organization (GO:0007030),1/130,0.7374055386466193,0.7479920538054073,0,0,0.7510214992171689,0.22877412793716959,TMED10
protein glycosylation (GO:0006486),1/130,0.7374055386466193,0.7479920538054073,0,0,0.7510214992171689,0.22877412793716959,STT3B
protein localization to plasma membrane (GO:0072659),1/136,0.7531737626902507,0.7628537022997152,0,0,0.7174238277686553,0.20336046840431216,ANK1
cellular calcium ion homeostasis (GO:0006874),1/136,0.7531737626902507,0.7628537022997152,0,0,0.7174238277686553,0.20336046840431216,ATP2B4
negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.7531737626902507,0.7628537022997152,0,0,0.7174238277686553,0.20336046840431216,HLA-DRB1
regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.7557086120750207,0.7650429575798999,0,0,0.7121124311793683,0.19946227244262016,HLA-DRB1
enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.7631587739219468,0.7718224717502807,0,0,0.6966367792465535,0.1882933822215555,FLT3
protein localization to cell periphery (GO:1990778),1/140,0.7631587739219468,0.7718224717502807,0,0,0.6966367792465535,0.1882933822215555,ANK1
negative regulation of DNA-binding transcription factor activity (GO:0043433),1/143,0.770382806068739,0.7787441389417101,0,0,0.6818150280996322,0.17786354338812732,CYLD
plasma membrane bounded cell projection assembly (GO:0120031),2/278,0.7786034009959798,0.7866658622488968,0,0,0.700243937437222,0.17523847919825508,SEPTIN6;ARHGEF6
positive regulation of cytosolic calcium ion concentration (GO:0007204),1/147,0.7796748679995761,0.7873601796604885,0,0,0.6630002024428099,0.16500635141373848,HMGB1
dephosphorylation (GO:0016311),1/153,0.792915931591639,0.8003373122321519,0,0,0.6366346901737101,0.1477234886815731,SSH2
regulation of signal transduction by p53 class mediator (GO:1901796),1/156,0.7992364104414724,0.8063197464276597,0,0,0.6242173843953599,0.13988617581850066,MDM2
organonitrogen compound biosynthetic process (GO:1901566),1/158,0.8033430375452021,0.8100639192569484,0,0,0.6162028176084842,0.13493206383868386,ALAS2
protein autophosphorylation (GO:0046777),1/159,0.8053648948460583,0.8117032314508478,0,0,0.6122716218744154,0.13253220429264387,FLT3
rRNA metabolic process (GO:0016072),1/162,0.811307189078891,0.8172902804437796,0,0,0.6007710430499036,0.1256263427314118,RPL15
heart development (GO:0007507),1/164,0.8151680667524497,0.8207761025925157,0,0,0.5933391761612621,0.12125536965459918,SOX4
regulation of neuron projection development (GO:0010975),1/165,0.8170689228827797,0.8218822891442393,0,0,0.5896912171092155,0.11913639380904953,FBXO7
negative regulation of canonical Wnt signaling pathway (GO:0090090),1/165,0.8170689228827797,0.8218822891442393,0,0,0.5896912171092155,0.11913639380904953,CYLD
nervous system development (GO:0007399),3/447,0.8375403215123616,0.8420609022467266,0,0,0.6505311281430685,0.11532997789474675,ZEB2;DPYSL2;NAV1
negative regulation of Wnt signaling pathway (GO:0030178),1/191,0.860208618735354,0.8644273956786367,0,0,0.5083225304640913,0.07654337907426711,CYLD
ncRNA processing (GO:0034470),1/201,0.8739584675789636,0.8778141667006354,0,0,0.4826600985221675,0.06502513862837575,RPL15
negative regulation of inflammatory response (GO:0050728),1/212,0.887533287229897,0.8905757617698623,0,0,0.4572409123806411,0.05455307105612747,HLA-DRB1
phosphate-containing compound metabolic process (GO:0006796),1/212,0.887533287229897,0.8905757617698623,0,0,0.4572409123806411,0.05455307105612747,HK1
cilium organization (GO:0044782),1/228,0.9047226118859699,0.907379653330569,0,0,0.4246652633406393,0.042520411458821024,SEPTIN6
anterograde trans-synaptic signaling (GO:0098916),1/244,0.9192955731320221,0.9215443392111121,0,0,0.39637941170508223,0.03335436968416536,SNCA
organelle assembly (GO:0070925),2/425,0.9330651806786368,0.9348902470467124,0,0,0.45345598389626196,0.03141552995421811,DDX6;SEPTIN6
central nervous system development (GO:0007417),1/268,0.9371002100532335,0.9384742572820506,0,0,0.36030700540580435,0.023407364314968107,SOX4
inorganic cation transmembrane transport (GO:0098662),1/274,0.9409028376433864,0.9418221369473858,0,0,0.3522799040040419,0.021459270944480545,ATP2B4
extracellular matrix organization (GO:0030198),1/300,0.9549064995347545,0.9553727624739804,0,0,0.3212185116233092,0.014821616233063837,ADAM10
chemical synaptic transmission (GO:0007268),1/306,0.9576369137467406,0.9576369137467406,0,0,0.3148025518856497,0.013626724993709103,SNCA
